1 00:00:05,640 --> 00:00:10,080 >>WELCOME TO THE 143 RD 2 00:00:10,080 --> 00:00:14,080 NATIONAL ADVISORY COUNCIL ON THE 3 00:00:14,080 --> 00:00:17,440 DRUG ABUSE AND IT'S REQUIRED AS 4 00:00:17,440 --> 00:00:18,640 MANY ADVISORY MEETINGS AS 5 00:00:18,640 --> 00:00:21,720 POSSIBLE BE OPEN TO THE PUBLIC. 6 00:00:21,720 --> 00:00:23,240 THIS INCLUDES MEETINGS OF THE 7 00:00:23,240 --> 00:00:24,000 NATIONAL ADVISORY COUNCIL AND 8 00:00:24,000 --> 00:00:25,680 DRUG ABUSE. 9 00:00:25,680 --> 00:00:26,800 TODAY'S MEETING IS OPEN TO THE 10 00:00:26,800 --> 00:00:29,600 PUBLIC AND BEING VIDEOCAST AND 11 00:00:29,600 --> 00:00:29,880 RECORDED. 12 00:00:29,880 --> 00:00:31,640 MINUTES OF THE MEETING WILL BE 13 00:00:31,640 --> 00:00:36,520 AVAILABLE ON THE NIDA HOME PAGE 14 00:00:36,520 --> 00:00:37,880 IN ACCORDANCE WITH THE OPEN 15 00:00:37,880 --> 00:00:41,600 COUNCIL MEETING POSTED ON THE 16 00:00:41,600 --> 00:00:42,440 NIH VIDEOCAST SITE. 17 00:00:42,440 --> 00:00:45,080 MEMBERS OF THE PUBLIC WHO WISH 18 00:00:45,080 --> 00:00:48,160 TO EXPRESS VIEWS REGARDING ANY 19 00:00:48,160 --> 00:00:50,480 ITEMS DISCUSSED DURING THE 20 00:00:50,480 --> 00:00:55,360 MEETING MAY WRITE SUSAN WEISS 21 00:00:55,360 --> 00:00:59,560 THE EXECUTIVE SECRETARY WITHIN 22 00:00:59,560 --> 00:01:00,920 10 DAYS OF THE MEETING. 23 00:01:00,920 --> 00:01:04,600 ANY LETTERS FROM THE PUBLIC WILL 24 00:01:04,600 --> 00:01:06,000 RECEIVE CAREFUL CORRECTIONS. 25 00:01:06,000 --> 00:01:07,520 ARE THERE AMENDMENTS OR 26 00:01:07,520 --> 00:01:09,480 CORRECTIONS TO THE MEETING OF 27 00:01:09,480 --> 00:01:10,600 THE SEPTEMBER COUNCIL MEETING 28 00:01:10,600 --> 00:01:13,360 THAT FOR WHICH YOU HAVE IN YOUR 29 00:01:13,360 --> 00:01:16,400 ELECTRONIC COUNCIL BOOKS? 30 00:01:16,400 --> 00:01:19,080 UNDER THE NIDA CURRENT COUNCIL. 31 00:01:19,080 --> 00:01:29,600 MOTION TO APPROVE THE MINUTES? 32 00:01:30,080 --> 00:01:30,360 REICH SECOND? 33 00:01:30,360 --> 00:01:37,320 EVERYONE IN FAVOR? 34 00:01:37,320 --> 00:01:41,480 ANY ABSTAINING? 35 00:01:41,480 --> 00:01:44,520 IF NOT I'LL GIVE YOU THE FUTURE 36 00:01:44,520 --> 00:01:45,400 COUNCIL DATES ANNOUNCING. 37 00:01:45,400 --> 00:01:49,920 THE NEXT ONE IS GOING TO BE MAY 38 00:01:49,920 --> 00:01:55,120 9 AND MAY 10 THIS YEAR JOINTLY 39 00:01:55,120 --> 00:01:58,280 WITH THE NCI AND SEPTEMBER 12 40 00:01:58,280 --> 00:01:58,880 WE'LL HAVE THE THIRD COUNCIL 41 00:01:58,880 --> 00:02:03,320 MEETING FOR 2023. 42 00:02:03,320 --> 00:02:05,480 AT THIS POINT I'M GOING TO 43 00:02:05,480 --> 00:02:07,040 INTRODUCE FOUR NEW MEMBERS FOR 44 00:02:07,040 --> 00:02:12,360 COUNCIL AND WANT TO WELCOME THEM 45 00:02:12,360 --> 00:02:20,040 AND WILL BE READING A SUCCINCT 46 00:02:20,040 --> 00:02:21,480 SUMMARY AND REPRESENT A DIVERSE 47 00:02:21,480 --> 00:02:22,560 SET OF EXPERTISE AND 48 00:02:22,560 --> 00:02:31,320 EXPERIENCES. 49 00:02:31,320 --> 00:02:37,680 SHE RECEIVED HER DOCTORATE FROM 50 00:02:37,680 --> 00:02:38,680 VIRGINIA COMMONWEALTH 51 00:02:38,680 --> 00:02:38,960 UNIVERSITY. 52 00:02:38,960 --> 00:02:40,920 SINCE GRADUATED SHE HAS DONE 53 00:02:40,920 --> 00:02:41,720 RESEARCH FOCUSSING AND 54 00:02:41,720 --> 00:02:44,120 UNDERSTANDING HOW GENETIC AND 55 00:02:44,120 --> 00:02:46,200 ENVIRONMENTAL FACTORS WORK 56 00:02:46,200 --> 00:02:47,480 TOGETHER TO SHAPE SUBSTANCE USE 57 00:02:47,480 --> 00:02:48,600 BEHAVIORS AND THEIR 58 00:02:48,600 --> 00:02:50,360 RELATIONSHIPS WITH OTHER MENTAL 59 00:02:50,360 --> 00:02:56,280 AND PHYSICAL OUTCOMES. 60 00:02:56,280 --> 00:02:57,920 WHILE EPIDEMIOLOGICAL TOOLS ARE 61 00:02:57,920 --> 00:03:02,080 KEY TO HER RESEARCH SHE ENGAGES 62 00:03:02,080 --> 00:03:08,640 IN TRANSLATIONAL IMAGING AND 63 00:03:08,640 --> 00:03:13,640 MULTIOMIC AND DATA. 64 00:03:13,640 --> 00:03:22,640 THE SECOND COUNCIL IS DR 65 00:03:22,640 --> 00:03:29,400 DR. DR. DUVERNAY AND PREVIOUSLY 66 00:03:29,400 --> 00:03:33,520 SERVED AS CHIEF SCIENTIFIC 67 00:03:33,520 --> 00:03:36,960 OFFICER AND HAS BEEN WITH THE 68 00:03:36,960 --> 00:03:38,760 COMPANY SINCE 2007. 69 00:03:38,760 --> 00:03:40,840 THROUGH HER ACADEMIC CAREERS HER 70 00:03:40,840 --> 00:03:45,080 FOCUS HAS PRIMARILY FOCUSSED ON 71 00:03:45,080 --> 00:03:48,520 ADDITION, NEURODEGENERATIVE 72 00:03:48,520 --> 00:03:50,320 DISORDER SUCH AS ALZHEIMER'S AND 73 00:03:50,320 --> 00:03:53,080 PARKINSON'S AND MOOD AND ANXIETY 74 00:03:53,080 --> 00:03:55,000 DISORDERS AND METABOLIC 75 00:03:55,000 --> 00:03:56,680 DISORDERS AND OBESITY. 76 00:03:56,680 --> 00:04:00,520 SHE HOLDS A Ph.D. IN CLINICAL 77 00:04:00,520 --> 00:04:02,880 NEUROPSYCHOLOGY FROM GEORGE 78 00:04:02,880 --> 00:04:12,640 MASON UNIVERSITY IN FAIRFAX, 79 00:04:12,640 --> 00:04:12,880 VIRGINIA. 80 00:04:12,880 --> 00:04:21,280 THE THIRD IS PROFESSOR AT THE 81 00:04:21,280 --> 00:04:22,440 UNIVERSITY SAN FRANCISCO. 82 00:04:22,440 --> 00:04:28,560 AND HAS BEEN RECOGNIZED FOR HER 83 00:04:28,560 --> 00:04:30,960 CONTRIBUTIONS TO HIV PUGH AND 84 00:04:30,960 --> 00:04:33,560 THE ZIKA VIRUS INFECTIONS. 85 00:04:33,560 --> 00:04:39,400 SINCE JANUARY 2020, SHE HAS 86 00:04:39,400 --> 00:04:40,480 DEVOTED EFFORTS TO SARS COV2 87 00:04:40,480 --> 00:04:41,000 RESEARCH. 88 00:04:41,000 --> 00:04:43,760 HER WORK IS FOCUSSED ON 89 00:04:43,760 --> 00:04:46,840 INFECTIOUS SARS COV2 AND 90 00:04:46,840 --> 00:04:49,360 HARNESSING THE HOST RESPONSE FOR 91 00:04:49,360 --> 00:04:50,760 NEW THERAPIES. 92 00:04:50,760 --> 00:04:57,440 HER LAB ALSO DEVELOPED NEW RAPID 93 00:04:57,440 --> 00:04:59,400 DIAGNOSTICS ON CRISPR AND PHONE 94 00:04:59,400 --> 00:05:01,280 TECHNOLOGIES AND HAS BEEN ON THE 95 00:05:01,280 --> 00:05:02,240 AMERICAN PHYSICIANS AND FELLOW 96 00:05:02,240 --> 00:05:05,240 OF THE AMERICAN ACADEMY OF 97 00:05:05,240 --> 00:05:05,560 MICROBIOLOGY. 98 00:05:05,560 --> 00:05:11,640 AND THE FOURTH MEMBER I WANT TO 99 00:05:11,640 --> 00:05:13,680 INTRODUCE TODAY IS A FULL 100 00:05:13,680 --> 00:05:17,920 PROFESSOR IN THE DEPARTMENT OF 101 00:05:17,920 --> 00:05:24,640 PSYCHIATRY WHERE HE HOLDS JOINT 102 00:05:24,640 --> 00:05:26,080 APPOINTMENTS IN THE USF 103 00:05:26,080 --> 00:05:32,400 DEPARTMENT OF CELLULAR AND 104 00:05:32,400 --> 00:05:37,360 MOLECULAR PHARMACOLOGY AND THE 105 00:05:37,360 --> 00:05:41,440 UCSF BIOLOGY INSTITUTE. 106 00:05:41,440 --> 00:05:43,040 HIS RESEARCH IS FOCUSSED ON 107 00:05:43,040 --> 00:05:48,200 UNDERSTANDING RECEPTOR MEDIATED 108 00:05:48,200 --> 00:05:49,760 CELL BIOLOGICAL MECHANISMS AND 109 00:05:49,760 --> 00:05:53,000 THE MECHANISTIC BASIS OF DRUG 110 00:05:53,000 --> 00:05:53,280 ADDICTION. 111 00:05:53,280 --> 00:05:55,800 HE HAS MADE SIGNIFICANT 112 00:05:55,800 --> 00:05:57,920 CONTRIBUTIONS TO FIELD OF CELL 113 00:05:57,920 --> 00:05:59,400 BIOLOGY, NEUROPSYCHIATRY, 114 00:05:59,400 --> 00:06:00,880 ADDICTION MEDICINE AND 115 00:06:00,880 --> 00:06:01,200 PHARMACOLOGY. 116 00:06:01,200 --> 00:06:04,680 HE HAS RECEIVED MULTIPLE HONORS 117 00:06:04,680 --> 00:06:05,360 INCLUDING ELECTION TO THE 118 00:06:05,360 --> 00:06:09,520 NATIONAL ACADEMY OF MEDICINE IN 119 00:06:09,520 --> 00:06:11,840 2011. 120 00:06:11,840 --> 00:06:14,440 HE RECEIVED HIS M.D. AND Ph.D. 121 00:06:14,440 --> 00:06:17,680 IN CELL BIOLOGY FROM YALE 122 00:06:17,680 --> 00:06:18,800 UNIVERSITY IN THE NIH SCIENTIST 123 00:06:18,800 --> 00:06:19,640 TRAINING PROGRAM. 124 00:06:19,640 --> 00:06:21,120 THAT CONCLUDES MY INTRODUCTION 125 00:06:21,120 --> 00:06:25,920 OF THE NEW MEMBERS AND THAT 126 00:06:25,920 --> 00:06:28,320 MOVES ME TO MY PRESENTATION. 127 00:06:28,320 --> 00:06:29,960 AT THIS POINT I'M GOING TO BE 128 00:06:29,960 --> 00:06:31,480 SHARING MY SCREEN BUT I WILL 129 00:06:31,480 --> 00:06:34,120 NEED FEEDBACK TO SEE IF YOU CAN 130 00:06:34,120 --> 00:06:44,360 SEE MY SLIDES. 131 00:06:53,200 --> 00:06:53,520 >>PERFECT. 132 00:06:53,520 --> 00:06:56,240 >>TODAY I WANT TO GO OVER THE 133 00:06:56,240 --> 00:06:57,920 SALIENT ISSUES THAT RELATE TO 134 00:06:57,920 --> 00:07:07,320 THE INSTITUTE AND SOME OF THE 135 00:07:07,320 --> 00:07:07,720 INT 136 00:07:07,720 --> 00:07:09,560 INTERINSTITUTE NADA GETS 137 00:07:09,560 --> 00:07:12,120 INVOLVED WITH AND THIS IS A 138 00:07:12,120 --> 00:07:14,280 DISCUSSION COME AROUND AND 139 00:07:14,280 --> 00:07:18,440 PRESENTING THE 2023 BUDGET 140 00:07:18,440 --> 00:07:22,520 APPROPRIATED TO NIDA. 141 00:07:22,520 --> 00:07:28,080 OUR BUDGET IN TERMS OF SEPARATE 142 00:07:28,080 --> 00:07:30,920 AND THE REASON IS WHATEVER 143 00:07:30,920 --> 00:07:33,280 PROJECTS SUPPORTED BY HEAL 144 00:07:33,280 --> 00:07:34,280 RELATED TO OPIOID USE DISORDERS 145 00:07:34,280 --> 00:07:35,800 HAVE TO BE APPROVED BY THE 146 00:07:35,800 --> 00:07:36,800 OFFICE OF THE DIRECTOR WHICH IS 147 00:07:36,800 --> 00:07:38,960 ACTUALLY THE ONE MAKING THE 148 00:07:38,960 --> 00:07:41,360 FINAL DECISIONS OF WHAT GETS 149 00:07:41,360 --> 00:07:43,360 FUNDED AND WHAT BUDGETS ARE 150 00:07:43,360 --> 00:07:50,000 ALLOCATED FOR THE PROJECTS. 151 00:07:50,000 --> 00:07:51,680 OVER ALL WE RECEIVED AN INCREASE 152 00:07:51,680 --> 00:07:55,360 TO THE BUDGET. 153 00:07:55,360 --> 00:07:57,560 BOTH FOR OUR BASE AND FUNDS 154 00:07:57,560 --> 00:07:59,040 THROUGH HEAL TO TARGET OPIOID 155 00:07:59,040 --> 00:08:06,320 USE DISORDERS AND OVERDOSES. 156 00:08:06,320 --> 00:08:09,280 THE WAY THE FUNDS ARE ALLOCATED 157 00:08:09,280 --> 00:08:11,600 VARIOUS SIGNIFICANTLY FOR 158 00:08:11,600 --> 00:08:13,840 NON-FIELD RESEARCH VERSUS FIELD 159 00:08:13,840 --> 00:08:14,480 RESEARCH. 160 00:08:14,480 --> 00:08:17,880 THIS REFLECTS IN PART FIELD 161 00:08:17,880 --> 00:08:20,960 RESEARCH HAS AN URGENCY TO 162 00:08:20,960 --> 00:08:21,920 ADVANCE SCIENCE RIGHT NOW AS 163 00:08:21,920 --> 00:08:23,400 FAST AS POSSIBLE CAN HELP 164 00:08:23,400 --> 00:08:25,720 DECREASE THE NUMBER OF OVERDOSE 165 00:08:25,720 --> 00:08:28,600 DEATHS THAT ARE PLAGUING THE 166 00:08:28,600 --> 00:08:28,840 COUNTRY. 167 00:08:28,840 --> 00:08:31,360 IN THE NON-HEAL RESEARCH WE HAVE 168 00:08:31,360 --> 00:08:34,400 AN OPPORTUNITY TO HAVE GREATER 169 00:08:34,400 --> 00:08:37,320 INVESTMENT IN SCIENCE AND BASIC 170 00:08:37,320 --> 00:08:42,640 SCIENCE RESEARCH BUT ALSO DO 171 00:08:42,640 --> 00:08:45,920 SIGNIFICANT INVESTMENT IN 172 00:08:45,920 --> 00:08:47,280 EPIDEMIOLOGY SERVICES AND 173 00:08:47,280 --> 00:08:47,760 CLINICAL TRIALS NETWORK. 174 00:08:47,760 --> 00:08:55,480 ON THE OTHER HAND, THE FIELD 175 00:08:55,480 --> 00:08:58,160 PORTFOLIO IS ON ACCELERATING 176 00:08:58,160 --> 00:09:00,280 CLINICAL TRIALS THAT CAN HELP 177 00:09:00,280 --> 00:09:04,800 DEVELOP GUIDELINES AND JUSTIFY 178 00:09:04,800 --> 00:09:07,360 THE UTILIZATION INCLUDING THE 179 00:09:07,360 --> 00:09:12,640 TREATMENT OF SUBSTANCE USE 180 00:09:12,640 --> 00:09:15,480 DISORDERS. 181 00:09:15,480 --> 00:09:17,480 WE'RE ALSO ACCELERATING THE 182 00:09:17,480 --> 00:09:18,360 THERAPEUTICS FOR THE TREATMENT 183 00:09:18,360 --> 00:09:20,520 OF OPIOID USE DISORDERS AND 184 00:09:20,520 --> 00:09:23,120 OVERDOSES AND MORE RECENTLY WE 185 00:09:23,120 --> 00:09:26,320 HAVE BEEN GIVEN THE FLEXIBILITY 186 00:09:26,320 --> 00:09:28,520 TO ALSO USE HEAL FUNDS TO 187 00:09:28,520 --> 00:09:29,920 ACCELERATE TREATMENT FOR 188 00:09:29,920 --> 00:09:39,440 STIMULANT USE DISORDERS. 189 00:09:39,440 --> 00:09:42,560 NIDA WANTED TO BE AWARE OF A NEW 190 00:09:42,560 --> 00:09:46,840 POSITION TO DR. CRAN AT NIDA 191 00:09:46,840 --> 00:09:48,240 DIVISION OF EPIDEMIOLOGY AND 192 00:09:48,240 --> 00:09:51,520 SERVICES RESEARCH WHO NOW IS 193 00:09:51,520 --> 00:09:54,120 GOING TO BE IN THE ROLE OF 194 00:09:54,120 --> 00:09:56,560 DIRECTORS OF THE OFFICE OF 195 00:09:56,560 --> 00:10:01,360 DIVERSITY AND DISPARITIES THAT 196 00:10:01,360 --> 00:10:03,960 IN THE PAST WAS LED BY ALBERT 197 00:10:03,960 --> 00:10:05,120 AVILA AND ALSO THE DEPUTY 198 00:10:05,120 --> 00:10:07,920 DIRECTOR FOR THE OFFICE OF 199 00:10:07,920 --> 00:10:09,360 RESEARCH TRAINING, DIVERSITY AND 200 00:10:09,360 --> 00:10:19,400 DISPARITY. 201 00:10:19,400 --> 00:10:25,360 IN TERMS OF LEADERSHIP WE'RE 202 00:10:25,360 --> 00:10:29,800 ACTIVE IN THE EXECUTIVE OFFICER. 203 00:10:29,800 --> 00:10:31,520 IS WE ARE SEARCHING FOR A NEW 204 00:10:31,520 --> 00:10:34,680 EXECUTIVE OFFICER. 205 00:10:34,680 --> 00:10:35,640 SIMILARLY, THE CLINICAL DIRECTOR 206 00:10:35,640 --> 00:10:38,160 THE SEARCH IS ONGOING AND 207 00:10:38,160 --> 00:10:43,320 FINALLY WE ARE FINALIZING THE 208 00:10:43,320 --> 00:10:44,880 REVIEW PROCESS FOR THE 209 00:10:44,880 --> 00:10:46,880 CANDIDATES PUT FORWARD FOR THE 210 00:10:46,880 --> 00:10:47,920 SEARCH COMMITTEE OF THE DIVISION 211 00:10:47,920 --> 00:10:55,960 OF THERAPEUTICS AND MEDICATION 212 00:10:55,960 --> 00:10:56,920 AND HOPEFULLY BY NEXT COUNCIL 213 00:10:56,920 --> 00:10:57,840 I'LL BE ABLE TO ANNOUNCE THE NEW 214 00:10:57,840 --> 00:11:05,080 POSITIONS. 215 00:11:05,080 --> 00:11:06,800 BEFORE I GO INTO SPECIFICS OF 216 00:11:06,800 --> 00:11:09,000 NIDA I WANT YOU TO BE AWARE OF 217 00:11:09,000 --> 00:11:12,000 THE CHANGES TO THE PEER REVIEW 218 00:11:12,000 --> 00:11:14,400 CRITERIA AND THE INTENT IS TO 219 00:11:14,400 --> 00:11:16,000 FOCUS THE PEER REVIEW ON 220 00:11:16,000 --> 00:11:19,360 ASSESSMENT OF THE SCIENTIFIC AND 221 00:11:19,360 --> 00:11:21,400 TECHNICAL MERIT OF THE GRANT 222 00:11:21,400 --> 00:11:25,240 APPLICATIONS AND THE BURDEN 223 00:11:25,240 --> 00:11:25,480 REVIEW. 224 00:11:25,480 --> 00:11:28,880 IT ALSO TRIES TO MITIGATE THE 225 00:11:28,880 --> 00:11:34,280 BIAS IN THE PEER-REVIEW PROCESS. 226 00:11:34,280 --> 00:11:35,800 INSTEAD OF FIVE FACTORS WITH 227 00:11:35,800 --> 00:11:44,320 SIGNIFICANT INVESTIGATOR AND 228 00:11:44,320 --> 00:11:45,760 APPROACH THERE'S THREE FACTOR 229 00:11:45,760 --> 00:11:47,440 THAT WILL BE EVALUATED. 230 00:11:47,440 --> 00:11:50,280 THE IMPORTANCE OF RESEARCH AND 231 00:11:50,280 --> 00:11:56,480 INTEGRATING WHAT WAS IN THE PAST 232 00:11:56,480 --> 00:11:58,160 INNOVATION. 233 00:11:58,160 --> 00:12:00,640 RIGOR WHICH S AND THE EXPERTISE 234 00:12:00,640 --> 00:12:03,320 AND RESOURCES THAT RELATE TO THE 235 00:12:03,320 --> 00:12:06,000 INVESTIGATOR AND TO THE PLACE 236 00:12:06,000 --> 00:12:07,520 WHERE THEY'RE GOING TO BE DOING 237 00:12:07,520 --> 00:12:08,760 THEIR RESEARCH. 238 00:12:08,760 --> 00:12:15,240 AND WHEREAS THE OTHER -- THE ONE 239 00:12:15,240 --> 00:12:16,360 IMPACTS WILL BE SCORED 1 TO 9 240 00:12:16,360 --> 00:12:17,920 THE ONE WILL BE SCORED AS 241 00:12:17,920 --> 00:12:18,480 APPROPRIATE FOR ADDITIONAL 242 00:12:18,480 --> 00:12:22,280 RESOURCES NEEDED. 243 00:12:22,280 --> 00:12:27,000 WE ARE AT THIS POINT, THE NIH IS 244 00:12:27,000 --> 00:12:28,280 RECOMMENDING AND I WOULD URGE 245 00:12:28,280 --> 00:12:29,920 YOU TO LOOK INTO IT AND IF YOU 246 00:12:29,920 --> 00:12:31,360 HAVE ANY CONCERNS OR 247 00:12:31,360 --> 00:12:33,240 SUGGESTIONS, THIS IS THE TIME TO 248 00:12:33,240 --> 00:12:43,120 HEAR TO MAKE YOUR VOICE COUNT. 249 00:12:43,120 --> 00:12:50,640 THE OTHER UPDATE IS ON THE 250 00:12:50,640 --> 00:13:00,920 TRAINING INITIATIVE IT HAS 251 00:13:00,920 --> 00:13:06,840 INVESTED OVER $3 BILLION IN 1166 252 00:13:06,840 --> 00:13:07,240 PROJECTS. 253 00:13:07,240 --> 00:13:10,520 YOU CAN SEE ALSO HOW THEY'VE 254 00:13:10,520 --> 00:13:11,720 BEEN RAMPING UP. 255 00:13:11,720 --> 00:13:14,280 AS A RESULT OF THAT, THIS 256 00:13:14,280 --> 00:13:19,080 FUNDING HAVE BEEN ABLE TO FUND 257 00:13:19,080 --> 00:13:24,160 1166 P.I.s, 234 INSTITUTIONS AND 258 00:13:24,160 --> 00:13:26,760 SUPPORTED 952 BRAIN AWARDS. 259 00:13:26,760 --> 00:13:28,600 IT HAS BEEN INCREDIBLY 260 00:13:28,600 --> 00:13:30,280 PRODUCTIVE AND JUST LOOKING AT 261 00:13:30,280 --> 00:13:32,520 THE NUMBER OF PUBLICATIONS YOU 262 00:13:32,520 --> 00:13:35,640 CAN SEE HOW THEY'RE GOING UP. 263 00:13:35,640 --> 00:13:38,760 AND THOUGH '22 LOOKS LOWER IT 264 00:13:38,760 --> 00:13:40,280 HASN'T BEEN UPDATED. 265 00:13:40,280 --> 00:13:41,520 IT'S CLEAR THE TECHNOLOGIES 266 00:13:41,520 --> 00:13:43,480 DERIVED FROM THE BRAIN AS WELL 267 00:13:43,480 --> 00:13:45,000 AS THE KNOWLEDGE IN THE 268 00:13:45,000 --> 00:13:46,960 CIRCUITRY AND CELL 269 00:13:46,960 --> 00:13:48,760 CLASSIFICATION IS BASICALLY 270 00:13:48,760 --> 00:13:50,520 EFFECTING THE REST OF THE 271 00:13:50,520 --> 00:13:51,560 NEUROSCIENCE FIELD INCLUDING THE 272 00:13:51,560 --> 00:14:02,080 SUBSTANCE ABUSE FIELD ITSELF. 273 00:14:05,120 --> 00:14:08,560 THE BRAIN MEETING IS JUNE 12 AND 274 00:14:08,560 --> 00:14:12,920 13 AND URGE YOU TO LOOK AT THE 275 00:14:12,920 --> 00:14:13,880 WEBSITE TO GET YOURSELF INFORMED 276 00:14:13,880 --> 00:14:15,240 ON FUNDING OPPORTUNITIES AND GET 277 00:14:15,240 --> 00:14:16,480 TO KNOW SOME OF THE RESEARCHERS 278 00:14:16,480 --> 00:14:17,760 AND THE PEOPLE THAT ARE MANAGING 279 00:14:17,760 --> 00:14:25,000 THE PROGRAM. 280 00:14:25,000 --> 00:14:27,920 LET ME JUMP INTO NIDA RELATED 281 00:14:27,920 --> 00:14:28,120 ISSUES. 282 00:14:28,120 --> 00:14:29,920 I ALWAYS GIVE YOU AN UPDATE IN 283 00:14:29,920 --> 00:14:34,800 THE FIRST COUNCIL OF THE YEAR 284 00:14:34,800 --> 00:14:37,320 WHAT THE FUTURE HAS SHOWN US AND 285 00:14:37,320 --> 00:14:39,320 OVER ALL THE NEWS IS GOOD 286 00:14:39,320 --> 00:14:43,680 BECAUSE YOU HAVE BEEN HEARING 287 00:14:43,680 --> 00:14:44,520 DURING THE COVID PANDEMIC 288 00:14:44,520 --> 00:14:49,920 THERE'S BEEN A SIGNIFICANT 289 00:14:49,920 --> 00:14:53,680 REDUCTION WE ADJUDICATE WE 290 00:14:53,680 --> 00:14:56,480 BELIEVE ARE DUE TO THE 291 00:14:56,480 --> 00:14:57,920 DISTANCING IMPOSED BY THE SOCIAL 292 00:14:57,920 --> 00:15:00,120 ISOLATION AND CLOSING OF SCHOOLS 293 00:15:00,120 --> 00:15:02,400 THAT PROTECT TEENAGERS FROM 294 00:15:02,400 --> 00:15:04,840 TAKING DRUGS AND HAVING PEER 295 00:15:04,840 --> 00:15:06,520 PRESSURE TO DO SO. 296 00:15:06,520 --> 00:15:09,400 WE WERE VERY CONCERNED AS 297 00:15:09,400 --> 00:15:11,160 TEENAGERS WENT BACK TO SCHOOL 298 00:15:11,160 --> 00:15:12,320 WHICH HAPPENED VERY MUCH ALREADY 299 00:15:12,320 --> 00:15:19,200 IN 2022 WHEN THE DATA FROM THIS 300 00:15:19,200 --> 00:15:28,440 MONITORING THE FUTURE THE 301 00:15:28,440 --> 00:15:29,600 EXPECTATION IS THE VALUES WOULD 302 00:15:29,600 --> 00:15:31,360 GO BACK AND THEY HAVE NOT AND 303 00:15:31,360 --> 00:15:32,680 THEY'VE BEEN STABLE FROM WHAT WE 304 00:15:32,680 --> 00:15:37,360 SAW IN 2021, THE LOWEST SINCE 305 00:15:37,360 --> 00:15:40,760 THE MONITORING THE FUTURE. 306 00:15:40,760 --> 00:15:42,760 VERY FEW INDICATORS WHEN ONE 307 00:15:42,760 --> 00:15:44,320 WENT BACK TO LEVELS SIMILAR TO 308 00:15:44,320 --> 00:15:45,640 THE PANDEMIC ERA. 309 00:15:45,640 --> 00:15:49,920 I WOULD SAY THE MOST NOTABLE ONE 310 00:15:49,920 --> 00:15:57,880 WAS ALCOHOL USE IN 12 GRADERS. 311 00:15:57,880 --> 00:16:01,080 INTERESTINGLY, NOR FOR 10th OR 312 00:16:01,080 --> 00:16:02,560 9th GRADERS. 313 00:16:02,560 --> 00:16:07,360 THIS WAS SPECIFIC FOR THE 12th 314 00:16:07,360 --> 00:16:07,600 GRADERS. 315 00:16:07,600 --> 00:16:10,400 WE DON'T KNOW HOW THESE LEVELS 316 00:16:10,400 --> 00:16:12,080 WILL BE NOR WHAT WILL BE FROM 317 00:16:12,080 --> 00:16:15,880 THE PERSPECTIVE OF DOWN STREAM 318 00:16:15,880 --> 00:16:17,840 CONSEQUENCES FROM THE STRESS AND 319 00:16:17,840 --> 00:16:19,360 MENTAL HEALTH CHALLENGES 320 00:16:19,360 --> 00:16:21,160 REPORTED IN THE ADOLESCENT 321 00:16:21,160 --> 00:16:23,320 POPULATION AND OTHER POPULATIONS 322 00:16:23,320 --> 00:16:25,360 BUT CERTAINLY PERHAPS HIGHER 323 00:16:25,360 --> 00:16:29,960 RATES AMONG THE AGE GROUPS 324 00:16:29,960 --> 00:16:36,160 POST-COVID PANDEMIC. 325 00:16:36,160 --> 00:16:46,640 I ALSO WANT TO TOUCH ON THE 326 00:16:49,880 --> 00:16:52,360 ELECTIONS AND MANY VOTED ON 327 00:16:52,360 --> 00:16:55,040 CANNABIS AND IT LOST AND WE HAVE 328 00:16:55,040 --> 00:16:58,680 21 STATES WHO HAVE VOTED 329 00:16:58,680 --> 00:17:02,040 RECREATIONAL MARIJUANA MAKING IT 330 00:17:02,040 --> 00:17:03,760 LEGAL. 331 00:17:03,760 --> 00:17:07,720 WE NOW HAVE 38 STATES WHO HAVE 332 00:17:07,720 --> 00:17:09,520 APPROVED MEDICAL MARIJUANA. 333 00:17:09,520 --> 00:17:12,520 YOU CAN SEE BASICALLY ALL THE 334 00:17:12,520 --> 00:17:13,840 UNITED STATES HAS BEEN COVERED 335 00:17:13,840 --> 00:17:17,080 WITH BLUES OR GREENS WHICH 336 00:17:17,080 --> 00:17:18,880 ACTUALLY GIVES A PERSPECTIVE OF 337 00:17:18,880 --> 00:17:21,960 WHAT SOME OF THE CHALLENGES ARE 338 00:17:21,960 --> 00:17:25,480 AND OPPORTUNITIES FOR RESEARCH. 339 00:17:25,480 --> 00:17:28,040 WE HAVE BEEN PREDICTING THAT 340 00:17:28,040 --> 00:17:29,880 THESE LEGALIZATION IS GOING TO 341 00:17:29,880 --> 00:17:31,360 RESULT IN AN INCREASE IN 342 00:17:31,360 --> 00:17:32,920 MARIJUANA CONSUMPTION. 343 00:17:32,920 --> 00:17:35,880 NOT SURPRISING, IT HAS 344 00:17:35,880 --> 00:17:36,320 MATERIALIZED. 345 00:17:36,320 --> 00:17:38,440 WE HAVE SEEN SIGNIFICANT 346 00:17:38,440 --> 00:17:40,200 INCREASES IN MARIJUANA 347 00:17:40,200 --> 00:17:41,360 CONSUMPTION AMONG AMERICANS. 348 00:17:41,360 --> 00:17:45,360 WE HAVE NOT SEEN IT PER SE IN 349 00:17:45,360 --> 00:17:48,520 ADOLESCENTS BUT WITH THE 18 350 00:17:48,520 --> 00:17:53,760 YEARS OR OLDER OF ALL AGES AND 351 00:17:53,760 --> 00:17:54,120 DEMOGRAPHICS. 352 00:17:54,120 --> 00:17:55,520 WHAT'S INTERESTING WHAT IS 353 00:17:55,520 --> 00:17:58,360 PORTRAYED BY THE DATA ANALYZED 354 00:17:58,360 --> 00:18:00,280 IS THAT IF WE ARE TO BE LOOKING 355 00:18:00,280 --> 00:18:03,440 AT IT WHAT ARE THE CONSEQUENCES, 356 00:18:03,440 --> 00:18:05,920 IT IS NOT SO MUCH THAT 357 00:18:05,920 --> 00:18:08,640 INCREASING NUMBER OF USERS. 358 00:18:08,640 --> 00:18:12,080 THE NUMBER OF USERS OF THAT 359 00:18:12,080 --> 00:18:15,200 REPORT BY USE OF MARIJUANA WHICH 360 00:18:15,200 --> 00:18:19,480 TRIPLED BETWEEN 1992 AND 2020. 361 00:18:19,480 --> 00:18:22,760 HE KNOWS AND I AGREE WHAT IS 362 00:18:22,760 --> 00:18:24,720 WORRISOME IS DRAMATIC INCREASES 363 00:18:24,720 --> 00:18:27,680 IN REGULAR USE OF MARIJUANA 364 00:18:27,680 --> 00:18:33,160 WHICH ARE THE ONES ASSOCIATED 365 00:18:33,160 --> 00:18:36,280 WITH MORE AFFECTS. 366 00:18:36,280 --> 00:18:39,680 WHERE MONTHLY USERS QUADRUPLE 367 00:18:39,680 --> 00:18:45,880 AND DAILY USERS INCREASED 14 368 00:18:45,880 --> 00:18:46,680 FOLD. 369 00:18:46,680 --> 00:18:49,360 THE BLUE LINES REPRESENT THE 370 00:18:49,360 --> 00:18:53,960 AMOUNT CONSUMED BY AN 371 00:18:53,960 --> 00:18:55,320 INDIVIDUAL. 372 00:18:55,320 --> 00:18:58,760 THE PATTERNS AND HARMFUL 373 00:18:58,760 --> 00:19:00,880 INCREASE WITH THE LEGALIZATION 374 00:19:00,880 --> 00:19:03,440 OF MARIJUANA AND THE DOSES 375 00:19:03,440 --> 00:19:05,560 PEOPLE ARE CONSUMING OF 376 00:19:05,560 --> 00:19:09,840 MARIJUANA HAVE ALSO DRAMATICALLY 377 00:19:09,840 --> 00:19:10,280 INCREASED. 378 00:19:10,280 --> 00:19:13,440 THIS IS WORK THAT BECOMES 379 00:19:13,440 --> 00:19:16,240 IMPORTANT. 380 00:19:16,240 --> 00:19:17,720 WE NEED TO UNDERSTAND WHAT ARE 381 00:19:17,720 --> 00:19:18,360 THE NEGATIVE CONSEQUENCES FROM 382 00:19:18,360 --> 00:19:24,520 IT. 383 00:19:24,520 --> 00:19:26,000 WE'VE ALSO PAID ATTENTION 384 00:19:26,000 --> 00:19:27,920 PRIORITIZING THE POTENTIAL 385 00:19:27,920 --> 00:19:29,560 NEGATIVE EFFECTS OF MARIJUANA 386 00:19:29,560 --> 00:19:30,760 CONSUMPTION AMONG YOUNG PEOPLE, 387 00:19:30,760 --> 00:19:32,160 CHILDREN, TEENAGERS AND PREGNANT 388 00:19:32,160 --> 00:19:36,280 WOMEN. 389 00:19:36,280 --> 00:19:38,160 INDEED, ONE OF THE REASONS WHY 390 00:19:38,160 --> 00:19:42,000 IT LED US TO INITIATIVE THE ABC 391 00:19:42,000 --> 00:19:44,840 STUDY IS TO HAVE A DRIED TO 392 00:19:44,840 --> 00:19:52,600 ENABLE US TO MONITOR WHETHER 393 00:19:52,600 --> 00:19:53,920 EXPOSURES TO DRUGS EARLY ON 394 00:19:53,920 --> 00:19:56,680 DURING ADOLESCENCE AFFECTED 395 00:19:56,680 --> 00:19:58,600 BRAIN DEVELOPMENT AND 396 00:19:58,600 --> 00:20:00,520 CONTROLLING FOR FACTORS THAT 397 00:20:00,520 --> 00:20:07,640 EXISTED PRIOR TO CONSUMPTION. 398 00:20:07,640 --> 00:20:11,560 THAT'S A CRITICISM AND THEY SAY 399 00:20:11,560 --> 00:20:15,040 THAT ADOLESCENTS USING MARIJUANA 400 00:20:15,040 --> 00:20:20,240 ARE DOING WORSE ACADEMIC WISE 401 00:20:20,240 --> 00:20:22,440 AND THE STUDY EVALUATING 402 00:20:22,440 --> 00:20:23,640 TEENAGERS AND CHILDREN 9 TO 10 403 00:20:23,640 --> 00:20:31,120 AND WE'LL ABLE TO DETERMINE IF 404 00:20:31,120 --> 00:20:34,960 MAY HAVE A CORRELATION WITH POOR 405 00:20:34,960 --> 00:20:36,160 PERFORMANCE AND WHETHER IT'S IN 406 00:20:36,160 --> 00:20:39,560 ANY WAY CONTRIBUTING TO THE 407 00:20:39,560 --> 00:20:44,200 MERGENCE OF PSYCHIATRIC 408 00:20:44,200 --> 00:20:46,280 ILLNESSES AND HOW THOSE 409 00:20:46,280 --> 00:20:46,960 TRAJECTORIES DIFFER AND AFFECT 410 00:20:46,960 --> 00:20:50,880 THE DEVELOPMENT OF THE BRAIN. 411 00:20:50,880 --> 00:20:56,360 IN PARALLEL, LAST YEAR WE 412 00:20:56,360 --> 00:20:59,760 LAUNCHED THE HEALTHY BRAIN AND 413 00:20:59,760 --> 00:21:02,160 DEVELOPMENT STUDY TO STUDY 414 00:21:02,160 --> 00:21:04,400 WHETHER MARIJUANA IN A 415 00:21:04,400 --> 00:21:05,880 LONGITUDINAL FASHION AND DURING 416 00:21:05,880 --> 00:21:08,360 PREGNANCY AFFECTS NEONATAL 417 00:21:08,360 --> 00:21:09,560 DEVELOPMENT. 418 00:21:09,560 --> 00:21:12,720 THESE STUDIES SIDE BY SIDE ARE 419 00:21:12,720 --> 00:21:14,520 VERY POWERFUL TOOLS WE CURRENTLY 420 00:21:14,520 --> 00:21:16,240 HAVE AND FOR WHICH WE'RE 421 00:21:16,240 --> 00:21:17,960 PARTNERING WITH COLLABORATIONS 422 00:21:17,960 --> 00:21:20,400 WITH MULTIPLE INSTITUTES 423 00:21:20,400 --> 00:21:23,440 INCLUDING THE NATIONAL INSTITUTE 424 00:21:23,440 --> 00:21:25,600 OF ALCOHOL ABUSE AND ALCOHOLISM 425 00:21:25,600 --> 00:21:32,240 AND INSTITUTES OF MENTAL HEALTH 426 00:21:32,240 --> 00:21:37,520 AND SUPPORT FROM OTHERS. 427 00:21:37,520 --> 00:21:47,880 THIS IS FOR SOLID DATA AND THERE 428 00:21:47,880 --> 00:21:49,880 ARE OTHER AREAS FOR NIDA TO 429 00:21:49,880 --> 00:21:52,240 PROMOTE RESEARCH ON DUE TO THE 430 00:21:52,240 --> 00:21:56,240 FREQUENT RATES OF CONSUMPTION. 431 00:21:56,240 --> 00:21:59,560 SO THESE ARE ILLUSTRATING THE 432 00:21:59,560 --> 00:22:02,920 MAIN PRIORITY AREAS APART FROM 433 00:22:02,920 --> 00:22:04,480 NEURODEVELOPMENTS WHERE WE ARE 434 00:22:04,480 --> 00:22:04,880 SEEKING RESEARCH. 435 00:22:04,880 --> 00:22:08,800 A PHARMACOLOGIC STUDY ON THE 436 00:22:08,800 --> 00:22:10,320 COMPOUNDS UNDERSTANDING THEIR 437 00:22:10,320 --> 00:22:16,360 AFFECT IN CELLULAR BIOLOGY AND 438 00:22:16,360 --> 00:22:17,920 EPIDEMIOLOGICS AND METABOLISM 439 00:22:17,920 --> 00:22:19,600 AND CONSEQUENCES AND 440 00:22:19,600 --> 00:22:21,040 UNDERSTANDING WHAT ARE THE 441 00:22:21,040 --> 00:22:22,440 FACTORS ASSOCIATED WITH 442 00:22:22,440 --> 00:22:23,400 VULNERABILITY FOR CANNABIS USE 443 00:22:23,400 --> 00:22:29,280 AND CANNABIS USE DISORDERS AND 444 00:22:29,280 --> 00:22:32,640 NEGATIVE CONSEQUENCES GENETIC 445 00:22:32,640 --> 00:22:33,800 AND SOCIAL DETERMINATES OF 446 00:22:33,800 --> 00:22:34,040 HEALTH. 447 00:22:34,040 --> 00:22:36,400 WE'RE INTERESTED IN BRAIN 448 00:22:36,400 --> 00:22:37,680 DEVELOPMENT BUT THERE'S ALSO 449 00:22:37,680 --> 00:22:38,360 EVIDENCE AND THERE'S BEEN A LOT 450 00:22:38,360 --> 00:22:43,360 OF WORK GOING ON TO TRY TO 451 00:22:43,360 --> 00:22:45,920 DETERMINE IF ADULTS THAT CONSUME 452 00:22:45,920 --> 00:22:48,120 MARIJUANA HAVE NEGATIVE AFFECTS 453 00:22:48,120 --> 00:22:49,840 ON THE BRAIN STRUCTURE OR 454 00:22:49,840 --> 00:22:51,880 NEUROCHEMISTRY AND THIS IS A 455 00:22:51,880 --> 00:22:55,360 STUDY THAT USES A RELATIVELY 456 00:22:55,360 --> 00:22:59,520 NOVEL TRACER WITH TOMOGRAPHY TO 457 00:22:59,520 --> 00:23:05,400 QUANTIFY THE SYNAPTIC DENSITY IN 458 00:23:05,400 --> 00:23:06,600 THE BRAIN AND WAS NOVEL. 459 00:23:06,600 --> 00:23:09,920 YOU CAN SEE HOW SIGNIFICANTLY 460 00:23:09,920 --> 00:23:15,120 REDUCED THE SYNAPTIC DENSITY 461 00:23:15,120 --> 00:23:21,720 THAT CONSUME CANNABIS IN OWLS 462 00:23:21,720 --> 00:23:25,360 AND OTHER OTHER TECHNOLOGIES 463 00:23:25,360 --> 00:23:27,680 INDICATE CONSUMPTION OF 464 00:23:27,680 --> 00:23:33,920 MARIJUANA MAY BE HARMFUL TO 465 00:23:33,920 --> 00:23:35,520 CERTAIN BRAIN REGIONS AND WE 466 00:23:35,520 --> 00:23:36,840 TEND TO POLARIZE STATEMENTS LIKE 467 00:23:36,840 --> 00:23:40,640 THIS BUT IT'S LIKELY THE AFFECTS 468 00:23:40,640 --> 00:23:42,520 ARE ASSOCIATED WITH REGULAR 469 00:23:42,520 --> 00:23:44,240 CONSUMPTION AND HIGHER DOSES. 470 00:23:44,240 --> 00:23:49,320 WE HAVE LITTLE INFORMATION AS OF 471 00:23:49,320 --> 00:23:57,360 NOW ON WHETHER THERE'S NEGATIVE 472 00:23:57,360 --> 00:23:59,120 CONSEQUENCES ON THIS AREA. 473 00:23:59,120 --> 00:24:00,400 AND WE NEED TO CONSIDER THE 474 00:24:00,400 --> 00:24:01,840 AFFECTS OF CANNABIS ON THE BRAIN 475 00:24:01,840 --> 00:24:05,680 ARE LIKELY TO BE AFFECTED BY THE 476 00:24:05,680 --> 00:24:10,480 LIFE STAGE OF THE INDIVIDUAL AND 477 00:24:10,480 --> 00:24:12,120 WE KNOW ALREADY FROM STUDIES WE 478 00:24:12,120 --> 00:24:17,360 KNOW THERE'S SIGNIFICANT 479 00:24:17,360 --> 00:24:22,560 DIFFERENCES ON THE WAY THAT 480 00:24:22,560 --> 00:24:23,320 CANNABIS AFFECTS MEN AND WOMEN 481 00:24:23,320 --> 00:24:25,320 AND WE NEED TO TAILOR 482 00:24:25,320 --> 00:24:31,680 INTERVENTIONS ACCORDINGLY. 483 00:24:31,680 --> 00:24:33,520 WE ARE ALSO PRIORITIZING TAKING 484 00:24:33,520 --> 00:24:34,960 ADVANTAGE OF THE DIFFERENCES BY 485 00:24:34,960 --> 00:24:40,640 WHICH THE STATES ARE LEGALIZING 486 00:24:40,640 --> 00:24:44,560 MARIJUANA TO DETERMINE TO LOOK 487 00:24:44,560 --> 00:24:46,080 AT WHAT IS ASSOCIATED WITH SAFER 488 00:24:46,080 --> 00:24:49,440 PATTERNS AND RESEARCH ON POLICY 489 00:24:49,440 --> 00:24:52,480 TO FLAG WHAT IS THE MOST 490 00:24:52,480 --> 00:24:55,360 EFFECTIVE INTERVENTIONS TO 491 00:24:55,360 --> 00:24:57,600 MINIMIZE HARMFUL AFFECTS AND 492 00:24:57,600 --> 00:25:01,360 RECOGNIZING PEOPLE ARE USING 493 00:25:01,360 --> 00:25:02,280 CANNABIS WHETHER IT IS APPROVED 494 00:25:02,280 --> 00:25:06,360 OR NOT BY THE FDA THEY'RE USING 495 00:25:06,360 --> 00:25:07,800 IT AND WE KNOW THAT CONSISTENTLY 496 00:25:07,800 --> 00:25:10,800 AND PARTICULARLY THE MOST 497 00:25:10,800 --> 00:25:11,520 FREQUENT INDICATION APPEARS TO 498 00:25:11,520 --> 00:25:12,800 BE FOR PAIN. 499 00:25:12,800 --> 00:25:16,440 IT BEHOOVES US AS A SCIENTIFIC 500 00:25:16,440 --> 00:25:21,600 ORGANIZATION TO DO STUDIES THAT 501 00:25:21,600 --> 00:25:24,280 CAN HELP DOCUMENT WHAT POTENTIAL 502 00:25:24,280 --> 00:25:28,120 MAKE CANNABIS WORK THE ACTIVE 503 00:25:28,120 --> 00:25:32,280 INGREDIENT, CBD OR THC AND THE 504 00:25:32,280 --> 00:25:33,920 POTENTIAL FOR CANNABIS USE 505 00:25:33,920 --> 00:25:38,000 DISORDERS OR FOR THE TREATMENT 506 00:25:38,000 --> 00:25:41,920 OF PAIN OR INFLAMMATORY PROCESS 507 00:25:41,920 --> 00:25:51,000 ASSOCIATED AMONG OTHERS WIN HIV. 508 00:25:51,000 --> 00:25:53,760 LET THE JUMP BACK TO THE TWO 509 00:25:53,760 --> 00:25:57,080 MOST AMBITIOUS STUDIES AT NIDA 510 00:25:57,080 --> 00:25:58,480 IN PARTNERSHIP WITH OTHER 511 00:25:58,480 --> 00:26:00,320 INSTITUTES. 512 00:26:00,320 --> 00:26:02,280 ONE IS THE ADOLESCENT BRAIN 513 00:26:02,280 --> 00:26:03,800 COGNITIVE DEVELOPMENT STUDY. 514 00:26:03,800 --> 00:26:05,520 I GIVE YOU AN UPDATE ON EVERY 515 00:26:05,520 --> 00:26:06,160 COUNCIL TO GET A SENSE OF WHERE 516 00:26:06,160 --> 00:26:09,760 WE ARE. 517 00:26:09,760 --> 00:26:12,240 THIS GIVES A SUMMARY OF THE 518 00:26:12,240 --> 00:26:14,680 RETENTION AND COMPLETION OF 519 00:26:14,680 --> 00:26:17,040 DIFFERENT CASES OF THE ABC. 520 00:26:17,040 --> 00:26:19,160 IT'S QUITE REMARKABLE AND I DO 521 00:26:19,160 --> 00:26:20,640 NOT KNOW OF ANY OTHER STUDY THAT 522 00:26:20,640 --> 00:26:21,440 HAS BEEN ABLE TO KEEP THAT LEVEL 523 00:26:21,440 --> 00:26:29,360 OF RETENTION. 524 00:26:29,360 --> 00:26:31,360 97.6% HAVE BEEN RETAINED AND HAS 525 00:26:31,360 --> 00:26:37,880 BEEN DEPOSITED ON AN ANNUAL 526 00:26:37,880 --> 00:26:39,080 BASIS EXCEPT LAST YEAR AND WE 527 00:26:39,080 --> 00:26:40,720 MISSED OUR DEADLINE. 528 00:26:40,720 --> 00:26:43,200 THE DEPOSITION OF THE BRAIN 529 00:26:43,200 --> 00:26:46,440 IMAGING DATA AND THE BEHAVIORAL 530 00:26:46,440 --> 00:26:50,600 DATA FROM THE ABC WILL NOT 531 00:26:50,600 --> 00:26:55,680 HAPPEN UNTIL 2023. 532 00:26:55,680 --> 00:27:00,680 WE'RE AND THEY'RE WORKING 533 00:27:00,680 --> 00:27:01,960 DILIGENTLY TO MAKE THIS HAPPEN 534 00:27:01,960 --> 00:27:03,080 AS SOON AS POSSIBLE. 535 00:27:03,080 --> 00:27:04,160 MEANWHILE YOU CAN SEE THE GROWTH 536 00:27:04,160 --> 00:27:09,640 IN THE PUBLICATIONS AND YOU CAN 537 00:27:09,640 --> 00:27:19,360 SEE THE INCREASE COMING FROM 538 00:27:19,360 --> 00:27:20,800 NON-ABC INVESTIGATORS AND WANT 539 00:27:20,800 --> 00:27:23,520 TO MAKE SURE PEOPLE THAT MAY NOT 540 00:27:23,520 --> 00:27:25,400 BE AS FAMILIAR CAN NONETHELESS 541 00:27:25,400 --> 00:27:27,000 TAKE ADVANTAGE OF THE DATA SETS. 542 00:27:27,000 --> 00:27:28,120 INCREDIBLY IMPORTANT FINDINGS 543 00:27:28,120 --> 00:27:29,040 HAVE HAPPENED. 544 00:27:29,040 --> 00:27:36,400 I THINK PERHAPS TO ME THE MOST 545 00:27:36,400 --> 00:27:37,320 RELATE TO HOW SOCIAL 546 00:27:37,320 --> 00:27:38,200 DETERMINATES OF HEALTH ARE 547 00:27:38,200 --> 00:27:40,000 INFLUENCING THE BRAIN 548 00:27:40,000 --> 00:27:42,000 DEVELOPMENT AND COGNITIVE 549 00:27:42,000 --> 00:27:49,360 PROCESSING OF THESE CHILDREN AND 550 00:27:49,360 --> 00:27:54,200 HOW IT IDENTIFIES FACTORS THAT 551 00:27:54,200 --> 00:27:57,040 SHOULD BE ACTIONABLE TO PREVENT 552 00:27:57,040 --> 00:28:02,360 AFFECTS FROM LOW-INCOME FAMILIES 553 00:28:02,360 --> 00:28:05,240 AND LACK OF OPPORTUNITYIES BUT 554 00:28:05,240 --> 00:28:07,200 HAS COME OUT WITH RESEARCH AND 555 00:28:07,200 --> 00:28:07,840 KNOWLEDGE RELEVANT TO THE 556 00:28:07,840 --> 00:28:11,400 CHALLENGES WE'RE FACING AS IT 557 00:28:11,400 --> 00:28:13,920 RELATES TO EVERYDAY LIFE FOR 558 00:28:13,920 --> 00:28:16,280 TEENAGERS SUCH AS THE USE OF 559 00:28:16,280 --> 00:28:16,600 SOCIAL MEDIA. 560 00:28:16,600 --> 00:28:18,760 THERE'S BEEN AN ENORMOUS AMOUNT 561 00:28:18,760 --> 00:28:22,280 OF CONCERN FOR THE INCREASING 562 00:28:22,280 --> 00:28:27,440 UTILIZATION OF SOCIAL MEDIA BY 563 00:28:27,440 --> 00:28:33,600 TEENAGERS AND LACKING AT USE AT 564 00:28:33,600 --> 00:28:36,640 SOCIAL MEDIA OR SCREEN TIME HAS 565 00:28:36,640 --> 00:28:40,840 BEEN ASSOCIATED PARTICULARLY 566 00:28:40,840 --> 00:28:42,280 AMONG BOYS FROM THE ABC HAVE A 567 00:28:42,280 --> 00:28:42,840 HIGHER RISK OF ANXIETY AND 568 00:28:42,840 --> 00:28:46,280 DEPRESSION. 569 00:28:46,280 --> 00:28:47,840 THERE'S FINDINGS THAT INDICATE 570 00:28:47,840 --> 00:28:53,440 MANY HOURS OF VIDEO GAMING ARE 571 00:28:53,440 --> 00:28:55,080 ASSOCIATED WITH BETTER 572 00:28:55,080 --> 00:28:55,720 PERFORMANCE ON REACTION TIMES 573 00:28:55,720 --> 00:29:00,480 AND WORKING MEMORY. 574 00:29:00,480 --> 00:29:03,400 THE POTENTIAL BOTH FOR GOOD AND 575 00:29:03,400 --> 00:29:06,360 BAD FOR THESE SOCIAL MEDIA 576 00:29:06,360 --> 00:29:08,200 PLATFORMS TO INFLUENCE THE WELL 577 00:29:08,200 --> 00:29:10,800 BEING OF ADOLESCENCE AND IT'S 578 00:29:10,800 --> 00:29:12,720 RESEARCH LIKE THIS ONE 579 00:29:12,720 --> 00:29:14,040 ULTIMATELY THAT CAN GIVE US A 580 00:29:14,040 --> 00:29:19,640 PERSPECTIVE OF HOW TO TARGET IT. 581 00:29:19,640 --> 00:29:21,080 AS WE KNOW IT'S LIKELY THERE'LL 582 00:29:21,080 --> 00:29:23,640 BE SIGNIFICANT DIFFERENCES 583 00:29:23,640 --> 00:29:24,600 BETWEEN ADOLESCENTS. 584 00:29:24,600 --> 00:29:25,720 SOME WILL BE MORE VULNERABLE 585 00:29:25,720 --> 00:29:26,880 THAN OTHERS AND MANY ARE NOT 586 00:29:26,880 --> 00:29:29,920 JUST GOING TO BE RELATED TO 587 00:29:29,920 --> 00:29:33,400 GENETICS AND BIOLOGY. 588 00:29:33,400 --> 00:29:34,760 ALSO BY THEIR SOCIAL SITUATION 589 00:29:34,760 --> 00:29:40,240 AND OTHER ALTERNATIVES AS A 590 00:29:40,240 --> 00:29:40,520 TEENAGER. 591 00:29:40,520 --> 00:29:43,000 FOR THE ABC WE LAUNCHED A 592 00:29:43,000 --> 00:29:44,440 TWO-YEAR PILOT AND THAT WAS 593 00:29:44,440 --> 00:29:46,120 COMPLETED AND WE PROVIDED THE 594 00:29:46,120 --> 00:29:50,280 FUNDING AND I THINK IN SEPTEMBER 595 00:29:50,280 --> 00:29:53,560 TO THE SITES THAT ARE GOING TO 596 00:29:53,560 --> 00:29:53,960 BE FUNDED. 597 00:29:53,960 --> 00:29:54,760 IT'S 27. 598 00:29:54,760 --> 00:29:57,640 I HAVE A MISTAKE BECAUSE WE DID 599 00:29:57,640 --> 00:29:59,920 INCREASE IT. 600 00:29:59,920 --> 00:30:05,360 27 SITES THAT ARE GOING TO BE 601 00:30:05,360 --> 00:30:15,920 FUNDED AND THEY ARE FINALIZING 602 00:30:16,200 --> 00:30:17,000 THE PILOTING WORK AND HAVE TO BE 603 00:30:17,000 --> 00:30:20,240 PASSED BY A CENTRALIZED IRB. 604 00:30:20,240 --> 00:30:21,640 THE PROTOCOL HAS FINALIZED FOR 605 00:30:21,640 --> 00:30:31,960 ONE TO THREE VISITS. 606 00:30:32,960 --> 00:30:34,920 THE ENROLLMENT OF THE STUDY 607 00:30:34,920 --> 00:30:37,320 COHORT ARE EXPECTED IN MAY. 608 00:30:37,320 --> 00:30:38,560 THESE THE NUMBERS IN TERMS OF 609 00:30:38,560 --> 00:30:41,680 ENROLLMENT FOR THE PILOTING OF 610 00:30:41,680 --> 00:30:42,360 THE DIFFERENT SITES THAT HAVE 611 00:30:42,360 --> 00:30:52,240 BEEN GRANTED THE FUNDS. 612 00:30:52,240 --> 00:30:53,920 THIS IS HIGHLIGHTING A PROJECT 613 00:30:53,920 --> 00:30:56,640 DONE WITH OTHER INSTITUTES AND 614 00:30:56,640 --> 00:31:01,120 WITH PARTNERSHIP FUNDING FROM 615 00:31:01,120 --> 00:31:05,920 THE HEAL INITIATIVE. 616 00:31:05,920 --> 00:31:11,160 THAT LEADS ME TO JUMP INTO THE 617 00:31:11,160 --> 00:31:11,960 OVERDOSE CRISIS. 618 00:31:11,960 --> 00:31:13,400 THIS IS THE MOST RECENT DATA 619 00:31:13,400 --> 00:31:16,400 FROM CDC THAT GOES TO THE LAST 620 00:31:16,400 --> 00:31:26,880 12 MONTHS FROM OCTOBER 2022. 621 00:31:35,680 --> 00:31:37,320 THE INCREASE IS NOT THE SAME AS 622 00:31:37,320 --> 00:31:38,560 THE FIRST YEAR AND SECOND YEAR. 623 00:31:38,560 --> 00:31:43,920 THE RATE OF INCREASE SEEMS TO 624 00:31:43,920 --> 00:31:47,560 HAVE BEEN SLOWING DOWN EACH 625 00:31:47,560 --> 00:31:52,840 TELLS YOU THE OVERDOSE 626 00:31:52,840 --> 00:32:03,040 MORTALITY. 627 00:32:03,040 --> 00:32:05,640 MANY OF THESE OVERDOSE DEATHS 628 00:32:05,640 --> 00:32:06,280 ARE OBSERVED IN COMBINATION WITH 629 00:32:06,280 --> 00:32:14,680 FENTANYL. 630 00:32:14,680 --> 00:32:19,800 IT DOES HIGHLIGHT IT'S SYNTHETIC 631 00:32:19,800 --> 00:32:21,880 DRUGS AND FENTANYL THE MAIN 632 00:32:21,880 --> 00:32:26,360 CAUSE OF MORTALITY. 633 00:32:26,360 --> 00:32:27,000 73,000 PEOPLE DIED IN THE UNITED 634 00:32:27,000 --> 00:32:28,960 STATES IN ONE YEAR FROM 635 00:32:28,960 --> 00:32:29,200 FENTANYL. 636 00:32:29,200 --> 00:32:34,680 OF THE DEATHS FROM COCAINE AND 637 00:32:34,680 --> 00:32:37,880 AMPHETAMINE IT'S ESTIMATED THE 638 00:32:37,880 --> 00:32:39,000 MAJORITY HAD FENTANYL ON BOARD 639 00:32:39,000 --> 00:32:43,400 AND YOU SEE A RISE IN MORTALITY 640 00:32:43,400 --> 00:32:48,360 FROM COCAINE AND 641 00:32:48,360 --> 00:32:48,720 METHAMPHETAMINE. 642 00:32:48,720 --> 00:32:50,240 THIS YEAR WE'RE SEEING GREATER 643 00:32:50,240 --> 00:32:55,000 RISES IN COCAINE LIKELY TO BE IN 644 00:32:55,000 --> 00:32:56,360 PART DUE TO THE AVAILABILITY OF 645 00:32:56,360 --> 00:33:05,840 THE DRUGS ACROSS THE COUNTRY. 646 00:33:05,840 --> 00:33:08,440 HEROIN CONTINUES TO GO DOWN. 647 00:33:08,440 --> 00:33:19,000 THERE'S A DECREASES IN DEATH AND 648 00:33:20,360 --> 00:33:22,920 THE OVERDOSE MORTALITY FROM 649 00:33:22,920 --> 00:33:27,080 METHADONE CONTINUES TO GO DOWN. 650 00:33:27,080 --> 00:33:30,640 THIS IS NOT BECAUSE WITH THE 651 00:33:30,640 --> 00:33:31,880 COVID PANDEMIC WITH THE V.A. AND 652 00:33:31,880 --> 00:33:35,800 SAMHSA MADE IT EASIER TO HAVE 653 00:33:35,800 --> 00:33:36,240 TAKE-HOME METHADONE. 654 00:33:36,240 --> 00:33:39,240 IT WAS CONCERNED THAT WOULD LEAD 655 00:33:39,240 --> 00:33:41,840 TO INCREASE IN MORTALITY. 656 00:33:41,840 --> 00:33:51,240 THE DIDN'T MATERIALIZE AND SO 657 00:33:51,240 --> 00:33:55,600 WHAT ARE THE STRATEGIES FROM THE 658 00:33:55,600 --> 00:33:57,400 PERSPECTIVE OF SCIENCE AND HOW 659 00:33:57,400 --> 00:34:01,360 DO WE PROMOTE RESEARCH TO HELP 660 00:34:01,360 --> 00:34:11,600 ADDRESS IT? 661 00:34:13,840 --> 00:34:19,280 BOTTOM LINE IS WE HAVE TOOLS TO 662 00:34:19,280 --> 00:34:23,760 PREVENT OVERDOSES AND RECAN 663 00:34:23,760 --> 00:34:26,320 REDUCE THE RISK OF OVERDOSE BUT 664 00:34:26,320 --> 00:34:27,960 YOU HAVE TO HAVE PATIENTS KEEP 665 00:34:27,960 --> 00:34:31,200 ON TAKING IT. 666 00:34:31,200 --> 00:34:32,800 ALSO, NALOXONE ADMINISTRATION IF 667 00:34:32,800 --> 00:34:34,400 YOU GIVE IT IN THE RIGHT DOSE IN 668 00:34:34,400 --> 00:34:37,400 A TIMELY FASHION, YOU WILL SAVE 669 00:34:37,400 --> 00:34:41,680 THE LIFE OF THAT PERSON. 670 00:34:41,680 --> 00:34:44,320 THOSE ARE THE NUMBERS WE GET AND 671 00:34:44,320 --> 00:34:48,480 I PRESENTED IT LAST COUNCIL AND 672 00:34:48,480 --> 00:34:51,480 WE CAN'T IGNORE THE NUMBER OF 673 00:34:51,480 --> 00:34:52,880 PEOPLE THAT HAVE DIED FROM AN 674 00:34:52,880 --> 00:34:54,880 OVERDOSE THAT RECEIVED 675 00:34:54,880 --> 00:34:59,800 MEDICATIONS FOR OPIOID USE 676 00:34:59,800 --> 00:35:02,120 DISORDER IN AVERAGE LESS, 16.4% 677 00:35:02,120 --> 00:35:06,280 AND SOME HAVING LOWER LEVELS OF 678 00:35:06,280 --> 00:35:07,320 PRESCRIPTION AND THESE ARE 679 00:35:07,320 --> 00:35:08,320 AFRICAN AMERICAN. 680 00:35:08,320 --> 00:35:09,960 SIMILARLY, LOOK AT THE NUMBERS 681 00:35:09,960 --> 00:35:12,160 OF INDIVIDUALS WHO DIED FROM AN 682 00:35:12,160 --> 00:35:17,920 OVERDOSE WHO RECEIVED NALOXONE. 683 00:35:17,920 --> 00:35:20,320 IT'S LESS THAN 20%. 684 00:35:20,320 --> 00:35:23,440 WHAT DO WE NEED TO DO TO EXPAND 685 00:35:23,440 --> 00:35:25,040 ACCESS TO MEDICATION AND IMPROVE 686 00:35:25,040 --> 00:35:28,040 RETENTION AND EXPAND AND BE MORE 687 00:35:28,040 --> 00:35:33,680 SUCCESSFUL IN ADMINISTERING 688 00:35:33,680 --> 00:35:35,800 NALOXONE. 689 00:35:35,800 --> 00:35:38,720 WE HAVE INITIATED PROJECTS AND 690 00:35:38,720 --> 00:35:40,560 EXPAND CLINICAL TRIALS TO DO 691 00:35:40,560 --> 00:35:41,960 UNDER THE NIDA CLINICAL TRIAL 692 00:35:41,960 --> 00:35:47,600 NETWORK AND EXPAND THE NUMBER OF 693 00:35:47,600 --> 00:35:54,440 SITES. 694 00:35:54,440 --> 00:35:58,040 THESE ARE BEING PERFORMED BY THE 695 00:35:58,040 --> 00:35:59,480 CLINICAL TRIAL NETWORK AND THE 696 00:35:59,480 --> 00:36:03,960 ONE I'LL BE HIGHLIGHTING IS TO 697 00:36:03,960 --> 00:36:07,400 UNDERSTAND THE HOW TO TREAT 698 00:36:07,400 --> 00:36:08,640 THRESHOLD OPIOID USE DISORDER OR 699 00:36:08,640 --> 00:36:09,720 MILD OPIOID USE DISORDER. 700 00:36:09,720 --> 00:36:15,280 THIS IS AN AREA WHERE WE HAVE 701 00:36:15,280 --> 00:36:22,280 LIMITED RESEARCH AND THERE'S 702 00:36:22,280 --> 00:36:23,920 DRUGS WITH FENTANYL OCCASIONAL 703 00:36:23,920 --> 00:36:25,520 USE OF OPIOID I AM POSES A RISK 704 00:36:25,520 --> 00:36:32,080 FOR OVERDOSES. 705 00:36:32,080 --> 00:36:33,520 FOR THE NETWORK AND THERE'S 706 00:36:33,520 --> 00:36:36,760 SEVERAL PROJECTS THAT GO FROM 707 00:36:36,760 --> 00:36:37,520 RANDOMIZED CLINICAL TRIALS TO 708 00:36:37,520 --> 00:36:39,240 HOW TO IMPLEMENT MEDICATIONS FOR 709 00:36:39,240 --> 00:36:42,280 OPIOID USE DISORDER TO WHAT ARE 710 00:36:42,280 --> 00:36:46,160 THE MODELS WE SAW TO BETTER OUR 711 00:36:46,160 --> 00:36:50,200 RETENTION OF PEOPLE IN TREATMENT 712 00:36:50,200 --> 00:36:52,600 AND MINIMIZE REINCARCERATION. 713 00:36:52,600 --> 00:36:59,160 THIS HAS BEEN AN EXTRAORDINARY 714 00:36:59,160 --> 00:37:01,880 SUCCESSFUL INITIATIVE NOT JUST 715 00:37:01,880 --> 00:37:03,880 IN TERMS OF RESEARCH FINDINGS 716 00:37:03,880 --> 00:37:05,880 BUT MORE IMPORTANTLY THROUGH THE 717 00:37:05,880 --> 00:37:09,920 PARTNERSHIP WE HAVE BEEN ABLE TO 718 00:37:09,920 --> 00:37:12,000 SLOWLY AND FINALLY START TO 719 00:37:12,000 --> 00:37:13,720 CHANGE THE CULTURE IN THE 720 00:37:13,720 --> 00:37:18,960 SETTINGS TO BE MORE OPEN TO 721 00:37:18,960 --> 00:37:20,560 PROVIDING TREATMENT FOR 722 00:37:20,560 --> 00:37:21,880 SUBSTANCE USE DISORDERS AND TO 723 00:37:21,880 --> 00:37:25,040 PROVIDE WITH MEDICATIONS FOR THE 724 00:37:25,040 --> 00:37:27,000 TREATMENT OF OPIOID USE DISORDER 725 00:37:27,000 --> 00:37:28,840 AS WELL AS RECOGNITION OF THE 726 00:37:28,840 --> 00:37:34,240 IMPORTANCE OF LINKAGE OF CARE TO 727 00:37:34,240 --> 00:37:36,160 THE COMMUNITY ONCE THEY LEAVE 728 00:37:36,160 --> 00:37:37,800 THE JAIL SYSTEM. 729 00:37:37,800 --> 00:37:44,080 THE FINAL ONE IS THE COMMUNITY 730 00:37:44,080 --> 00:37:51,160 STUDY WHICH HAS FOUR STATES TO 731 00:37:51,160 --> 00:37:55,080 DEVELOP MODELS THAT CAN MAKE 732 00:37:55,080 --> 00:37:57,200 JUSTICE, HEALTH CARE, STATE AND 733 00:37:57,200 --> 00:38:03,000 COMMUNITY PROVIDERS IN A 734 00:38:03,000 --> 00:38:09,920 HARMONIZED WAY AS A MEANS TO 735 00:38:09,920 --> 00:38:10,680 REDUCE OVERDOSE DEATHS AND 736 00:38:10,680 --> 00:38:12,480 DESPITE THE CHALLENGES OF THE 737 00:38:12,480 --> 00:38:14,080 COVID PANDEMIC HAS BEEN ABLE TO 738 00:38:14,080 --> 00:38:15,880 MAKE MAJOR CONVENIENCES. 739 00:38:15,880 --> 00:38:16,560 -- ADVANCES. 740 00:38:16,560 --> 00:38:18,240 WE WANT TO COME BACK TO THE DATA 741 00:38:18,240 --> 00:38:25,480 AGAIN. 742 00:38:25,480 --> 00:38:26,600 WE GUIDE FROM THE BASIC 743 00:38:26,600 --> 00:38:31,800 KNOWLEDGE AND OUR UNDERSTANDING 744 00:38:31,800 --> 00:38:34,200 TO ARRIVE AT INTERVENTIONS THAT 745 00:38:34,200 --> 00:38:37,040 WILL BE NEEDED AND I WANT TO 746 00:38:37,040 --> 00:38:42,000 EMPHASIZE FENTANYL AGAIN. 747 00:38:42,000 --> 00:38:45,800 THIS FENTANYL AND IT'S DRIVING 748 00:38:45,800 --> 00:38:47,560 THAT INCREASING DRIVE IN 749 00:38:47,560 --> 00:38:48,320 OVERDOSE MORTALITY. 750 00:38:48,320 --> 00:38:50,840 THIS IS EMERGING IN 2016 AND 751 00:38:50,840 --> 00:38:52,320 IT'S GONE UP AND UP AND UP AND 752 00:38:52,320 --> 00:38:53,000 PEOPLE ARE DYING. 753 00:38:53,000 --> 00:38:55,760 SO THIS IS DRIVEN BY TWO 754 00:38:55,760 --> 00:38:56,040 FACTORS. 755 00:38:56,040 --> 00:38:59,960 ONE IS PHARMACOLOGIC AND FOR US 756 00:38:59,960 --> 00:39:03,240 AS AN AGENCY UNDERSTANDING THE 757 00:39:03,240 --> 00:39:04,520 PHARMACOLOGIC CHARACTERISTICS AS 758 00:39:04,520 --> 00:39:07,400 A WAY OF TAILORING 759 00:39:07,400 --> 00:39:08,000 INTERVENTIONS. 760 00:39:08,000 --> 00:39:14,920 THE OTHER ONE IS THE MASSIVE 761 00:39:14,920 --> 00:39:16,280 PROFIT DEALING WITH HAS GIVEN TO 762 00:39:16,280 --> 00:39:17,920 THE MARKET THAT'S A DIFFERENT 763 00:39:17,920 --> 00:39:20,120 TYPE OF CHALLENGE. 764 00:39:20,120 --> 00:39:21,760 FROM THE PERSPECTIVE OF 765 00:39:21,760 --> 00:39:22,760 PHARMACOLOGY, WE KNOW FENTANYL 766 00:39:22,760 --> 00:39:24,680 IS VERY POTENT. 767 00:39:24,680 --> 00:39:27,680 THE NUMBER THAT IS USED IN 768 00:39:27,680 --> 00:39:30,120 GENERAL IS 50 TIMES MORE POTENT 769 00:39:30,120 --> 00:39:32,120 THAN HEROIN. 770 00:39:32,120 --> 00:39:34,680 WHAT THAT MEANS IS A 2 MILLIGRAM 771 00:39:34,680 --> 00:39:37,000 DOSE OF FENTANYL CAN BE LETHAL. 772 00:39:37,000 --> 00:39:41,960 SO WE HAVE A VERY POTENT DRUG 773 00:39:41,960 --> 00:39:44,320 THAT CAN RESULT IN DEPRESSION 774 00:39:44,320 --> 00:39:48,040 AND OVERDOSE AND DEATH AT 775 00:39:48,040 --> 00:39:49,440 RELATIVELY LOW DOSE AND IT'S 776 00:39:49,440 --> 00:39:50,600 ALSO A HIGHLY REWARDING DRUG 777 00:39:50,600 --> 00:39:55,920 THAT CAN PRODUCE ADDICTION. 778 00:39:55,920 --> 00:40:00,080 WE'RE SEEING PEOPLE THAT ARE 779 00:40:00,080 --> 00:40:02,080 SEEKING OUT FENTANYL AND WHEN 780 00:40:02,080 --> 00:40:03,960 THEY COMBINE IT WITH OTHER DRUGS 781 00:40:03,960 --> 00:40:05,080 THERE'S NO STANDARD. 782 00:40:05,080 --> 00:40:10,120 THE CONTENT OF FENTANYL OF THE 783 00:40:10,120 --> 00:40:17,600 PRODUCTS VARIES ENORMOUSLY AND 784 00:40:17,600 --> 00:40:26,680 THEY FOUND A RANGE OF DOSES FROM 785 00:40:26,680 --> 00:40:32,520 .02 TO .05 MILLIGRAM TO KILL YOU 786 00:40:32,520 --> 00:40:34,840 TWICE AND THIS IS THE ELEMENT 787 00:40:34,840 --> 00:40:37,400 WHEN SOMEONE CONSUMES DRUGS. 788 00:40:37,400 --> 00:40:42,640 ANOTHER ASPECT THAT HAS 789 00:40:42,640 --> 00:40:49,400 ATTRACTED ATTENTION FROM THE 790 00:40:49,400 --> 00:40:56,120 LOOKING AT THE OVERDOSE THIS 791 00:40:56,120 --> 00:41:05,360 GETS INTO THE BRAIN AND CAUSES 792 00:41:05,360 --> 00:41:08,120 RESPIRATORY DEPRESSION AND THE 793 00:41:08,120 --> 00:41:11,360 TIME TO ADMINISTER NALOXONE 794 00:41:11,360 --> 00:41:12,440 CONSTRAINED AND THIS IS WHERE 795 00:41:12,440 --> 00:41:17,640 RESEARCHERS WERE THINKING HOW WE 796 00:41:17,640 --> 00:41:21,720 CAN TACK A LOT. 797 00:41:22,000 --> 00:41:26,640 THE OTHER ASPECT IS OVERDOSE 798 00:41:26,640 --> 00:41:27,840 REVERSES FROM FENTANYL HIGHER 799 00:41:27,840 --> 00:41:28,040 DOSES. 800 00:41:28,040 --> 00:41:30,480 THIS IS CONSISTENT WITH ANIMAL 801 00:41:30,480 --> 00:41:30,960 DATA. 802 00:41:30,960 --> 00:41:37,640 WE NEED TO GIVE HIGHER DOSE OF 803 00:41:37,640 --> 00:41:41,920 NALOXONE TO REVERSE RESPIRATORY 804 00:41:41,920 --> 00:41:44,280 DEPRESSION AND THEY FREQUENTLY 805 00:41:44,280 --> 00:41:46,560 REQUIRE MULTIPLE DOSES AND THIS 806 00:41:46,560 --> 00:41:47,760 IS BEING REPORTED THROUGH THE 807 00:41:47,760 --> 00:41:53,520 LITERATURE AND WHAT WE KNOW IS 808 00:41:53,520 --> 00:41:58,760 NALOXONE USE HAS BEEN GOING UP 809 00:41:58,760 --> 00:42:00,240 AND UP AND THERE'S INSTANCES 810 00:42:00,240 --> 00:42:01,440 WHERE MORE THAN 10 DOSES HAD TO 811 00:42:01,440 --> 00:42:02,680 BE REPEATED. 812 00:42:02,680 --> 00:42:06,080 THE OTHER COMPONENT THAT IS 813 00:42:06,080 --> 00:42:07,960 RELEVANT IS THE PHYSICAL 814 00:42:07,960 --> 00:42:09,360 DEPENDENCE PRODUCED BY FENTANYL 815 00:42:09,360 --> 00:42:12,160 BECAUSE OF THE HIGH POTENCY IS 816 00:42:12,160 --> 00:42:17,640 STRONGER THAN HEROIN. 817 00:42:17,640 --> 00:42:22,080 IT'S A CHALLENGE TO GET INTO 818 00:42:22,080 --> 00:42:27,000 TREATMENT THOSE WITH THIS 819 00:42:27,000 --> 00:42:30,200 DISORDER AND THERE'S SUCCESS 820 00:42:30,200 --> 00:42:36,760 WITH BUPRENORPHINE AND THE RATE 821 00:42:36,760 --> 00:42:40,920 OF RELAPSE WITH PEOPLE TAKING 822 00:42:40,920 --> 00:42:44,160 BUPRENORPHINE THE 823 00:42:44,160 --> 00:42:45,720 DISCONTINUATION IS HIGHER THAN 824 00:42:45,720 --> 00:42:49,000 THOSE WITH FENTANYL USE DISORDER 825 00:42:49,000 --> 00:42:52,880 AND THERE'S EVIDENCE SOME 826 00:42:52,880 --> 00:42:53,960 INDIVIDUALS THE INITIATION OF 827 00:42:53,960 --> 00:43:03,720 BREW PREN -- BUPRENORPHINE IS 828 00:43:03,720 --> 00:43:07,240 BEING EFFECTIVE AND THE DIAGRAM 829 00:43:07,240 --> 00:43:08,200 JUST PUBLISHED RECENTLY BRINGS 830 00:43:08,200 --> 00:43:14,440 FORWARD THE NOTION OF HOW WE CAN 831 00:43:14,440 --> 00:43:21,800 START TO LOOK AT IT AND LOOKED 832 00:43:21,800 --> 00:43:24,760 AT FENTANYL GETTING TO THE BRAIN 833 00:43:24,760 --> 00:43:27,960 RAPIDLY AND THE LIPO PHILIC 834 00:43:27,960 --> 00:43:32,000 NATURE ALLOWS IT TO INSERT 835 00:43:32,000 --> 00:43:33,960 ITSELF IN THE MEMBRANES AND 836 00:43:33,960 --> 00:43:39,720 ACCUMULATE BY THE SITE OF THE 837 00:43:39,720 --> 00:43:40,000 RECEPTOR. 838 00:43:40,000 --> 00:43:43,080 IT'S SURROUNDED BY AN ACQUEOUS 839 00:43:43,080 --> 00:43:44,480 ENVIRONMENT AND FENTANYL ALSO 840 00:43:44,480 --> 00:43:48,040 GETS THERE AND BUPRENORPHINE. 841 00:43:48,040 --> 00:43:51,440 WHEN YOU GIVE NALOXONE IT GOES 842 00:43:51,440 --> 00:43:54,320 TO THE SITE AND THROWS OUT 843 00:43:54,320 --> 00:43:57,360 WHETHER IT IS BOUND TO MORE TEEN 844 00:43:57,360 --> 00:43:58,120 OR FENTANYL. 845 00:43:58,120 --> 00:44:00,520 AND NALOXONE CANNOT GET ITSELF 846 00:44:00,520 --> 00:44:05,800 TO THE MEMBRANE AND THE FENTANYL 847 00:44:05,800 --> 00:44:08,440 MOVES TOWARDS OCCUPYING THE SITE 848 00:44:08,440 --> 00:44:11,040 AND THEY EXPLAIN THIS MAY BE THE 849 00:44:11,040 --> 00:44:14,720 REASON WHY WHEN YOU GIVE 850 00:44:14,720 --> 00:44:19,680 NALOXONE WITH FENTANYL YOU 851 00:44:19,680 --> 00:44:21,280 ACTUALLY CAN RESTORE 852 00:44:21,280 --> 00:44:21,600 RESPIRATION. 853 00:44:21,600 --> 00:44:24,120 BUT IN THE CASE OF FENTANYL, 854 00:44:24,120 --> 00:44:27,320 ONCE YOU MOVE NALOXONE OUT OF 855 00:44:27,320 --> 00:44:28,800 THE PREPARATION, YOU AGAIN SEE 856 00:44:28,800 --> 00:44:33,120 THE RESPIRATION GOES DOWN. 857 00:44:33,120 --> 00:44:41,160 TO THE EXTENT THIS IS AN ISSUE 858 00:44:41,160 --> 00:44:51,640 THAT COULD EXPLAIN WHY AND 859 00:44:59,200 --> 00:45:00,160 THERE'S MAYBE A NOTION THAT 860 00:45:00,160 --> 00:45:07,520 PERHAPS LOOKING AT OPIOIDS THAT 861 00:45:07,520 --> 00:45:13,480 HAVE THE LIPOFELICITY MAY HAVE 862 00:45:13,480 --> 00:45:15,200 AN INTERVENTION TO GET RID OF 863 00:45:15,200 --> 00:45:20,000 THE ACCUMULATION BY THE RECEPTOR 864 00:45:20,000 --> 00:45:21,760 SUCH THAT IF YOU WERE DO GIVE 865 00:45:21,760 --> 00:45:27,040 THIS ONE WOULD BE BUPRENORPHINE 866 00:45:27,040 --> 00:45:29,400 SUCH THAT YOU WILL NOT PRODUCE 867 00:45:29,400 --> 00:45:32,120 THIS BUMPING UP WITH FENTANYL 868 00:45:32,120 --> 00:45:38,040 AFTER THE DRUG HAS BEEN REMOVED. 869 00:45:38,040 --> 00:45:41,480 AND IT HIGHLIGHTS WHY IT'S 870 00:45:41,480 --> 00:45:43,360 IMPORTANT FOR US TO ADVANCE 871 00:45:43,360 --> 00:45:48,120 BASIC PHARMACOLOGY AND IT'S 872 00:45:48,120 --> 00:45:54,440 IMPORTANT TO ADVANCE ALTERNATIVE 873 00:45:54,440 --> 00:45:55,920 MEDICATIONS FOR REVERSAL AND 874 00:45:55,920 --> 00:46:01,640 IT'S NOT JUST FENTANYL BUT THE 875 00:46:01,640 --> 00:46:07,440 ENORMOUS PROFITS COMING ABOUT BY 876 00:46:07,440 --> 00:46:08,640 THE SALE OF FENTANYL. 877 00:46:08,640 --> 00:46:10,200 THIS IS BECAUSE YOU DON'T HAVE 878 00:46:10,200 --> 00:46:12,280 TO CULTIVATE ANYTHING AND SUPPLY 879 00:46:12,280 --> 00:46:15,160 CHAINS ARE ABSENT. 880 00:46:15,160 --> 00:46:20,760 THE SYNTHESIS OF FENTANYL IS 881 00:46:20,760 --> 00:46:27,880 RELATIVELY EASY. 882 00:46:27,880 --> 00:46:31,280 AS A RESULT YOU HAVE WHAT ISSESE 883 00:46:31,280 --> 00:46:33,920 TO GET IN OTHER COUNTRIES AND 884 00:46:33,920 --> 00:46:44,480 CAN BE TRANSPORTED EASILY AND TO 885 00:46:50,800 --> 00:46:53,280 THE HIGH POTENCY OF FENTANYL HAS 886 00:46:53,280 --> 00:46:58,040 BECOME AN INCENTIVE FOR DRUG 887 00:46:58,040 --> 00:46:58,920 DEALERS TO STOP OTHER DRUGS THAT 888 00:46:58,920 --> 00:47:03,720 ARE HARDER TO PRODUCE, LIKE 889 00:47:03,720 --> 00:47:07,320 COCAINE OR HEROIN THEY'RE 890 00:47:07,320 --> 00:47:09,400 DILUTING THOSE DRUGS AND A BIT 891 00:47:09,400 --> 00:47:11,520 OF FENTANYL WILL MAKE A POWERFUL 892 00:47:11,520 --> 00:47:14,200 DRUG AND THE PROFIT SO MUCH 893 00:47:14,200 --> 00:47:16,320 LARGER WITH FENTANYL THAN WITH 894 00:47:16,320 --> 00:47:19,440 ANY OTHER DRUG WE KNOW OF 895 00:47:19,440 --> 00:47:30,080 INCLUDING ILLICITLY MANUFACTURED 896 00:47:31,480 --> 00:47:37,120 DRUGS AND THEY'RE DISGUISING THE 897 00:47:37,120 --> 00:47:41,920 MANUFACTURING OF FILLS WHICH ARE 898 00:47:41,920 --> 00:47:49,560 BASICALLY FENTANYL. 899 00:47:49,560 --> 00:47:50,680 THESE PEOPLE ARE NOW VULNERABLE 900 00:47:50,680 --> 00:48:00,480 TO HAVING AN OVERDOSE. 901 00:48:00,480 --> 00:48:05,880 OVERDOSE FATALITIES HAVE 902 00:48:05,880 --> 00:48:07,440 INCREASED BY TEENAGERS AND IT 903 00:48:07,440 --> 00:48:15,680 KEEPS GOING UP. 904 00:48:15,680 --> 00:48:19,960 THIS IS DRIVEN LIKELY BY 905 00:48:19,960 --> 00:48:27,760 TEENAGERS BECAUSE THEY CONSUME 906 00:48:27,760 --> 00:48:30,440 STIMULANTS AND THEY MAY BE 907 00:48:30,440 --> 00:48:32,080 OCCASIONAL LIKE PEOPLE NOT DRUG 908 00:48:32,080 --> 00:48:34,600 USERS MAY OCCASIONALLY CONSUME 909 00:48:34,600 --> 00:48:35,680 THESE DRUGS THEY BUY FROM THE 910 00:48:35,680 --> 00:48:39,440 WEB BECAUSE THEY CANNOT GET 911 00:48:39,440 --> 00:48:41,440 PHYSICIANS TO PRESCRIBE THEM. 912 00:48:41,440 --> 00:48:42,520 THIS MAKES THE WHOLE CHALLENGE 913 00:48:42,520 --> 00:48:44,080 OF CONTROLLING THE OVERDOSE 914 00:48:44,080 --> 00:48:53,560 CRISIS WORSE. 915 00:48:53,560 --> 00:48:57,520 I WANT TO FOLLOW UP ON THE DEATH 916 00:48:57,520 --> 00:49:08,040 OF TEENAGERS AND YEARS LOST AND 917 00:49:12,280 --> 00:49:13,680 IT'S BASICALLY DOUBLED. 918 00:49:13,680 --> 00:49:19,240 PERHAPS MORE THAN DOUBLES. 919 00:49:19,240 --> 00:49:21,920 I'M SHOWING IT HERE THAT AND 920 00:49:21,920 --> 00:49:26,920 IT'S NOT JUST A NUMBER OF KIDS 921 00:49:26,920 --> 00:49:30,080 DYING BUT THERE'S A HUGE IMPACT 922 00:49:30,080 --> 00:49:34,560 IN LIVES LOST. 923 00:49:34,560 --> 00:49:35,880 I THINK IT DESERVES ATTENTION IN 924 00:49:35,880 --> 00:49:37,800 GENERAL AND I WANT TO PUT IT IN 925 00:49:37,800 --> 00:49:40,280 YOUR BRAINS, MALES HAVE A 926 00:49:40,280 --> 00:49:43,880 GREATER RATES OF OVERDOSE 927 00:49:43,880 --> 00:49:47,360 MORTALITIIES THAN FEMALES AND 928 00:49:47,360 --> 00:49:52,080 IT'S ACTUALLY THE RATE OF 929 00:49:52,080 --> 00:49:55,320 MORTALITY FROM OVERDOSES THE 930 00:49:55,320 --> 00:49:57,480 DIFFERENCE BETWEEN MALES AND 931 00:49:57,480 --> 00:50:00,320 FEMALES IS LARGER IN OVERDOSE 932 00:50:00,320 --> 00:50:00,720 MORTALITY. 933 00:50:00,720 --> 00:50:02,160 THE DIFFERENCE IS DIFFERENT IN 934 00:50:02,160 --> 00:50:04,000 THE PATTERNS OF CONSUMPTION OR 935 00:50:04,000 --> 00:50:08,840 OPIOID USE DISORDER. 936 00:50:08,840 --> 00:50:10,120 UNDERSTANDING THE PATTERNS AND 937 00:50:10,120 --> 00:50:16,200 HOW THEY'RE TAKING THE DRUGS IN 938 00:50:16,200 --> 00:50:22,960 GREATER RISK ANOTHER ITEM 939 00:50:22,960 --> 00:50:24,840 RELEVANT WE'RE SEEING MORE AND 940 00:50:24,840 --> 00:50:27,840 MORE DRUG COMBINATIONS CAUSING 941 00:50:27,840 --> 00:50:29,400 PEOPLE TO DIE AND DRUGS 942 00:50:29,400 --> 00:50:30,840 CONTRIBUTING MORE TO OVERDOSES. 943 00:50:30,840 --> 00:50:34,920 THE ONE THAT'S GENERATED A LOT 944 00:50:34,920 --> 00:50:45,480 OF ATTENTION IS XYLAZINE IS A 945 00:50:55,240 --> 00:51:04,520 DRUG ASSOCIATED WITH SEVERE VASO 946 00:51:04,520 --> 00:51:09,720 CONSTRICTION RESULTING IN LIMB 947 00:51:09,720 --> 00:51:10,040 AMPUTATIONS. 948 00:51:10,040 --> 00:51:16,760 THE NUMBER OF DEATHS HAVE BEEN 949 00:51:16,760 --> 00:51:17,640 GOING UP. 950 00:51:17,640 --> 00:51:26,560 AND THE DEATHS THAT HAVE 951 00:51:26,560 --> 00:51:29,960 XYLAZINE HAVE GONE UP AND 90% OF 952 00:51:29,960 --> 00:51:37,040 THE DEATHS WITH XYLAZINE ARE 953 00:51:37,040 --> 00:51:37,680 ASSOCIATED WITH OTHER DRUGS AND 954 00:51:37,680 --> 00:51:39,640 THIS IS 2020 AND THE NUMBER OF 955 00:51:39,640 --> 00:51:40,880 DEATHS IN THE NUMBER OF STATES 956 00:51:40,880 --> 00:51:47,000 WHERE THERE WAS AT LEAST ONE 957 00:51:47,000 --> 00:51:49,560 XYLAZINE DETECTED RESPONSIBLE 958 00:51:49,560 --> 00:51:59,920 FOR OVERDOGS DEATHS. 959 00:52:02,240 --> 00:52:06,960 AND THERE'S STUDIES TO 960 00:52:06,960 --> 00:52:09,920 UNDERSTAND WHY DO THEY MIX WITH 961 00:52:09,920 --> 00:52:16,920 FENTANYL AND WHAT HAS BEEN 962 00:52:16,920 --> 00:52:17,480 REPORTED MORE OR LESS 963 00:52:17,480 --> 00:52:23,560 CONSISTENCY IS TO PROLONG THE 964 00:52:23,560 --> 00:52:25,640 AFFECTS FENTANYL AND THIS COULD 965 00:52:25,640 --> 00:52:31,760 ENSURE THE DRUG IS NOT CLEARED 966 00:52:31,760 --> 00:52:33,760 FROM THE TISSUE. 967 00:52:33,760 --> 00:52:34,600 THIS IS A FIELD THAT REQUIRES 968 00:52:34,600 --> 00:52:44,880 MORE ATTENTION. 969 00:52:49,120 --> 00:52:51,840 AND THIS IS WHEN THE PRESIDENT 970 00:52:51,840 --> 00:52:55,160 SIGNED INTO LAW HR2617 THE 971 00:52:55,160 --> 00:53:00,000 CONSOLIDATED APPROPRIATIONS ACT 972 00:53:00,000 --> 00:53:09,360 FOR 2023 IN WHICH ELIMINATED THE 973 00:53:09,360 --> 00:53:19,760 WAIVER AND REMOVED THE 974 00:53:20,520 --> 00:53:21,360 BUPRENORPHINE PRESCRIBING AND 975 00:53:21,360 --> 00:53:24,280 WHAT WE NEED SO UNDERSTAND IS 976 00:53:24,280 --> 00:53:29,960 THE STATES CAN IMPLEMENT AS THEY 977 00:53:29,960 --> 00:53:30,400 WANT. 978 00:53:30,400 --> 00:53:32,480 IT IS POSSIBLE THAT WHERE SOME 979 00:53:32,480 --> 00:53:34,560 STATES MAY NOT REQUIRE THE X 980 00:53:34,560 --> 00:53:36,040 WAIVER AND REMOVE THE PATIENT 981 00:53:36,040 --> 00:53:41,440 CAP, OTHER STATES MAY NOT BE 982 00:53:41,440 --> 00:53:52,000 DOING THAT AND THIS OFFERS FROM 983 00:53:54,040 --> 00:53:55,280 THE RESEARCH PERSPECTIVE AN 984 00:53:55,280 --> 00:53:57,960 OPPORTUNITY TO UNDERSTAND HOW 985 00:53:57,960 --> 00:54:03,080 THE IMPLEMENTATION OR LACK OF 986 00:54:03,080 --> 00:54:04,320 WILL INFLUENCE THE OUTCOMES OF 987 00:54:04,320 --> 00:54:05,080 THE VARIOUS STATES. 988 00:54:05,080 --> 00:54:10,240 WITH THAT I HAVE MY LAST SLIDE. 989 00:54:10,240 --> 00:54:15,920 MORALS THE SAME SLIDE BUT NOT 990 00:54:15,920 --> 00:54:18,160 IDENTICAL AND I WANT EVERYBODY 991 00:54:18,160 --> 00:54:19,920 TO HAVE IT IN FRONT OF THEIR 992 00:54:19,920 --> 00:54:21,760 BRAIN IT ADDRESSES WHAT ASPECTS 993 00:54:21,760 --> 00:54:23,360 OF SCIENCE WE NEED TO MOVE 994 00:54:23,360 --> 00:54:23,800 FORWARD. 995 00:54:23,800 --> 00:54:25,520 HOW THE CRISIS WE'RE LIVING WITH 996 00:54:25,520 --> 00:54:26,520 THE OVERDOSE IS FORCING US TO 997 00:54:26,520 --> 00:54:32,520 THINK IN DIFFERENT WAYS. 998 00:54:32,520 --> 00:54:35,080 WE NEED TO CONTINUE DEVELOPING 999 00:54:35,080 --> 00:54:36,400 RESEARCH AND SCIENCE BECAUSE IF 1000 00:54:36,400 --> 00:54:41,960 WE DON'T, PATIENT WHO'S HAVE 1001 00:54:41,960 --> 00:54:45,920 SEVERE PAIN WILL REFER TO 1002 00:54:45,920 --> 00:54:47,560 ILLICIT OPIOIDS WHICH ARE 1003 00:54:47,560 --> 00:54:47,840 DANGEROUS. 1004 00:54:47,840 --> 00:54:50,320 WE NEED TO CONTINUE ON RESEARCH 1005 00:54:50,320 --> 00:54:52,200 AND NOT JUST FROM IMPLEMENTATION 1006 00:54:52,200 --> 00:54:53,840 AND SERVICES RESEARCH WHICH IS 1007 00:54:53,840 --> 00:54:57,520 CRUCIAL BUT ALSO FROM THE 1008 00:54:57,520 --> 00:54:59,360 PERSPECTIVE OF NEW TREATMENTS 1009 00:54:59,360 --> 00:55:03,120 FOR OPIOID USE DISORDER WHETHER 1010 00:55:03,120 --> 00:55:05,640 NEW FORMATIONS, NOVEL TARGETS 1011 00:55:05,640 --> 00:55:07,440 THAT CAN IMPROVE THE WELL BEING 1012 00:55:07,440 --> 00:55:13,600 OF AN INDIVIDUAL AND IMPROVE THE 1013 00:55:13,600 --> 00:55:17,920 LIKELIHOOD OF STOPPING TAKING 1014 00:55:17,920 --> 00:55:19,360 DRUGS EVEN IF IT'S NOT LEADING 1015 00:55:19,360 --> 00:55:23,000 TO ABSTINENCE AND WE ALSO HAVE 1016 00:55:23,000 --> 00:55:28,360 ADVANCES ON HOW TO DELIVER 1017 00:55:28,360 --> 00:55:30,720 TECHNOLOGIES LIKE CURRENT 1018 00:55:30,720 --> 00:55:31,880 STIMULATION OR ULTRA SOUND 1019 00:55:31,880 --> 00:55:34,720 STIMULATION AND EXPLORING THE 1020 00:55:34,720 --> 00:55:36,520 WAYS WE CAN USE THEM BY 1021 00:55:36,520 --> 00:55:37,440 THEMSELVES OR IN COMBINATION 1022 00:55:37,440 --> 00:55:41,960 WITH MEDICATIONS TO IMPROVE 1023 00:55:41,960 --> 00:55:44,800 RETENTION IS AN AREA LIKELY TO 1024 00:55:44,800 --> 00:55:48,800 LEAD TO GREATER SUCCESS. 1025 00:55:48,800 --> 00:55:56,440 IT'S OBVIOUS ALSO AS MORE PEOPLE 1026 00:55:56,440 --> 00:55:59,280 CONSUME COCAINE AND 1027 00:55:59,280 --> 00:55:59,880 METHAMPHETAMINE AND MANY IN 1028 00:55:59,880 --> 00:56:01,120 COMBINATION WITH FENTANYL BUT 1029 00:56:01,120 --> 00:56:02,880 MANY DIDN'T KNOW THEY WERE 1030 00:56:02,880 --> 00:56:06,160 CONSUMING FENTANYL. 1031 00:56:06,160 --> 00:56:12,960 THEREFORE THE URGENCY TO 1032 00:56:12,960 --> 00:56:14,520 INSTIGATE TREATMENT WE CURRENTLY 1033 00:56:14,520 --> 00:56:16,360 DO NOT HAVE MEDICATIONS FOR 1034 00:56:16,360 --> 00:56:17,960 OTHER SUBSTANCE USE DISORDER 1035 00:56:17,960 --> 00:56:25,440 APART FROM ALCOHOL AND OPIOIDS 1036 00:56:25,440 --> 00:56:29,960 AND OVERDOSE TREATMENTS IT'S 1037 00:56:29,960 --> 00:56:31,880 BECOME HARDER TO REVERSE 1038 00:56:31,880 --> 00:56:34,080 OVERDOSES WHERE IT'S COMBINED 1039 00:56:34,080 --> 00:56:42,040 WITH OTHER DRUGS. 1040 00:56:42,040 --> 00:56:42,720 WE'RE SEEING CAPITOL HILLING 1041 00:56:42,720 --> 00:56:47,080 EXIST WHEN PEOPLE ARE OVERDOSING 1042 00:56:47,080 --> 00:56:50,160 WITH -- WE'RE SEEING CHALLENGES 1043 00:56:50,160 --> 00:56:54,000 THAT EXIST WHEN PEOPLE ARE 1044 00:56:54,000 --> 00:56:56,000 OVERDOSING WITH FENTANYL AND 1045 00:56:56,000 --> 00:56:59,240 WHEN WE LOOK AT ISSUES RELATED 1046 00:56:59,240 --> 00:57:02,560 TO OVERDOSES IS PREVENTION AND 1047 00:57:02,560 --> 00:57:05,040 PREVENTION OF DRUG USE IS 1048 00:57:05,040 --> 00:57:06,760 CRUCIAL FOR ADDRESSING THE 1049 00:57:06,760 --> 00:57:07,880 OVERDOSE CRISIS. 1050 00:57:07,880 --> 00:57:10,400 I SHOWED THE DATA ON ADOLESCENTS 1051 00:57:10,400 --> 00:57:12,120 FOR THAT REASON. 1052 00:57:12,120 --> 00:57:13,920 IT'S CHILLING TO SEE THAT 1053 00:57:13,920 --> 00:57:16,320 MORTALITY FROM TEENAGERS FROM 1054 00:57:16,320 --> 00:57:17,640 FENTANYL OVERDOSES AND YET DRUG 1055 00:57:17,640 --> 00:57:20,480 USE CAN BE PREVENTED AND YET WE 1056 00:57:20,480 --> 00:57:25,240 ARE NOT IMPLEMENTED ALREADY 1057 00:57:25,240 --> 00:57:25,840 DEVELOPED EVIDENCE BASED 1058 00:57:25,840 --> 00:57:26,880 PREVENTION INTERVENTION. 1059 00:57:26,880 --> 00:57:29,760 THE QUESTION IS WHAT TYPE OF 1060 00:57:29,760 --> 00:57:32,840 SCIENCE CAN HELP US INCENTIVIZE 1061 00:57:32,840 --> 00:57:34,200 SOME OF THE PREVENTION MEASURES 1062 00:57:34,200 --> 00:57:37,960 AND WHAT OPPORTUNITIES DO WE 1063 00:57:37,960 --> 00:57:40,480 HAVE OF DEVELOP NOVEL PREVENTION 1064 00:57:40,480 --> 00:57:41,160 INTERVENTION TO TAKE ADVANTAGE 1065 00:57:41,160 --> 00:57:45,040 OF THE TECHNOLOGIES WE HAVE 1066 00:57:45,040 --> 00:57:47,640 AMONG OTHERS BY EXCESS OF 1067 00:57:47,640 --> 00:57:52,600 WEARABLES OR ACCESS OF 1068 00:57:52,600 --> 00:57:54,320 APPLICATIONS THAT COULD DECREASE 1069 00:57:54,320 --> 00:57:55,600 COST AND MAKE THE INTERVENTION 1070 00:57:55,600 --> 00:58:03,680 MORE ACCESSIBLE. 1071 00:58:03,680 --> 00:58:08,640 TWO TOPICS IN GENERAL ARE DATA 1072 00:58:08,640 --> 00:58:10,000 SCIENCE AND WE'RE FASCINATED 1073 00:58:10,000 --> 00:58:13,760 WHAT WE CAN DO APPLYING 1074 00:58:13,760 --> 00:58:14,360 ARTIFICIAL INTELLIGENCE WITH 1075 00:58:14,360 --> 00:58:15,720 GOOD QUALITY DATA. 1076 00:58:15,720 --> 00:58:21,520 HOW TRANSFORMATIVE IT IS. 1077 00:58:21,520 --> 00:58:23,400 WE NEED TO RELATE TO DATA TO 1078 00:58:23,400 --> 00:58:25,440 SUBSTANCE USE DISORDERS IN 1079 00:58:25,440 --> 00:58:30,960 GENERAL AND HAVE DATA ON WHAT'S 1080 00:58:30,960 --> 00:58:32,120 HAPPENING IN THE COUNTRY RELATED 1081 00:58:32,120 --> 00:58:33,800 TO OVERDOSE MORTALITY OR THE 1082 00:58:33,800 --> 00:58:44,200 TYPES OF DRUGS EMERGING. 1083 00:58:46,680 --> 00:58:50,880 AND IT WOULD BE GREAT IF WE HAD 1084 00:58:50,880 --> 00:58:55,120 INFORMATION THAT PERTAINED TO 1085 00:58:55,120 --> 00:58:56,720 KNOW WHEN TO INTERVENE AND 1086 00:58:56,720 --> 00:58:59,360 UNDERSTAND IF OUR INTERVENTIONS 1087 00:58:59,360 --> 00:59:00,240 ARE HAVING EFFECT. 1088 00:59:00,240 --> 00:59:02,840 I THINK AT THE END OF THE DAY 1089 00:59:02,840 --> 00:59:04,160 WHAT COVID AND THE CRISIS IS 1090 00:59:04,160 --> 00:59:07,440 MAKING US AWARE OF AS WE'RE 1091 00:59:07,440 --> 00:59:10,000 SEEING THE EMERGENCE OF PATTERNS 1092 00:59:10,000 --> 00:59:11,480 OF DRUG CONSUMPTION SO DANGEROUS 1093 00:59:11,480 --> 00:59:15,240 MANY ARE DRIVEN BY WHAT WE HAVE 1094 00:59:15,240 --> 00:59:15,840 RECOGNIZED AS SOCIAL 1095 00:59:15,840 --> 00:59:18,160 DETERMINATES OF HEALTH. 1096 00:59:18,160 --> 00:59:20,160 AND PEOPLE THAT ARE MORE 1097 00:59:20,160 --> 00:59:20,760 VULNERABLE HAPPEN TO BE MORE 1098 00:59:20,760 --> 00:59:23,320 NEGLECTED. 1099 00:59:23,320 --> 00:59:28,280 NEGLECTED BECAUSE OF LACK OF 1100 00:59:28,280 --> 00:59:29,000 ECONOMIC OPPORTUNITIES. 1101 00:59:29,000 --> 00:59:30,760 NEGLECTED BECAUSE OF 1102 00:59:30,760 --> 00:59:35,400 DISCRIMINATION AND STIGMA AND 1103 00:59:35,400 --> 00:59:37,120 UNDERSTANDING HOW THOSE 1104 00:59:37,120 --> 00:59:37,560 PRACTICES INCLUDING 1105 00:59:37,560 --> 00:59:42,400 CRIMINALIZATION OF INDIVIDUALS 1106 00:59:42,400 --> 00:59:46,240 THAT TAKE DRUGS NEGATIVELY 1107 00:59:46,240 --> 00:59:47,880 INFLUENCES THE OUTCOME OF THAT 1108 00:59:47,880 --> 00:59:52,320 PERSON AND IMPACT THE COMMUNITY 1109 00:59:52,320 --> 00:59:54,600 AND COULD ONE DAY AND HOPEFULLY 1110 00:59:54,600 --> 00:59:56,080 NOT FAR FROM NOW CHANGE THE WAY 1111 00:59:56,080 --> 00:59:57,360 WE ADDRESS DRUG USE IN OUR 1112 00:59:57,360 --> 01:00:01,680 COUNTRY. 1113 01:00:01,680 --> 01:00:02,880 THANK YOU FOR YOUR ATTENTION AND 1114 01:00:02,880 --> 01:00:05,960 I'M GOING TO STOP SHARING SO YOU 1115 01:00:05,960 --> 01:00:12,040 CAN ASK QUESTIONS. 1116 01:00:12,040 --> 01:00:17,400 >>I HAVE A QUESTION ABOUT 1117 01:00:17,400 --> 01:00:17,680 XYLAZINE. 1118 01:00:17,680 --> 01:00:20,040 IT SEEMS IT'S 40 TIMES MORE 1119 01:00:20,040 --> 01:00:21,840 POTENT THAN FENTANYL AND MAKING 1120 01:00:21,840 --> 01:00:23,240 AN APPEARANCE IN OHIO AND D.C. 1121 01:00:23,240 --> 01:00:24,560 AND I DON'T KNOW WHAT THE MAP 1122 01:00:24,560 --> 01:00:25,760 WILL LOOK LIKE A YEAR FROM NOW. 1123 01:00:25,760 --> 01:00:31,280 WHAT HAVE YOU HEARD ABOUT THAT? 1124 01:00:31,280 --> 01:00:32,640 >>THERE'S EMERGENCE IN CERTAIN 1125 01:00:32,640 --> 01:00:43,160 STATES AND AREAS AND LOCATIONS. 1126 01:01:01,640 --> 01:01:05,800 WE DON'T KNOW THE NATURE OF THE 1127 01:01:05,800 --> 01:01:07,440 ILLICIT MARKET AND ONE AREA 1128 01:01:07,440 --> 01:01:09,640 WE'VE HAD DISCUSSIONS WITH ONDCP 1129 01:01:09,640 --> 01:01:16,680 AND CDC IS HOW TO GENERATE WHAT 1130 01:01:16,680 --> 01:01:18,600 CAN GIVE US A PULSE OF THE TYPES 1131 01:01:18,600 --> 01:01:20,160 OF DRUGS EMERGING AND HOW 1132 01:01:20,160 --> 01:01:26,400 RAPIDLY THEY ARE CHANGING. 1133 01:01:26,400 --> 01:01:29,000 I DON'T THINK WE REALLY KNOW 1134 01:01:29,000 --> 01:01:30,240 BECAUSE WE'RE NOT SYSTEMATICALLY 1135 01:01:30,240 --> 01:01:31,440 MEASURING IT. 1136 01:01:31,440 --> 01:01:33,920 >>I THOUGHT I'D BRING IT UP IN 1137 01:01:33,920 --> 01:01:35,680 CASE PEOPLE HAVE INFORMATION TO 1138 01:01:35,680 --> 01:01:36,080 SHARE. 1139 01:01:36,080 --> 01:01:37,040 WE'RE SEEING A COUPLE THINGS 1140 01:01:37,040 --> 01:01:47,520 PUBLISHED BUT NOT TOO MANY. 1141 01:01:54,440 --> 01:01:56,480 >>AMAZING AND WONDERFUL TALK. 1142 01:01:56,480 --> 01:02:00,120 I WAS STRUCK BY THE CANNABIS 1143 01:02:00,120 --> 01:02:01,440 DAILY USER RISE, 14 TIMES 1144 01:02:01,440 --> 01:02:03,240 INCREASE IN CANNABIS AND OF 1145 01:02:03,240 --> 01:02:06,440 COURSE THE AVAILABILITY AND 1146 01:02:06,440 --> 01:02:07,680 GETTING NEW USERS BUT 14 TIMES 1147 01:02:07,680 --> 01:02:08,680 IS DRAMATIC. 1148 01:02:08,680 --> 01:02:10,920 I DON'T THINK THE OLD DATA OF 1149 01:02:10,920 --> 01:02:13,120 CANNABIS BEING A GATEWAY DRUG 1150 01:02:13,120 --> 01:02:17,480 HAS GONE AWAY IN TERMS OF HOW 1151 01:02:17,480 --> 01:02:19,440 ACCESS AND AVAILABILITY WILL 1152 01:02:19,440 --> 01:02:25,240 COMPOUND OUR PROBLEMS EVEN WITH 1153 01:02:25,240 --> 01:02:28,200 THE OTHER ON THE HEELS OF THE 1154 01:02:28,200 --> 01:02:30,400 OTHER DRUGS USED AND ESCALATION 1155 01:02:30,400 --> 01:02:32,800 OVER TIME. 1156 01:02:32,800 --> 01:02:34,800 MY QUESTION IS THE INCREASE IN 1157 01:02:34,800 --> 01:02:36,520 THE TRANSITION TO DAILY USE 1158 01:02:36,520 --> 01:02:37,440 THERE'S A NEED TO UNDERSTAND 1159 01:02:37,440 --> 01:02:43,840 THAT BETTER IN TERMS OF THE 1160 01:02:43,840 --> 01:02:48,920 NEUROBIOLOGY AND TO DO STUDIES 1161 01:02:48,920 --> 01:02:51,720 AND IMAGING AND UNDERSTANDING 1162 01:02:51,720 --> 01:02:52,600 EARLY TARGETS. 1163 01:02:52,600 --> 01:02:53,720 I'M WONDERING IF YOU ALL HAVE 1164 01:02:53,720 --> 01:03:00,040 BEEN THINKING ABOUT THAT, I KNOW 1165 01:03:00,040 --> 01:03:01,240 HAVE YOU AND WHETHER THERE'S 1166 01:03:01,240 --> 01:03:02,920 SOME THOUGHTS IN PRIORITIES IN 1167 01:03:02,920 --> 01:03:03,600 THAT REGARD. 1168 01:03:03,600 --> 01:03:06,200 >>ABSOLUTELY AND THANK YOU FOR 1169 01:03:06,200 --> 01:03:16,440 THE QUESTION. 1170 01:03:18,920 --> 01:03:21,520 THERE WAS A RECOMMENDATION AND 1171 01:03:21,520 --> 01:03:24,360 THAT ANY INVESTIGATOR DOING 1172 01:03:24,360 --> 01:03:26,960 RESEARCH MY ONE AND FUNDED BY 1173 01:03:26,960 --> 01:03:30,760 NIDA USE A STANDARD DOSE. 1174 01:03:30,760 --> 01:03:33,280 THE STANDARD DOSE WE'RE 1175 01:03:33,280 --> 01:03:35,760 PROPOSING IS 5 MILLIGRAMS OF 1176 01:03:35,760 --> 01:03:35,920 THC. 1177 01:03:35,920 --> 01:03:39,440 WITH THE UNDERSTANDING THERE'LL 1178 01:03:39,440 --> 01:03:42,080 BE A RELATIVELY LARGE MARGIN OF 1179 01:03:42,080 --> 01:03:43,080 ERROR IN THE CONSUMPTION PATTERN 1180 01:03:43,080 --> 01:03:45,560 BUT THAT'S THE FIRST STEP TO TRY 1181 01:03:45,560 --> 01:03:48,680 TO GET DATA THAT ACTUALLY GETS 1182 01:03:48,680 --> 01:03:52,240 US AN IDEA OF THE DOSES PEOPLE 1183 01:03:52,240 --> 01:03:53,520 ARE CONSUMING OF TCH. 1184 01:03:53,520 --> 01:03:57,600 IN THE PAST THE WAY WE'RE DOING 1185 01:03:57,600 --> 01:03:58,840 IT SAYING DO YOU CONSUME 1186 01:03:58,840 --> 01:04:00,480 MARIJUANA OR NOT BUT THERE'S NO 1187 01:04:00,480 --> 01:04:05,320 ESTIMATION OF THE PATTERNS OF 1188 01:04:05,320 --> 01:04:06,200 CONSUMPTION AND YET WE KNOW 1189 01:04:06,200 --> 01:04:09,080 DOSES MAKE A BIG DIFFERENCE. 1190 01:04:09,080 --> 01:04:12,840 AND DOES IT EMERGE AS IT RELATES 1191 01:04:12,840 --> 01:04:14,240 TO THE SYNDROME SPECIFICALLY 1192 01:04:14,240 --> 01:04:17,040 ASSOCIATED WITH HIGH CONSUMPTION 1193 01:04:17,040 --> 01:04:21,880 OF NON-THC OR THE PSYCHOSIS 1194 01:04:21,880 --> 01:04:23,360 ASSOCIATED WITH THC. 1195 01:04:23,360 --> 01:04:26,720 THAT'S THE FIRST MOVE WE DID TO 1196 01:04:26,720 --> 01:04:28,960 STANDARDIZE METRICS TO COMPARE 1197 01:04:28,960 --> 01:04:31,120 FINDINGS FROM ONE STUDY TO THE 1198 01:04:31,120 --> 01:04:32,280 OTHER AND REQUESTING THE 1199 01:04:32,280 --> 01:04:37,560 DEVELOPMENT OF A REGISTRY SO WE 1200 01:04:37,560 --> 01:04:39,320 CAN LEARN ON POPULATION SCIENCE. 1201 01:04:39,320 --> 01:04:40,720 WE HAVE LITTLE INFORMATION AS IT 1202 01:04:40,720 --> 01:04:45,920 RELATES TO THE USE OF MEDICAL 1203 01:04:45,920 --> 01:04:46,520 MARIJUANA. 1204 01:04:46,520 --> 01:04:50,880 WE KNOW PAIN IS THE MAIN REASON 1205 01:04:50,880 --> 01:04:51,840 BUT THOUSAND IT AFFECT THE 1206 01:04:51,840 --> 01:04:55,080 PATTERNS OF CONSUMPTION OF OTHER 1207 01:04:55,080 --> 01:04:58,000 DRUGS OR THEIR UTILIZATION OF 1208 01:04:58,000 --> 01:04:59,120 OTHER MEDICATIONS. 1209 01:04:59,120 --> 01:05:01,320 THAT'S AN AREA WHERE WE HAVE 1210 01:05:01,320 --> 01:05:06,520 LITTLE INFORMATION AND WE WANT 1211 01:05:06,520 --> 01:05:11,560 TO COMPARE THAT AND INCENTIVIZE 1212 01:05:11,560 --> 01:05:14,600 RESEARCHERS TO PAY ATTENTION TO 1213 01:05:14,600 --> 01:05:16,320 ABOUT TO THE CONSEQUENCES OF THE 1214 01:05:16,320 --> 01:05:26,720 HIGH CONSUMPTION OF THC. 1215 01:05:44,760 --> 01:05:45,920 >>I HAVE A QUICK QUESTION 1216 01:05:45,920 --> 01:05:47,720 REGARDING HIV INFECTION AND 1217 01:05:47,720 --> 01:05:53,200 WHETHER WE SEE A CHANGE IN NEW 1218 01:05:53,200 --> 01:06:03,720 INFECTIONS OR HIV MANAGEMENT AND 1219 01:06:07,000 --> 01:06:12,080 WHAT'S THE USE OF INTENTIONAL 1220 01:06:12,080 --> 01:06:13,520 AND UNINTENTIONAL OVERDOSES AND 1221 01:06:13,520 --> 01:06:15,760 IS THERE GOOD RESEARCH I CAN 1222 01:06:15,760 --> 01:06:16,080 GET? 1223 01:06:16,080 --> 01:06:18,800 >>AS IT RELATES TO THE PATTERNS 1224 01:06:18,800 --> 01:06:22,320 OF DRUG USE THE INCIDENTS OF HIV 1225 01:06:22,320 --> 01:06:24,760 FROM THE PERSPECTIVE OF THE RISE 1226 01:06:24,760 --> 01:06:28,840 WE'RE OBSERVING ON 1227 01:06:28,840 --> 01:06:29,960 METHAMPHETAMINE IN THE COUNTRY 1228 01:06:29,960 --> 01:06:32,120 IS ASSOCIATED WITH A SIGNIFICANT 1229 01:06:32,120 --> 01:06:33,920 INCREASE RISK OF HIV. 1230 01:06:33,920 --> 01:06:35,600 THAT STEEMZ TO BE THE SINGLE 1231 01:06:35,600 --> 01:06:37,440 FACTOR THAT HAD CHANGE THE MOST 1232 01:06:37,440 --> 01:06:41,840 IN TERMS OF INCREASING THE RISE 1233 01:06:41,840 --> 01:06:44,160 OF HIV AMONG DRUG USERS. 1234 01:06:44,160 --> 01:06:45,880 IN THE PAST WE PAID A LOT OF 1235 01:06:45,880 --> 01:06:46,880 ATTENTION TO INJECTION DRUG USE 1236 01:06:46,880 --> 01:06:49,520 BUT APPARENTLY WHAT 1237 01:06:49,520 --> 01:06:54,000 METHAMPHETAMINE IS DOING IS 1238 01:06:54,000 --> 01:06:55,080 PROMOTES SEXUALLY RISKY 1239 01:06:55,080 --> 01:06:56,520 BEHAVIORS AND PEOPLE WHO USE 1240 01:06:56,520 --> 01:06:58,520 METHAMPHETAMINE AND MEN THAT 1241 01:06:58,520 --> 01:06:59,480 HAVE SEX WITH MEN DESCRIBE THIS 1242 01:06:59,480 --> 01:07:04,360 WHEN THEY WANT TO ENGAGE IN 1243 01:07:04,360 --> 01:07:07,480 SEXUALLY RISKY BEHAVIOR THEY MAY 1244 01:07:07,480 --> 01:07:11,080 CONSUME METHAMPHETAMINE. 1245 01:07:11,080 --> 01:07:12,640 FROM THAT PERSPECTIVE AND FROM 1246 01:07:12,640 --> 01:07:16,640 THE PERSPECTIVE OF OPIOIDS 1247 01:07:16,640 --> 01:07:20,160 ITSELF, WE HAD SEEN AN INCREASE 1248 01:07:20,160 --> 01:07:23,080 IN INJECTION DRUGS FROM 2010, 1249 01:07:23,080 --> 01:07:25,760 2011 ASSOCIATED WITH AN INCREASE 1250 01:07:25,760 --> 01:07:28,120 IN HEPATITIS C BUT NOT SO MUCH 1251 01:07:28,120 --> 01:07:29,040 ON HIV. 1252 01:07:29,040 --> 01:07:32,760 OVER ALL, THE INCIDENTS OF HIV 1253 01:07:32,760 --> 01:07:33,960 AMONG INJECTION DRUG USE HAS 1254 01:07:33,960 --> 01:07:34,840 BEEN STABLE. 1255 01:07:34,840 --> 01:07:40,240 WE DO SEE DIFFERENCES ACROSS THE 1256 01:07:40,240 --> 01:07:41,520 COUNTRY AND IN MARYLAND THERE 1257 01:07:41,520 --> 01:07:48,280 WAS AN INCREASE IN THE CASES OF 1258 01:07:48,280 --> 01:07:49,560 HIV FROM DRUG USE AND SOME ARE 1259 01:07:49,560 --> 01:07:54,160 RELATED TO PRACTICES SUCH AS 1260 01:07:54,160 --> 01:07:55,200 SYRINGE EXCHANGE PROGRAMS AND 1261 01:07:55,200 --> 01:07:58,000 YOU SEE THAT AREA HAVING AN 1262 01:07:58,000 --> 01:08:00,280 INCREASE IN HIV. 1263 01:08:00,280 --> 01:08:01,360 TO YOUR OTHER QUESTION ABOUT 1264 01:08:01,360 --> 01:08:06,320 WHAT WE KNOW ABOUT THE 1265 01:08:06,320 --> 01:08:07,560 COMBINATION OF HIV AND DRUG USE 1266 01:08:07,560 --> 01:08:11,000 IN TERMS OF INTENTIONAL OR 1267 01:08:11,000 --> 01:08:16,040 NON-INTENTIONAL OVERDOSES. 1268 01:08:16,040 --> 01:08:23,320 WE KNOW IN GENERAL INTENTIONAL 1269 01:08:23,320 --> 01:08:30,760 OVERDOSES, SUICIDE ACCOUNT FOR 1270 01:08:30,760 --> 01:08:36,560 15% AND PROBABLY THAT'S A LOW 1271 01:08:36,560 --> 01:08:40,440 ESTIMATE AND PEOPLE WITH HIV AND 1272 01:08:40,440 --> 01:08:44,640 COMORBIDITIES FROM GROUPS THAT 1273 01:08:44,640 --> 01:08:48,280 ARE STIGMATIZED HAVE AN INCREASE 1274 01:08:48,280 --> 01:08:50,040 AND THOSE WITH PSYCHIATRIC 1275 01:08:50,040 --> 01:08:51,840 DISORDERS THAT ARE STIGMATIZED. 1276 01:08:51,840 --> 01:08:54,800 BUT SPECIFICALLY WHAT IS THE 1277 01:08:54,800 --> 01:09:00,400 RATE FOR RISK FOR INTENTIONAL 1278 01:09:00,400 --> 01:09:01,600 OVERDOSE ON HIV? 1279 01:09:01,600 --> 01:09:03,960 I THERE'S A NO NUMBERS I RECALL 1280 01:09:03,960 --> 01:09:06,200 SEEING BUT WE'LL LOOK AT IT 1281 01:09:06,200 --> 01:09:07,480 BECAUSE IT'S IMPOSSIBLE TO HAVE 1282 01:09:07,480 --> 01:09:09,400 A SYSTEMATIC LOOK AT EVERYTHING 1283 01:09:09,400 --> 01:09:10,240 BUT I DON'T RECALL ANYONE 1284 01:09:10,240 --> 01:09:20,640 MENTIONING ANY NUMBER. 1285 01:09:26,760 --> 01:09:27,800 >>TWO COMMENTS. 1286 01:09:27,800 --> 01:09:30,920 ON YOUR LAST SLIDE YOU MENTIONED 1287 01:09:30,920 --> 01:09:33,640 CRIMINALIZATION AND STIGMA. 1288 01:09:33,640 --> 01:09:38,280 AND BC AND CANADA JUST 1289 01:09:38,280 --> 01:09:38,920 DECRIMINALIZED POSSESSION OF 1290 01:09:38,920 --> 01:09:43,000 SMALL AMOUNTS OF WHAT WE CALL 1291 01:09:43,000 --> 01:09:43,960 ILLICIT DRUGS INCLUDING THE 1292 01:09:43,960 --> 01:09:45,840 DRUGS WE'RE TALKING ABOUT NOW SO 1293 01:09:45,840 --> 01:09:47,160 IT WILL BE FASCINATING WHAT 1294 01:09:47,160 --> 01:09:48,560 HAPPENS THERE IN TERMS OF ACCESS 1295 01:09:48,560 --> 01:09:49,720 TO TREATMENT AND HARM REDUCTION 1296 01:09:49,720 --> 01:09:51,920 AND ALL THAT. 1297 01:09:51,920 --> 01:09:54,840 TWO IS YOU ALSO SPOKE ABOUT THE 1298 01:09:54,840 --> 01:09:55,520 TIMELINESS OF DATA WHICH I AGREE 1299 01:09:55,520 --> 01:09:58,600 IS SO IMPORTANT. 1300 01:09:58,600 --> 01:10:04,960 I WOULD ADD THE CRITICAL NEED TO 1301 01:10:04,960 --> 01:10:08,560 PAY ATTENTION THE QUALITY OF 1302 01:10:08,560 --> 01:10:19,080 DATA IS SO UNEVEN IN THE GROUPS 1303 01:10:19,480 --> 01:10:20,760 WHETHER RURAL FOLKS AND THERE'S 1304 01:10:20,760 --> 01:10:22,080 INDIGENOUS DATA GENOCIDE I WANT 1305 01:10:22,080 --> 01:10:22,680 TO ENCOURAGE PEOPLE TO CHECK 1306 01:10:22,680 --> 01:10:32,760 OUT. 1307 01:10:38,000 --> 01:10:40,560 >>DID THE DATA RELIABLE OR IS 1308 01:10:40,560 --> 01:10:43,320 THERE ERROR AND EVERYTHING WILL 1309 01:10:43,320 --> 01:10:45,120 PERPETUATE THE ERROR AND THERE'S 1310 01:10:45,120 --> 01:10:48,920 AN ISSUE OF NOT BEING EQUITABLE 1311 01:10:48,920 --> 01:10:50,520 AND IT'S ALREADY IN YOUR DATA 1312 01:10:50,520 --> 01:10:52,040 SET YOU HAVE PREJUDICE INSERTED 1313 01:10:52,040 --> 01:10:53,040 ON THE WAY THE DATA IS COLLECTED 1314 01:10:53,040 --> 01:11:03,360 AND RATED. 1315 01:11:03,360 --> 01:11:09,040 AND WE NEED TO BE PROACTIVE TO 1316 01:11:09,040 --> 01:11:14,360 ENSURE THE DATA DOES NOT WE DO 1317 01:11:14,360 --> 01:11:17,120 NOT PERPETUATE IT AND IT'S BEEN 1318 01:11:17,120 --> 01:11:19,480 RELEVANT GOING THROUGH THE ABC 1319 01:11:19,480 --> 01:11:23,440 WHERE WE HAVE SURVEYS FOR 1320 01:11:23,440 --> 01:11:25,320 FAMILIES, PARENTS FROM UNDER 1321 01:11:25,320 --> 01:11:26,760 REPRESENTED GROUPS WHERE THE WAY 1322 01:11:26,760 --> 01:11:28,040 THEY RESPOND IS DIFFERENT. 1323 01:11:28,040 --> 01:11:29,440 THE WAY THEY INTERPRET THE 1324 01:11:29,440 --> 01:11:30,520 QUESTION IS DIFFERENT. 1325 01:11:30,520 --> 01:11:34,280 BUT IT IS RATED AS IF IT WERE 1326 01:11:34,280 --> 01:11:35,480 HOME GENEOUS. 1327 01:11:35,480 --> 01:11:41,920 THIS RESULTS IN BASICALLY DATA 1328 01:11:41,920 --> 01:11:48,240 THAT CAN BE PREJUDICE LIKE AND 1329 01:11:48,240 --> 01:11:50,200 DISTORTS THE REALITY. 1330 01:11:50,200 --> 01:11:51,960 THIS IS GOING TO BE RELEVANT FOR 1331 01:11:51,960 --> 01:11:53,080 THE ABC GOING FORWARD. 1332 01:11:53,080 --> 01:12:02,320 I DON'T THINK IN GENERAL IN 1333 01:12:02,320 --> 01:12:05,440 SURVEYS THERE'S BEEN AWARENESS 1334 01:12:05,440 --> 01:12:07,480 AND REALIZING WHAT MAY BE A 1335 01:12:07,480 --> 01:12:09,680 SURVEY OBTAINED IN WHITE PEOPLE 1336 01:12:09,680 --> 01:12:10,480 MAY NOT NECESSARILY PERTAIN TO 1337 01:12:10,480 --> 01:12:20,720 ANOTHER ONE. 1338 01:12:25,560 --> 01:12:28,640 >>THANK YOU FOR THE TALK WHICH 1339 01:12:28,640 --> 01:12:31,480 WAS SO COMPREHENSIVE AND 1340 01:12:31,480 --> 01:12:32,640 DISHEARTENING WATCHING THE 1341 01:12:32,640 --> 01:12:34,240 NUMBERS GO UP. 1342 01:12:34,240 --> 01:12:39,480 IT'S DISSPIRITING BUT IT DOES 1343 01:12:39,480 --> 01:12:41,920 SPUR US ON TO THINK OF WAYS TO 1344 01:12:41,920 --> 01:12:43,480 ADDRESS THE PROBLEM IN A 1345 01:12:43,480 --> 01:12:48,480 MULTI-PRONGED WAY AND CONSIDER 1346 01:12:48,480 --> 01:12:55,360 THE RESEARCH QUESTIONS TO 1347 01:12:55,360 --> 01:12:56,320 SURFACE NEW KNOWLEDGE. 1348 01:12:56,320 --> 01:12:57,960 THE PRACTICE AND DESCRIBER 1349 01:12:57,960 --> 01:13:01,960 COMMUNITY IS VERY DYNAMIC AS YOU 1350 01:13:01,960 --> 01:13:03,800 POINT OUT WITH THE CHANGES. 1351 01:13:03,800 --> 01:13:05,200 WITH THE COMPREHENSIVE 1352 01:13:05,200 --> 01:13:08,720 APPROPRIATIONS ACT WE SAW BOTH 1353 01:13:08,720 --> 01:13:12,080 THE ACT WHICH ON ONE HAND LIFT 1354 01:13:12,080 --> 01:13:15,680 THE EX-WAIVER REQUIREMENT 1355 01:13:15,680 --> 01:13:17,840 FEDERALLY AND LIFTED THE CAPS 1356 01:13:17,840 --> 01:13:19,280 BUT AS YOU POINT OUT WE DON'T 1357 01:13:19,280 --> 01:13:21,120 KNOW WHAT STATES WILL DO AND IT 1358 01:13:21,120 --> 01:13:26,160 WILL BE A PATCH WORK. 1359 01:13:26,160 --> 01:13:28,000 SIMULTANEOUSLY WE DON'T KNOW 1360 01:13:28,000 --> 01:13:29,080 WHAT THE EDUCATIONAL 1361 01:13:29,080 --> 01:13:29,960 REQUIREMENTS WILL BE AND IN THE 1362 01:13:29,960 --> 01:13:32,120 FAST WE HAD A FUNDED PROGRAM 1363 01:13:32,120 --> 01:13:37,400 THROUGH THE DATA ORGANIZATION SO 1364 01:13:37,400 --> 01:13:46,480 EIGHT HOUR TRAININGS WERE GRATIS 1365 01:13:46,480 --> 01:13:49,840 AND WE SIMULTANEOUSLY HAVE THE 1366 01:13:49,840 --> 01:13:50,640 ENDING OF THE PUBLIC HEALTH 1367 01:13:50,640 --> 01:13:51,680 EMERGENCY WHICH NOW CALLED INTO 1368 01:13:51,680 --> 01:13:54,120 QUESTION WHETHER WE'D BE ABLE TO 1369 01:13:54,120 --> 01:13:56,160 ISSUE BUPRENORPHINE WITHOUT AN 1370 01:13:56,160 --> 01:13:57,120 IN-PERSON VISIT AND THE WHOLE 1371 01:13:57,120 --> 01:14:02,840 IDEA OF BEING ABLE TO DO THAT 1372 01:14:02,840 --> 01:14:07,480 EXTEND 1373 01:14:07,480 --> 01:14:08,760 EXTENDED PLACES WITH SOMEBODY 1374 01:14:08,760 --> 01:14:10,320 CANNOT ACCESS SOMEBODY LIVE. 1375 01:14:10,320 --> 01:14:11,880 IT'S ABOUT TO HAPPEN IN A 1376 01:14:11,880 --> 01:14:14,560 THREE -- MONTH IT'S ALL CHANGED. 1377 01:14:14,560 --> 01:14:17,920 SO NONE OF US KNOW HOW THIS WILL 1378 01:14:17,920 --> 01:14:24,280 PLAY OUT. 1379 01:14:24,280 --> 01:14:25,440 WHAT PART WILL BE GOOD AND IT'S 1380 01:14:25,440 --> 01:14:29,760 A RIPE OPPORTUNITY TO STUDY AND 1381 01:14:29,760 --> 01:14:32,520 CONSIDER STUDYING IMPLEMENTATION 1382 01:14:32,520 --> 01:14:37,880 STRATEGIES AND HOW THOSE MIGHT 1383 01:14:37,880 --> 01:14:48,360 HAVE IMPACT OF INTERVENTION 1384 01:14:51,640 --> 01:14:52,360 STRATEGIES BECAUSE IT BLENDS 1385 01:14:52,360 --> 01:14:53,920 INTO PREVENTION. 1386 01:14:53,920 --> 01:14:55,120 WE KNOW WE HAVE MANY MISSED 1387 01:14:55,120 --> 01:14:56,080 OPPORTUNITIES AS PEOPLE HAVE 1388 01:14:56,080 --> 01:14:57,080 TOUCH POINTS WITH THE HEALTH 1389 01:14:57,080 --> 01:15:01,400 CARE SYSTEM. 1390 01:15:01,400 --> 01:15:03,240 THEY'RE NEVER SCREENED I'M SORRY 1391 01:15:03,240 --> 01:15:04,720 BUT IT'S RARE THEY'RE SCREENED 1392 01:15:04,720 --> 01:15:06,840 WITH PEDIATRICS OR OB AND IN THE 1393 01:15:06,840 --> 01:15:07,800 HEALTH SYSTEM. 1394 01:15:07,800 --> 01:15:11,080 IF YOU TALK TO PATIENTS YOU'LL 1395 01:15:11,080 --> 01:15:12,040 FIND THEY HAD THEIR ACTUAL 1396 01:15:12,040 --> 01:15:13,600 EXAMINE AND NO ONE TALKS TO THEM 1397 01:15:13,600 --> 01:15:23,960 WITH THE USE OF DRUGS. 1398 01:15:24,800 --> 01:15:26,240 RESEARCH THAT IMPLEMENTS THAT 1399 01:15:26,240 --> 01:15:29,480 KIND OF TOUCH POINTS AND LOOK AT 1400 01:15:29,480 --> 01:15:30,080 PREVENTIONS/EARLY INTERVENTION 1401 01:15:30,080 --> 01:15:31,880 OR CASE FINDING WITHIN THE 1402 01:15:31,880 --> 01:15:32,320 HEALTH CARE SYSTEM. 1403 01:15:32,320 --> 01:15:33,920 THAT DOESN'T HAPPEN. 1404 01:15:33,920 --> 01:15:44,440 IN TERMS OF RETENTION, SAMHSA 1405 01:15:47,800 --> 01:15:50,640 PRODUCED A DOCUMENT FROM 2015 TO 1406 01:15:50,640 --> 01:15:52,240 2019 LOOKING AT RACIAL AND 1407 01:15:52,240 --> 01:15:53,120 ETHNIC DIFFERENCES AND DIVIDED 1408 01:15:53,120 --> 01:15:58,800 IT BY GENDER ACROSS ALL 1409 01:15:58,800 --> 01:16:01,600 SUBSTANCES AND BOTH USE DISORDER 1410 01:16:01,600 --> 01:16:03,480 AND ACCESS TO TREATMENT. 1411 01:16:03,480 --> 01:16:04,920 THE VARIABILITY BY RACE, 1412 01:16:04,920 --> 01:16:05,920 ETHNICITY AND GENDER IS 1413 01:16:05,920 --> 01:16:10,600 STRIKING. 1414 01:16:10,600 --> 01:16:11,960 AGAIN, FOR US TO RESEARCH WHAT'S 1415 01:16:11,960 --> 01:16:17,960 MOST EFFECTIVE, PROGRAMS THAT 1416 01:16:17,960 --> 01:16:20,160 ACTUALLY LOOK AT CULTURALLY 1417 01:16:20,160 --> 01:16:21,840 SENSITIVE AND INTERVENTION 1418 01:16:21,840 --> 01:16:22,440 STRATEGIES BECAUSE IT'S NOT 1419 01:16:22,440 --> 01:16:23,600 GOING TO BE THE SAME IN 1420 01:16:23,600 --> 01:16:25,120 DIFFERENT POPULATIONS. 1421 01:16:25,120 --> 01:16:26,160 IT'S NOT. 1422 01:16:26,160 --> 01:16:26,920 THOSE THREE AREAS ARE RIPE FOR 1423 01:16:26,920 --> 01:16:36,200 RESEARCH. 1424 01:16:36,200 --> 01:16:38,040 ALL THIS IS GOING ON WHILE WE 1425 01:16:38,040 --> 01:16:40,280 WATCH THE NUMBERS TICK UP. 1426 01:16:40,280 --> 01:16:45,960 IT'S INCREDIBLY DISHEARTENING TO 1427 01:16:45,960 --> 01:16:48,560 SEE THAT. 1428 01:16:48,560 --> 01:16:54,280 AND THERE'S DIFFERENT PARTS OF 1429 01:16:54,280 --> 01:16:55,560 THE COUNTRY PILLS AVAILABLE FOR 1430 01:16:55,560 --> 01:17:02,400 YOUNG AND OLDER PEOPLE ARE 1431 01:17:02,400 --> 01:17:05,800 TAKING AND THERE ARE PEOPLE 1432 01:17:05,800 --> 01:17:09,760 USING NOT KNOWING THEY'RE ABOUT 1433 01:17:09,760 --> 01:17:11,920 TO I HAVE TAINTED DRUG AND YOUNG 1434 01:17:11,920 --> 01:17:15,640 PEOPLE ARE DYING AND AS FAR AS A 1435 01:17:15,640 --> 01:17:16,960 PUBLIC HEALTH INTERVENTION WHAT 1436 01:17:16,960 --> 01:17:18,520 SHOULD WE BE DOING? 1437 01:17:18,520 --> 01:17:21,960 SHOULD WE BE UTILIZING TEST 1438 01:17:21,960 --> 01:17:22,200 STRIPS? 1439 01:17:22,200 --> 01:17:27,080 SHOULD THEY BE DISPENSED WITH 1440 01:17:27,080 --> 01:17:30,040 NALOXONE AND THOSE INTERVENTIONS 1441 01:17:30,040 --> 01:17:33,920 FROM A PUBLIC HEALTH STANDPOINT 1442 01:17:33,920 --> 01:17:36,920 WE NEED THE ABILITY TO STUDY AND 1443 01:17:36,920 --> 01:17:38,760 KNOW WHETHER WE'RE BEING 1444 01:17:38,760 --> 01:17:39,040 EFFECTIVE. 1445 01:17:39,040 --> 01:17:40,360 THOSE ARE SOME OF MY THOUGHTS IN 1446 01:17:40,360 --> 01:17:40,880 RESPOND TO YOUR EXCELLENT 1447 01:17:40,880 --> 01:17:51,160 PRESENTATION. 1448 01:17:51,160 --> 01:17:54,480 >>WE'RE FUNDING PROJECTS AND 1449 01:17:54,480 --> 01:17:57,880 UNDERSTANDING HOW THE CHANGES IN 1450 01:17:57,880 --> 01:17:58,560 BUPRENORPHINE WILL BE 1451 01:17:58,560 --> 01:17:59,640 IMPLEMENTED BY THE STATE. 1452 01:17:59,640 --> 01:18:02,200 THIS IS AN AREA THAT'S NEW. 1453 01:18:02,200 --> 01:18:08,080 FOR THE OTHERS, YES, ONE OF THE 1454 01:18:08,080 --> 01:18:18,640 ONES AND FACILITATE THE AREAS OF 1455 01:18:20,920 --> 01:18:25,520 HEALTH CARE SYSTEM. 1456 01:18:25,520 --> 01:18:35,720 WE HAVE IT. 1457 01:18:36,360 --> 01:18:38,280 AND THE STRUCTURE COULD ADD 1458 01:18:38,280 --> 01:18:38,600 PREVENTION. 1459 01:18:38,600 --> 01:18:43,960 THAT'S ONE OF THE ONES WE'RE 1460 01:18:43,960 --> 01:18:47,720 VERY MUCH LAUNCHES PRODUCTS 1461 01:18:47,720 --> 01:18:52,720 ACROSS THE CLINICAL TRIALS 1462 01:18:52,720 --> 01:18:53,520 NETWORK AND SEEKING 1463 01:18:53,520 --> 01:18:57,920 OPPORTUNITIES THROUGH MODELS 1464 01:18:57,920 --> 01:18:59,040 THAT CAN FACILITATE. 1465 01:18:59,040 --> 01:19:09,280 I AGREE 100%. 1466 01:19:09,520 --> 01:19:15,360 I BROUGHT UP THE ISSUE OF 1467 01:19:15,360 --> 01:19:17,600 BUPRENORPHINE TO GET RESEARCHERS 1468 01:19:17,600 --> 01:19:19,520 IN THE FIELD WITH THAT EXPERTISE 1469 01:19:19,520 --> 01:19:29,960 TO START TO LOOK INTO IT. 1470 01:19:37,640 --> 01:19:39,080 >>YOU ARE NOT MUTED BUT I 1471 01:19:39,080 --> 01:19:39,680 CANNOT HEAR YOU. 1472 01:19:39,680 --> 01:19:45,440 >>SORRY ABOUT THAT. 1473 01:19:45,440 --> 01:19:52,520 I ALSO WANTED TO THANK NORRA -- 1474 01:19:52,520 --> 01:19:54,240 NORA FOR HER PRESENTATION AND 1475 01:19:54,240 --> 01:19:55,720 THE ABC STUDIES YOU REVIEWED AND 1476 01:19:55,720 --> 01:19:57,400 THEY'RE LANDMARK STUDIES AND 1477 01:19:57,400 --> 01:19:59,480 THINKING OF THEM TOGETHER NOT 1478 01:19:59,480 --> 01:20:00,920 JUST IN THE SCOPE OF THE DATA 1479 01:20:00,920 --> 01:20:03,800 THEY HAVE PRODUCED BECAUSE ABC 1480 01:20:03,800 --> 01:20:05,160 HAS BECOME A MODEL AS SOMEONE 1481 01:20:05,160 --> 01:20:07,880 FROM THE GENETICS WORLD THE 1482 01:20:07,880 --> 01:20:09,680 AVAILABILITY OF DATA FOR YOUNG 1483 01:20:09,680 --> 01:20:11,160 INVESTIGATORS TO LAUNCH THEIR 1484 01:20:11,160 --> 01:20:13,520 CAREERS HAS BEEN EXTRAORDINARY 1485 01:20:13,520 --> 01:20:23,120 TO THE FIELD. 1486 01:20:23,120 --> 01:20:25,600 AND THE AFFECT OF PRENATAL 1487 01:20:25,600 --> 01:20:27,600 EXPOSURE ON CHILD DEVELOPMENT 1488 01:20:27,600 --> 01:20:29,400 GOING FORWARD TO THE CHILDREN 1489 01:20:29,400 --> 01:20:30,920 MATURING INTO ADULTS WHO 1490 01:20:30,920 --> 01:20:32,520 THEMSELVES HAVE FAMILIES AND 1491 01:20:32,520 --> 01:20:37,680 UNDERSTANDING THAT TRY -- TRIAD 1492 01:20:37,680 --> 01:20:39,320 AND BRINGING IT BACK AND THERE'S 1493 01:20:39,320 --> 01:20:40,960 AN OPPORTUNITY TO UNDERSTAND THE 1494 01:20:40,960 --> 01:20:45,120 EARLIEST EXPOSURES OR RISK 1495 01:20:45,120 --> 01:20:47,560 FACTORS MAY BE FOR CHILDHOOD AND 1496 01:20:47,560 --> 01:20:48,200 ADOLESCENT SUBSTANCE USE WHICH 1497 01:20:48,200 --> 01:20:49,600 MANY POINTED OUT ARE ON THE 1498 01:20:49,600 --> 01:20:49,880 INCREASE. 1499 01:20:49,880 --> 01:20:52,760 I WAS WONDERING IF THERE ARE 1500 01:20:52,760 --> 01:20:55,200 POSSIBILITIES AS WE LEARN MORE 1501 01:20:55,200 --> 01:20:57,520 ABOUT PRENATAL USE TO THINK OF 1502 01:20:57,520 --> 01:20:58,600 PREVENTION, EDUCATION. 1503 01:20:58,600 --> 01:21:02,480 HOW CAN WE INFORM OUR PREGNANT 1504 01:21:02,480 --> 01:21:04,120 MOTHERS ABOUT THE POTENTIAL 1505 01:21:04,120 --> 01:21:06,560 CONSEQUENCES AND HAZARDS OF 1506 01:21:06,560 --> 01:21:07,600 USING IN THIS CASE MARIJUANA 1507 01:21:07,600 --> 01:21:09,960 DURING PREGNANCY AND WHAT YOUR 1508 01:21:09,960 --> 01:21:19,360 THOUGHTS WERE ABOUT THAT. 1509 01:21:19,360 --> 01:21:22,400 >>WHY WE LAUNCHED ABC AND THE 1510 01:21:22,400 --> 01:21:23,480 URGENCY TO UNDERSTAND MARIJUANA 1511 01:21:23,480 --> 01:21:27,240 IN A STUDY LONGITUDINAL AND WITH 1512 01:21:27,240 --> 01:21:28,520 HIV AND WHILE THERE'S ATTENTION 1513 01:21:28,520 --> 01:21:30,800 AS THERE SHOULD BE ON THE 1514 01:21:30,800 --> 01:21:32,480 AFFECTS OF ALCOHOL ON PREGNANCY 1515 01:21:32,480 --> 01:21:38,000 THERE'S LESS ATTENTION FOR 1516 01:21:38,000 --> 01:21:38,280 MARIJUANA. 1517 01:21:38,280 --> 01:21:41,000 YET WE KNOW THE CONSUMPTION HAS 1518 01:21:41,000 --> 01:21:42,960 INCREASED FOURFOLD OVER SIX, 1519 01:21:42,960 --> 01:21:53,520 EIGHT YEARS IN WOMEN AND YOU SEE 1520 01:21:58,200 --> 01:21:58,440 ADVERTISEMENT. 1521 01:21:58,440 --> 01:22:04,000 FOR US TO HAVE CREDIBILITY WE 1522 01:22:04,000 --> 01:22:07,200 NEED TO SHOW OBJECTIVE EVIDENCE 1523 01:22:07,200 --> 01:22:12,480 WHY YOU SHOULD NOT CONSUME 1524 01:22:12,480 --> 01:22:20,120 MARIJUANA. 1525 01:22:20,120 --> 01:22:21,640 AND ONE COULD MAKE AN ARGUMENT 1526 01:22:21,640 --> 01:22:24,560 ONE WAY OR ANOTHER REGARDLESS OF 1527 01:22:24,560 --> 01:22:25,560 THAT MY PERSPECTIVE WHEN IT 1528 01:22:25,560 --> 01:22:28,880 COMES TO PREGNANCY IS WHILE 1529 01:22:28,880 --> 01:22:30,320 WE'RE COLLECTING THE EVIDENCE 1530 01:22:30,320 --> 01:22:31,120 THERE'S SUFFICIENT DATA ALREADY 1531 01:22:31,120 --> 01:22:36,880 TO SUGGEST IT COULD BE HARMFUL 1532 01:22:36,880 --> 01:22:43,440 SO IT'S BETTER TO BE CAREFUL AND 1533 01:22:43,440 --> 01:22:45,680 RECOMMEND NO CONSUMPTION OF THE 1534 01:22:45,680 --> 01:22:45,880 DRUG. 1535 01:22:45,880 --> 01:22:53,960 THE RISKS ARE HIGH. 1536 01:22:53,960 --> 01:22:57,120 YOU HAVE DATA THAT GIVES CAUSE 1537 01:22:57,120 --> 01:22:58,880 FOR CONCERN AND EDUCATING THE 1538 01:22:58,880 --> 01:23:00,800 PUBLIC IS CRUCIAL AND GIVING 1539 01:23:00,800 --> 01:23:03,560 CLEAR-CUT OBJECTIVE DATA THAT 1540 01:23:03,560 --> 01:23:06,400 CAN BE UTILIZED TO EDUCATE THE 1541 01:23:06,400 --> 01:23:16,880 PUBLIC AND TO GUIDE POLICIES. 1542 01:23:19,560 --> 01:23:29,840 AND MINIMIZE RISKS. 1543 01:23:34,320 --> 01:23:40,200 >>I DON'T SEE ANY OTHER RAISED 1544 01:23:40,200 --> 01:23:42,040 HANDS. 1545 01:23:42,040 --> 01:23:43,640 ANY OTHER QUESTIONS? 1546 01:23:43,640 --> 01:23:47,600 COMMENTS? 1547 01:23:47,600 --> 01:23:53,600 >>GREAT UPDATE. 1548 01:23:53,600 --> 01:23:55,360 >>OUR NEXT PRESENTATION IS 1549 01:23:55,360 --> 01:23:57,920 GOING TO BE BY AMY NEWMAN WHO 1550 01:23:57,920 --> 01:24:04,080 WILL TALK ABOUT THE NIDA IRP AND 1551 01:24:04,080 --> 01:24:09,640 GIVE AN OVERVIEW A SAMPLE OF 1552 01:24:09,640 --> 01:24:17,640 WHAT IS HAPPENING IN THE IRP BUT 1553 01:24:17,640 --> 01:24:19,520 SHOULD BE INFORMATIVE AND 1554 01:24:19,520 --> 01:24:29,720 ENJOYABLE. 1555 01:24:33,680 --> 01:24:35,640 >>THANK YOU FOR GIVING ME A 1556 01:24:35,640 --> 01:24:37,440 CHANCE TO TELL COUNCIL WHAT IS 1557 01:24:37,440 --> 01:24:38,600 HOT AT THE IRP. 1558 01:24:38,600 --> 01:24:41,960 >>YOU'RE STILL NOT SHOWING THE 1559 01:24:41,960 --> 01:24:46,160 RIGHT SCREEN. 1560 01:24:46,160 --> 01:24:56,400 >>THANK YOU. 1561 01:24:59,480 --> 01:24:59,680 THANK YOU. 1562 01:24:59,680 --> 01:25:02,680 I WANT TO START WITH WHOER AND 1563 01:25:02,680 --> 01:25:04,640 OUR MISSION TO ADVANCE SCIENCE 1564 01:25:04,640 --> 01:25:05,400 ON THE CAUSES AND CONSEQUENCES 1565 01:25:05,400 --> 01:25:07,760 OF DRUG ABUSE AND ADDICTION AND 1566 01:25:07,760 --> 01:25:09,440 APPLY THAT KNOWLEDGE TO IMPROVE 1567 01:25:09,440 --> 01:25:10,840 INDIVIDUAL AND PUBLIC HEALTH. 1568 01:25:10,840 --> 01:25:12,080 WE'RE LOCATED IN BALTIMORE. 1569 01:25:12,080 --> 01:25:14,800 WE'RE ON A JOHNS HOPKINS CAMPUS 1570 01:25:14,800 --> 01:25:16,360 WHICH MEANS WE'RE NOT ON THE 1571 01:25:16,360 --> 01:25:18,320 BETHESDA CAMPUS WHERE THE REST 1572 01:25:18,320 --> 01:25:22,640 OF THE NIH RESIDES. 1573 01:25:22,640 --> 01:25:25,560 THE CHALLENGE OF THAT IS THOUGH 1574 01:25:25,560 --> 01:25:27,960 MORE THAN 40% OF OUR BUDGET GOES 1575 01:25:27,960 --> 01:25:30,160 TO THE NIH, WE DON'T HAVE ACCESS 1576 01:25:30,160 --> 01:25:32,480 TO MUCH OF THE RESOURCES ON THE 1577 01:25:32,480 --> 01:25:32,920 BETHESDA CAMPUS. 1578 01:25:32,920 --> 01:25:38,960 FOR EXAMPLE, WE HAVE OUR OWN 1579 01:25:38,960 --> 01:25:39,800 PHARMACEU 1580 01:25:39,800 --> 01:25:40,480 PHARMACY AND CLINIC AND EXPENSES 1581 01:25:40,480 --> 01:25:48,400 ASSOCIATED WITH THOSE. 1582 01:25:48,400 --> 01:25:51,320 WE LOOK TO MECHANISMS AND 1583 01:25:51,320 --> 01:25:52,480 CIRCUITRY AND UNDERSTAND 1584 01:25:52,480 --> 01:25:53,200 UNDERLYING SUBSTANCE USE 1585 01:25:53,200 --> 01:25:54,880 DISORDER WITH THE AIM OF 1586 01:25:54,880 --> 01:25:56,480 TRANSLATING THESE FINDINGS INTO 1587 01:25:56,480 --> 01:25:59,440 IMPROVEMENTS IN PREVENTION AND 1588 01:25:59,440 --> 01:25:59,720 TREATMENT. 1589 01:25:59,720 --> 01:26:01,080 WE'RE A TRAINING INSTITUTION. 1590 01:26:01,080 --> 01:26:02,880 WE ARE DEDICATED TO PROVIDING 1591 01:26:02,880 --> 01:26:09,920 THE BEST MENTORING AND TRAINING 1592 01:26:09,920 --> 01:26:19,560 OPPORTUNITIES FOR TRAINEES TO 1593 01:26:19,560 --> 01:26:21,040 ADVANCE THEIR CAREERS AND 1594 01:26:21,040 --> 01:26:22,440 PROMOTING A COLLEGIAL CULTURE 1595 01:26:22,440 --> 01:26:24,160 AND I HOPE THE REST OF THE 1596 01:26:24,160 --> 01:26:24,760 DISCUSSION AND PRESENTATION 1597 01:26:24,760 --> 01:26:35,240 YOU'LL SEE EXAMPLES OF THAT. 1598 01:26:36,200 --> 01:26:37,440 WE HAD THE CHALLENGE OF COVID 1599 01:26:37,440 --> 01:26:38,880 AND WAS APPOINTED SCIENTIFIC 1600 01:26:38,880 --> 01:26:39,960 DIRECTOR OF 2020. 1601 01:26:39,960 --> 01:26:41,560 I HAD THE OPPORTUNITY AS BEING 1602 01:26:41,560 --> 01:26:47,080 THE ACTING SD FOR TWO YEARS 1603 01:26:47,080 --> 01:26:50,560 BEFORE THAT EVERYTHING HAS 1604 01:26:50,560 --> 01:26:51,840 HAPPENED UNDER THE CHALLENGE OF 1605 01:26:51,840 --> 01:26:55,680 COVID IN OUR BACKGROUND. 1606 01:26:55,680 --> 01:26:58,760 MY VISION IS OUTSTANDING SCIENCE 1607 01:26:58,760 --> 01:27:02,360 DIRECTED TOWARDS SUBSTANCE USE 1608 01:27:02,360 --> 01:27:04,760 DISORDER WITH AN EMPHASIS ON 1609 01:27:04,760 --> 01:27:05,400 ADDICTION MEDICINE AND 1610 01:27:05,400 --> 01:27:07,360 NEUROSCIENCE AND NEURO IMAGING, 1611 01:27:07,360 --> 01:27:10,080 PHYSIOLOGY AND DEVELOPMENTS OF 1612 01:27:10,080 --> 01:27:11,080 NEW TREATMENT MODALITY. 1613 01:27:11,080 --> 01:27:12,320 WE'RE ALSO FOCUSSED ON THE 1614 01:27:12,320 --> 01:27:13,800 DEVELOPMENT OF NEW TECHNOLOGIES, 1615 01:27:13,800 --> 01:27:18,840 NEW BEHAVIORAL MODELS, NEW DRUGS 1616 01:27:18,840 --> 01:27:21,640 AND TREATMENTS AND THE HALLMARK 1617 01:27:21,640 --> 01:27:24,560 OF THE IRP IS WE ENGAGE IN 1618 01:27:24,560 --> 01:27:26,320 LONG-TERM AND HIGH-RISK PROJECTS 1619 01:27:26,320 --> 01:27:27,400 WITH AN EMPHASIS ON 1620 01:27:27,400 --> 01:27:32,480 COLLABORATIVE AND TEAM SCIENCE. 1621 01:27:32,480 --> 01:27:37,400 FOR COLOR THESE IN BLACK ARE 1622 01:27:37,400 --> 01:27:40,840 WHAT WE ALWAYS HAD AND IN PURPLE 1623 01:27:40,840 --> 01:27:42,200 ARE THINGS INITIATED IN THE LAST 1624 01:27:42,200 --> 01:27:43,120 FEW YEARS. 1625 01:27:43,120 --> 01:27:48,760 AS YOU SAW EARLIER TODAY WE HAVE 1626 01:27:48,760 --> 01:27:50,680 A STRONG SCIENTIFIC COUNCIL AND 1627 01:27:50,680 --> 01:27:52,280 OUR TENURE TRACK INVESTIGATORS 1628 01:27:52,280 --> 01:27:53,320 MUST BE REVIEWED EVERY FOUR 1629 01:27:53,320 --> 01:27:55,520 YEARS THOUGH WE CAN BE REVIEWED 1630 01:27:55,520 --> 01:28:00,440 IN LESS TIME THAN THAT. 1631 01:28:00,440 --> 01:28:02,520 BECAUSE I'M REFLECTING WHOLE 1632 01:28:02,520 --> 01:28:03,800 BRANCHES OF THE SAME TIME AND 1633 01:28:03,800 --> 01:28:04,800 WE'RE STILL IN THE PROCESS OF 1634 01:28:04,800 --> 01:28:07,840 DOING THAT, SOME MAY BE REVIEWED 1635 01:28:07,840 --> 01:28:10,560 IN SHORTER PERIODS AND SOME HAVE 1636 01:28:10,560 --> 01:28:13,720 TO BE REVIEWED IN FOUR YEARS. 1637 01:28:13,720 --> 01:28:16,640 SOMETIMES YOU'LL SEE A MIX UP IN 1638 01:28:16,640 --> 01:28:18,160 WHO'S BEING REVIEWED BUT 1639 01:28:18,160 --> 01:28:19,080 NONETHELESS EVERYONE GETS 1640 01:28:19,080 --> 01:28:20,560 REVIEWED EVERY FOUR YEARS. 1641 01:28:20,560 --> 01:28:21,920 IN ADDITION TO THE CRITERIA WE 1642 01:28:21,920 --> 01:28:25,520 REVIEWED ON, WE ADDED A 1643 01:28:25,520 --> 01:28:27,520 DIVERSITY INCLUSION, 1644 01:28:27,520 --> 01:28:30,040 ACCESSIBILITY AND EQUITY SUPPORT 1645 01:28:30,040 --> 01:28:32,360 PIECE TO OUR INTERVIEW. 1646 01:28:32,360 --> 01:28:34,160 IT TURNS OUT I DIDN'T ASK 1647 01:28:34,160 --> 01:28:35,200 PERMISSION BUT TURNED OUT LATER 1648 01:28:35,200 --> 01:28:36,960 WE WERE THE FIRST INSTITUTE TO 1649 01:28:36,960 --> 01:28:38,920 DO THAT AND I WAS THEN ASKED TO 1650 01:28:38,920 --> 01:28:40,120 LEAD A GROUP OF SCIENTIFIC 1651 01:28:40,120 --> 01:28:45,640 DIRECTORS TO CREATE THAT 1652 01:28:45,640 --> 01:28:49,160 VERBIAGE FOR ALL NIH INTRAMURAL 1653 01:28:49,160 --> 01:28:52,240 PROGRAMS AND HAD THE NEW GRANT 1654 01:28:52,240 --> 01:28:54,680 ARE BRANCH REVIEWS AND I USE 1655 01:28:54,680 --> 01:28:55,680 THEM AS AN ADVISORY COUNCIL. 1656 01:28:55,680 --> 01:28:57,120 IT'S IMPORTANT THEY BE REVIEWED 1657 01:28:57,120 --> 01:28:59,480 EVERY FOUR YEARS ON THEIR 1658 01:28:59,480 --> 01:29:01,160 LEADERSHIP TO BE SURE WE HAVE 1659 01:29:01,160 --> 01:29:03,560 THE STRONGEST LEADERSHIP WE CAN 1660 01:29:03,560 --> 01:29:05,800 WITHIN THE INTRAMURAL PROGRAM 1661 01:29:05,800 --> 01:29:07,560 AND THAT IS AN NIH-WIDE CHANGE. 1662 01:29:07,560 --> 01:29:10,000 ONE OF THE THINGS I FOCUSSED 1663 01:29:10,000 --> 01:29:11,920 ATTENTION ON IS BUILDING OUR 1664 01:29:11,920 --> 01:29:14,840 CLINICAL PORTFOLIO. 1665 01:29:14,840 --> 01:29:16,960 WE HAVE FOUR CLINICAL TENURE 1666 01:29:16,960 --> 01:29:18,520 TRACK INVESTIGATORS AND 1667 01:29:18,520 --> 01:29:20,160 REINVENTING THE OFFICE OF THE 1668 01:29:20,160 --> 01:29:21,960 CLINICAL DIRECTOR TO PROVIDE THE 1669 01:29:21,960 --> 01:29:25,280 BEST SUPPORT FOR OUR CLINICAL 1670 01:29:25,280 --> 01:29:25,560 PORTFOLIO. 1671 01:29:25,560 --> 01:29:28,800 WE ALSO HAVE NEW LEADERSHIP IN 1672 01:29:28,800 --> 01:29:30,000 OUR SCIENTIFIC COMPUTING AND 1673 01:29:30,000 --> 01:29:31,720 I.T. SUPPORT AND EVERYBODY'S 1674 01:29:31,720 --> 01:29:32,440 GENERATING A LOT OF DATA. 1675 01:29:32,440 --> 01:29:34,280 WE DON'T ALL KNOW HOW TO STORE 1676 01:29:34,280 --> 01:29:36,360 IT AND MANAGE IT AND ANALYZE IT 1677 01:29:36,360 --> 01:29:38,440 AND SO IT REQUIRES A GREAT DEAL 1678 01:29:38,440 --> 01:29:43,520 OF EFFORT IN THIS REALM. 1679 01:29:43,520 --> 01:29:46,040 FINALLY WE'RE DEDICATED TO 1680 01:29:46,040 --> 01:29:47,400 ADDICTION SCIENCE AT THE 1681 01:29:47,400 --> 01:29:50,040 INTRAMURAL PROGRAM. 1682 01:29:50,040 --> 01:29:58,280 THIS SANE ORGANIZATIONAL CHART. 1683 01:29:58,280 --> 01:30:03,920 I WANT TO SHOW YOU ARE HOUSED IN 1684 01:30:03,920 --> 01:30:05,680 THE BRANCHES AND IN THE LAST 1685 01:30:05,680 --> 01:30:07,680 COUPLE YEARS THESE ARE ALL THE 1686 01:30:07,680 --> 01:30:16,720 CHANGES WE'VE MADE. 1687 01:30:16,720 --> 01:30:18,960 AND THERE WERE GROUPS IN THE 1688 01:30:18,960 --> 01:30:20,160 WRONG PLACE TO SERVE THE WHOLE 1689 01:30:20,160 --> 01:30:23,920 INSTITUTE. 1690 01:30:23,920 --> 01:30:24,880 IMPLEMENTING THE CHANGES MEANS 1691 01:30:24,880 --> 01:30:27,280 WE NOW HAVE A MEAN, CLEAN 1692 01:30:27,280 --> 01:30:28,080 MACHINE THAT DOES RESEARCH THAT 1693 01:30:28,080 --> 01:30:30,360 WE CAN DO BETTER THAN EVER WITH 1694 01:30:30,360 --> 01:30:32,400 THE CHANGES THAT WE HAVE 1695 01:30:32,400 --> 01:30:32,960 IMPLEMENTED AND CONTINUE TO 1696 01:30:32,960 --> 01:30:35,120 IMPLEMENT. 1697 01:30:35,120 --> 01:30:38,440 I ALSO AM VERY DEDICATED NOT 1698 01:30:38,440 --> 01:30:41,160 ONLY TO SUPPORTING ALL OUR 1699 01:30:41,160 --> 01:30:41,960 PRINCIPLE INVESTIGATORS BUT 1700 01:30:41,960 --> 01:30:45,920 GROWING THE NEXT GENERATION OF 1701 01:30:45,920 --> 01:30:46,240 INVESTIGATORS. 1702 01:30:46,240 --> 01:30:48,600 THESE GRANT ARROWS INDICATE THE 1703 01:30:48,600 --> 01:30:49,320 FOUR TENURE TRACK INVESTIGATORS 1704 01:30:49,320 --> 01:30:53,440 BROUGHT THROUGH TO TENURE. 1705 01:30:53,440 --> 01:30:56,320 THESE. 1706 01:30:56,320 --> 01:30:58,280 [LISTING NAMES] 1707 01:30:58,280 --> 01:31:01,280 THEY'RE NEWLY TENURED 1708 01:31:01,280 --> 01:31:04,040 INVESTIGATES AT THE IRP. 1709 01:31:04,040 --> 01:31:05,720 THE CHANGES WILL GIVE US A GREAT 1710 01:31:05,720 --> 01:31:07,520 LAUNCHING PAD TO NOT ONLY DO THE 1711 01:31:07,520 --> 01:31:09,960 GREAT WORK WE'VE BEEN DOING BUT 1712 01:31:09,960 --> 01:31:20,400 EVEN BETTER IN THE FUTURE. 1713 01:31:27,560 --> 01:31:30,240 WE STARTED OUT WITH DEVELOPING 1714 01:31:30,240 --> 01:31:36,080 OR STARTING THE ADDICTION 1715 01:31:36,080 --> 01:31:40,480 MEDICINES BRANCH AND WE HAVE TWO 1716 01:31:40,480 --> 01:31:41,920 INVESTIGATORS THAT WORK WITH 1717 01:31:41,920 --> 01:31:45,720 THEM. 1718 01:31:45,720 --> 01:31:48,600 WE HIRED A NEW TENURE TRACK 1719 01:31:48,600 --> 01:31:50,960 INVESTIGATOR IN THE NEUROIMAGING 1720 01:31:50,960 --> 01:31:51,880 BRANCH. 1721 01:31:51,880 --> 01:31:58,600 THIS WAS UPON THE RETIREMENT OF 1722 01:31:58,600 --> 01:32:09,120 ELLIOT STEIN AND NOW THE NEW 1723 01:32:21,160 --> 01:32:24,480 NEUROIMAGING CORPS WE CAN OPEN 1724 01:32:24,480 --> 01:32:27,240 IT UP TO SCIENTISTS ACROSS THE 1725 01:32:27,240 --> 01:32:30,760 PROGRAM AND WE HAVE A CORE LED 1726 01:32:30,760 --> 01:32:33,560 SERVICES BASIC AND PRE CLINICAL 1727 01:32:33,560 --> 01:32:35,760 SCIENTISTS AS WELL AS OUR 1728 01:32:35,760 --> 01:32:36,240 CLINICAL RESEARCHERS. 1729 01:32:36,240 --> 01:32:38,760 WE'RE REINVENTING THE OFFICE OF 1730 01:32:38,760 --> 01:32:39,480 THE CLINICAL DIRECTOR. 1731 01:32:39,480 --> 01:32:41,640 WE HAVE A CLINICAL DIRECTOR 1732 01:32:41,640 --> 01:32:44,280 SEARCH WHICH I HOPE WILL CON 1733 01:32:44,280 --> 01:32:50,320 INCLUDE WITH A DIRECTOR IN 2023. 1734 01:32:50,320 --> 01:32:55,520 AND IMPORTANTLY AND HAVE TO 1735 01:32:55,520 --> 01:32:59,960 STRENGTHEN OUR PARTNERSHIP WITH 1736 01:32:59,960 --> 01:33:02,600 NCATS WHICH HAS THE CAPABLE TO 1737 01:33:02,600 --> 01:33:04,440 TRANSLATE MEDICINES TO THE CL 1738 01:33:04,440 --> 01:33:08,040 CLINIC AND PHARMA WITHOUT PHARMA 1739 01:33:08,040 --> 01:33:11,640 WE CAN CURE IN RATS AND MONKEYS 1740 01:33:11,640 --> 01:33:15,360 BUT WE NEED TO GET IT IN HUMAN 1741 01:33:15,360 --> 01:33:15,640 PATIENTS. 1742 01:33:15,640 --> 01:33:18,560 AN EXAMPLE OF THIS WORK IS A 1743 01:33:18,560 --> 01:33:20,440 COMPOUND FROM ANY LAB THAT'S A 1744 01:33:20,440 --> 01:33:21,720 CLINICAL CANDIDATE FOR THE 1745 01:33:21,720 --> 01:33:23,320 TREATMENT OF OPIOID USE 1746 01:33:23,320 --> 01:33:23,600 DISORDER. 1747 01:33:23,600 --> 01:33:25,680 WE DISCOVERED THIS AS A HIGHLY 1748 01:33:25,680 --> 01:33:29,520 SELECTIVE D3 RECEPTOR ANTAGONIST 1749 01:33:29,520 --> 01:33:31,520 TO PREVENT OR TREAT OPIOID USE 1750 01:33:31,520 --> 01:33:32,120 DISORDER. 1751 01:33:32,120 --> 01:33:35,480 IN PARTNERSHIP WITH NCATS WHO 1752 01:33:35,480 --> 01:33:37,040 RECEIVED FUEL MONEY WE HAVE 1753 01:33:37,040 --> 01:33:38,240 DEVELOPED THIS TOWARD AN IND. 1754 01:33:38,240 --> 01:33:48,640 IN NOVEMBER WE HAD AN FDA 1755 01:33:48,640 --> 01:33:50,440 PRE-IND WRITTEN REVIEW AND 1756 01:33:50,440 --> 01:33:53,200 THERE'S BEEN WORK TO GET TO THIS 1757 01:33:53,200 --> 01:33:53,440 STAGE. 1758 01:33:53,440 --> 01:33:54,920 WE HAVE SO FAR SURVIVED THE 1759 01:33:54,920 --> 01:33:55,720 VALLEY OF DEATH. 1760 01:33:55,720 --> 01:34:01,960 WE HOPE WE CONTINUE AND THAT WE 1761 01:34:01,960 --> 01:34:04,320 WILL BE SUCCESSFUL IN GETTING 1762 01:34:04,320 --> 01:34:05,760 THIS INTO CLINICAL TRIALS AND 1763 01:34:05,760 --> 01:34:07,520 HELPING FOR A CORPORATE PARTNER 1764 01:34:07,520 --> 01:34:18,040 WORKING WITH US AND DOING THIS. 1765 01:34:18,720 --> 01:34:24,840 WE HAVE TO HAVE TO CONTINUE AND 1766 01:34:24,840 --> 01:34:30,320 I APPOINTED MORALE AS OUR 1767 01:34:30,320 --> 01:34:32,640 ASSOCIATE DIRECTOR FOR 1768 01:34:32,640 --> 01:34:35,080 TECHNOLOGY AND DIRECTS OUR THREE 1769 01:34:35,080 --> 01:34:36,960 TECHNOLOGY CORES AND INITIATED A 1770 01:34:36,960 --> 01:34:38,080 TECHNOLOGY DEVELOPMENT 1771 01:34:38,080 --> 01:34:39,240 INITIATIVE WHICH IS INCLUDING 1772 01:34:39,240 --> 01:34:42,960 MANY OF OUR INVESTIGATORS AND 1773 01:34:42,960 --> 01:34:43,600 TRAINEES IN LEARNING MORE ABOUT 1774 01:34:43,600 --> 01:34:50,280 TECHNOLOGY DEVELOPMENT. 1775 01:34:50,280 --> 01:34:54,600 AND AN EXAMPLE OF THE WORK DONE 1776 01:34:54,600 --> 01:34:57,240 IS THIS COOL 3-D RECONSTRUCTION 1777 01:34:57,240 --> 01:35:07,760 OF SYNAPTIC MARKERS WE COLLECT 1778 01:35:08,360 --> 01:35:09,520 IMAGES AND RECONSTRUCT THE 1779 01:35:09,520 --> 01:35:11,840 IMAGES INTO THREE DIMENSION AND 1780 01:35:11,840 --> 01:35:13,520 IDENTIFY MARKERS AND SO FORTH SO 1781 01:35:13,520 --> 01:35:17,600 THEY CAN BE REALLY GET DEEP INTO 1782 01:35:17,600 --> 01:35:19,280 UNDERSTANDING HOW CIRCUITS WORK 1783 01:35:19,280 --> 01:35:24,400 AND HOW THEY'RE AFFECTED BY 1784 01:35:24,400 --> 01:35:27,680 SUBSTANCE USE AND THERE'S 3-D 1785 01:35:27,680 --> 01:35:30,520 RESTRICTION AND THERE'S 1786 01:35:30,520 --> 01:35:32,480 ELECTROMICROSCOPE IMAGES AND THE 1787 01:35:32,480 --> 01:35:37,080 CONSTRUCTION SHOWS ONE AXON 1788 01:35:37,080 --> 01:35:39,360 TERMINAL ESTABLISHED A SYMMETRIC 1789 01:35:39,360 --> 01:35:40,480 SYNAPSE ON ANOTHER DENDRITE. 1790 01:35:40,480 --> 01:35:42,200 THIS WORK IS BEING USED BY A 1791 01:35:42,200 --> 01:35:47,840 NUMBER OF LABORATORIES BUT THIS 1792 01:35:47,840 --> 01:35:58,320 IS AN EXAMPLE AND THE GLU 1793 01:36:00,600 --> 01:36:06,680 GLUTAMATERGIC NEURONS WERE 1794 01:36:06,680 --> 01:36:10,320 AFFECTED AND WE HAVE AN 1795 01:36:10,320 --> 01:36:13,040 NEUROIMAGING RESEARCH BRANCH AND 1796 01:36:13,040 --> 01:36:15,160 WORK ON PHOTO MAGNETIC 1797 01:36:15,160 --> 01:36:20,600 STIMULATION ON RODENTS AND THIS 1798 01:36:20,600 --> 01:36:24,760 WORK IS THING TO TO BE 1799 01:36:24,760 --> 01:36:29,480 TRANSLATED TO HUMAN TMS STUDIES. 1800 01:36:29,480 --> 01:36:33,920 AND THIS IS A LEADER IN 1801 01:36:33,920 --> 01:36:36,360 DEVELOPING BEHAVIORAL MODEL FOR 1802 01:36:36,360 --> 01:36:37,480 SUBSTANCE USE DISORDER AND 1803 01:36:37,480 --> 01:36:39,560 OTHERS AS YOU CAN SEE IN THE 1804 01:36:39,560 --> 01:36:41,760 CO-AUTHOR LINE HAVE BEEN WORKING 1805 01:36:41,760 --> 01:36:47,120 ON AN OPIOID RECEPTOR KNOCK IN 1806 01:36:47,120 --> 01:36:50,040 RAT AND PUBLISHED A PAPER 1807 01:36:50,040 --> 01:36:52,200 SHOWING THE AFFECT OF SELECT 1808 01:36:52,200 --> 01:36:57,040 LESIONS IN THE RECEPTORS FROM 1809 01:36:57,040 --> 01:36:59,600 HEROIN ON MALES AND FEMALES. 1810 01:36:59,600 --> 01:37:01,280 THESE ARE A COUPLE EXAMPLES OF 1811 01:37:01,280 --> 01:37:02,080 THIS TECHNOLOGY WE'RE USING TO 1812 01:37:02,080 --> 01:37:07,240 DO OUR SCIENCE. 1813 01:37:07,240 --> 01:37:12,560 IT'S NOT JUST US. 1814 01:37:12,560 --> 01:37:13,920 AND WE'RE DOING TRANS NIH 1815 01:37:13,920 --> 01:37:15,600 SCIENCE BY WORKING WITH OTHER 1816 01:37:15,600 --> 01:37:16,840 GROUPS AND OTHER INSTITUTES. 1817 01:37:16,840 --> 01:37:19,000 ONE OF THE THINGS I'VE BEEN A 1818 01:37:19,000 --> 01:37:19,840 GREAT ADVOCATE FOR THE CENTER 1819 01:37:19,840 --> 01:37:21,560 FOR COMPULSIVE BEHAVIORS. 1820 01:37:21,560 --> 01:37:32,080 THIS IS SOMETHING SET UP BY AND 1821 01:37:32,320 --> 01:37:33,840 THIS INVOLVES 10 INSTITUTES AND 1822 01:37:33,840 --> 01:37:35,880 FELLOWS THAT PUT IN COMPETITIVE 1823 01:37:35,880 --> 01:37:36,240 APPLICATIONS. 1824 01:37:36,240 --> 01:37:40,680 TYPICALLY WITH PROJECTS THAT GO 1825 01:37:40,680 --> 01:37:45,640 ACROSS INSTITUTES AND GET 1826 01:37:45,640 --> 01:37:46,600 FUNDING FOR THEIR OPPORTUNITY TO 1827 01:37:46,600 --> 01:37:48,640 SHARE THEIR RESEARCH IN MONTHLY 1828 01:37:48,640 --> 01:37:50,200 MEETINGS AND AN ANNUAL RETREAT. 1829 01:37:50,200 --> 01:37:52,040 IT'S A TERRIFIC PROGRAM AND OUR 1830 01:37:52,040 --> 01:37:58,280 P.I.s BENEFIT GREATLY FROM IT. 1831 01:37:58,280 --> 01:37:59,800 YOU HEARD FROM INVESTIGATORS 1832 01:37:59,800 --> 01:38:05,280 THAT NEED HELP IN HANDLING BIG 1833 01:38:05,280 --> 01:38:07,160 DATA. 1834 01:38:07,160 --> 01:38:09,040 AND WE HAVE ADVANCED TO WORK 1835 01:38:09,040 --> 01:38:11,120 WITH A WELL ESTABLISHED PROGRAM 1836 01:38:11,120 --> 01:38:13,640 AT THE NIH AND HAVE TERRIFIC 1837 01:38:13,640 --> 01:38:18,280 INTERACTION TO HELP US WITH 1838 01:38:18,280 --> 01:38:19,480 THOSE DATA ANALYSIS. 1839 01:38:19,480 --> 01:38:22,160 WE STARTED A CLINICAL 1840 01:38:22,160 --> 01:38:23,480 INTERACTION WITH NIDDK USING 1841 01:38:23,480 --> 01:38:24,720 RODE CAP FOR THEIR MEDICAL 1842 01:38:24,720 --> 01:38:26,400 RECORDS AND HAVE SIX NEW 1843 01:38:26,400 --> 01:38:30,480 SECONDARY APPOINTMENTS WITH 1844 01:38:30,480 --> 01:38:33,920 P.I.s FROM NIAAA, NIMH AND 1845 01:38:33,920 --> 01:38:40,400 NINDS. 1846 01:38:40,400 --> 01:38:42,800 AND OPEN UP THE OPPORTUNITY FOR 1847 01:38:42,800 --> 01:38:44,960 TRANS-NIH RESEARCH AND THESE ARE 1848 01:38:44,960 --> 01:38:46,880 ADJUNCT FACULTY AND NOT COSTING 1849 01:38:46,880 --> 01:38:49,480 ME MONEY AND IMPROVE THE 1850 01:38:49,480 --> 01:38:53,960 DEMOGRAPHIC AND RICHNESS OF THE 1851 01:38:53,960 --> 01:38:59,320 WORK AND CAN CO-MENTOR TRAINING 1852 01:38:59,320 --> 01:39:04,520 AND HELPING KNIGHT AB TO BE A 1853 01:39:04,520 --> 01:39:05,080 STRONGER INSTITUTE WITHOUT 1854 01:39:05,080 --> 01:39:07,600 HIRING OUR OWN FACULTY WHICH IS 1855 01:39:07,600 --> 01:39:17,200 NOT PHYSICALLY POSSIBLE. 1856 01:39:17,200 --> 01:39:19,320 AND WE HAVE A NUMBER OF 1857 01:39:19,320 --> 01:39:29,520 INVESTIGATORS THAT JOINED 1858 01:39:29,520 --> 01:39:30,360 APPOINTME 1859 01:39:30,360 --> 01:39:35,880 APPOINTMENTS AND THEY SHOWED 1860 01:39:35,880 --> 01:39:40,280 THERE'S POTENTIAL AS A THERAPY 1861 01:39:40,280 --> 01:39:41,600 FOR ALCOHOL USE DISORDERS USING 1862 01:39:41,600 --> 01:39:43,400 ANIMAL AND RODENT STUDIES AND WE 1863 01:39:43,400 --> 01:39:46,880 HAD AN NDC HIGHLIGHT OF THEM 1864 01:39:46,880 --> 01:39:47,680 RECENTLY MANY OF US HAD THE 1865 01:39:47,680 --> 01:39:55,280 OPPORTUNITY TO SEE. 1866 01:39:55,280 --> 01:39:58,080 AND THERE'S A NEWLY TENURED 1867 01:39:58,080 --> 01:40:00,280 PRINCIPLE INVESTIGATOR IN THE 1868 01:40:00,280 --> 01:40:05,920 NEUROLOGICAL INSTITUTE AND 1869 01:40:05,920 --> 01:40:07,520 ADJUNCT APPOINTEE AND INTERESTED 1870 01:40:07,520 --> 01:40:12,640 IN TRANSMISSION OF DOPAMINE AND 1871 01:40:12,640 --> 01:40:23,200 PATCH CLAMP AXONS IN MOUSE MAINS 1872 01:40:24,760 --> 01:40:34,840 AND WITH RHESUS MACAQUES THEY 1873 01:40:34,840 --> 01:40:39,520 CONTACTED US BECAUSE THIS IS A 1874 01:40:39,520 --> 01:40:41,280 HIGHLY SELECTIVE DOPAMINE LIGAND 1875 01:40:41,280 --> 01:40:45,120 AND THEY WERE ABLE TO SHOW 1876 01:40:45,120 --> 01:40:46,160 PHYSIOLOGICALLY THEY BEHAVE 1877 01:40:46,160 --> 01:40:47,360 SIMILAR TO THOSE IN MICE 1878 01:40:47,360 --> 01:40:48,960 SUGGESTING A SPECIES TRANSLATION 1879 01:40:48,960 --> 01:40:58,240 OF THE WORK THAT THEY WERE DOING 1880 01:40:58,240 --> 01:41:03,120 I LIKE IT BRAG ABOUT MY FOLKS. 1881 01:41:03,120 --> 01:41:11,480 AND JEFF SCHAUMBAUM BECAME A 1882 01:41:11,480 --> 01:41:12,120 DISTINGUISHED INVESTIGATOR BUT 1883 01:41:12,120 --> 01:41:14,960 THERE'S ONLY 50 AT THE NIH AND 1884 01:41:14,960 --> 01:41:18,360 ONLY COME UP A FEW YEARS AND 1885 01:41:18,360 --> 01:41:20,080 THIS OPPORTUNITY CAME UP IN 1886 01:41:20,080 --> 01:41:20,280 2020. 1887 01:41:20,280 --> 01:41:21,840 WE PUT IN AN APPLICATION FOR 1888 01:41:21,840 --> 01:41:25,520 JEFF AND BECAME OUR FIRST NIH 1889 01:41:25,520 --> 01:41:26,640 DISTINGUISHED INVESTIGATOR. 1890 01:41:26,640 --> 01:41:29,040 AND OUR NEW TENURE TRACK 1891 01:41:29,040 --> 01:41:29,960 INVESTIGATORS BECAME AN NIH 1892 01:41:29,960 --> 01:41:32,400 DISTINGUISHED SCHOLAR. 1893 01:41:32,400 --> 01:41:37,480 THIS DIFFERS IN DIRECTED TOWARD 1894 01:41:37,480 --> 01:41:43,920 TENURE TRACK INVESTIGATORS. 1895 01:41:43,920 --> 01:41:47,040 AND GIVES A COHORT OF TENURE 1896 01:41:47,040 --> 01:41:48,160 TRACK INVESTIGATORS TO WORK WITH 1897 01:41:48,160 --> 01:41:53,960 AND LEARN HOW TO BETTER DO 1898 01:41:53,960 --> 01:41:55,320 SCIENCE AT THE NIH INTRAMURAL 1899 01:41:55,320 --> 01:42:01,240 PROGRAM AND WE HAVE ALL WON THE 1900 01:42:01,240 --> 01:42:05,920 PRESTIGIOUS MINING FOR AWARD. 1901 01:42:05,920 --> 01:42:15,640 AND LORENZO WAS A WINNER AND WE 1902 01:42:15,640 --> 01:42:18,720 HAVE ANOTHER PIONEER AWARD 1903 01:42:18,720 --> 01:42:18,960 WINNER. 1904 01:42:18,960 --> 01:42:21,760 WE HAVE NUMEROUS BED TO BEDSIDE 1905 01:42:21,760 --> 01:42:23,600 AWARD AND MANY RECEIVED K99 AND 1906 01:42:23,600 --> 01:42:25,920 GET THE FARE AWARD A COMPETITIVE 1907 01:42:25,920 --> 01:42:31,120 TRAVEL AWARD ACROSS THE NIH. 1908 01:42:31,120 --> 01:42:35,760 SINCE 2020 OUR P.I.s HAVE 1909 01:42:35,760 --> 01:42:37,440 RECEIVED COUNCIL REVIEWS AND 1910 01:42:37,440 --> 01:42:40,360 SCORES 1 OF 2 OUT OF NINE AND 1911 01:42:40,360 --> 01:42:42,880 ARE LEADERS IN DEI INITIATIVES. 1912 01:42:42,880 --> 01:42:44,440 WE'RE HIGHLY PUBLISHED AND 1913 01:42:44,440 --> 01:42:45,360 HIGHLY SIGHTED. 1914 01:42:45,360 --> 01:42:51,440 THE DATA WERE GIVEN TO ME BY MY 1915 01:42:51,440 --> 01:42:55,080 GOOD FRIEND AND WE SHARE 1916 01:42:55,080 --> 01:42:55,560 BUILDINGS WITH THEM. 1917 01:42:55,560 --> 01:42:57,200 SENT ME THE DATA AND SAID YOU'LL 1918 01:42:57,200 --> 01:43:02,920 LIKE TO SEE THIS AND IT TURNS 1919 01:43:02,920 --> 01:43:04,680 OUT AND THIS IS ACROSS 1920 01:43:04,680 --> 01:43:05,920 INSTITUTES WITH AT LEAST 200 1921 01:43:05,920 --> 01:43:07,680 MILLION OR MORE PER FIVE YEARS. 1922 01:43:07,680 --> 01:43:13,440 AT LEAST $40 MILLION A YEAR PER 1923 01:43:13,440 --> 01:43:17,520 YEAR OVER FIVE YEARS EACH BAR 1924 01:43:17,520 --> 01:43:18,440 REPRESENTS AN INTRAMURAL PROGRAM 1925 01:43:18,440 --> 01:43:19,760 AND YOU'RE LOOKING AT 1926 01:43:19,760 --> 01:43:25,720 PUBLICATIONS PER MILLION DOLLARS 1927 01:43:25,720 --> 01:43:29,920 PER YEAR ACROSS INSTITUTES AND 1928 01:43:29,920 --> 01:43:30,120 WE WERE A 1929 01:43:30,960 --> 01:43:32,360 ABOVE THAT OVER FOUR AND WERE 1930 01:43:32,360 --> 01:43:33,640 NUMBER ONE ACROSS ALL INSTITUTES 1931 01:43:33,640 --> 01:43:39,560 PER $100 MILLION. 1932 01:43:39,560 --> 01:43:41,960 IMPORTANTLY, IT'S NOT JUST THAT 1933 01:43:41,960 --> 01:43:44,040 WE PUBLIC ALL OF PAPERS BUT IN 1934 01:43:44,040 --> 01:43:46,760 THE 10% MOST CITED PUBLICATIONS. 1935 01:43:46,760 --> 01:43:47,920 ADDICTION SCIENCE IS NOT ONE OF 1936 01:43:47,920 --> 01:43:49,280 THE BIGGER ONES AT THE NIH. 1937 01:43:49,280 --> 01:43:54,840 WE'RE COMPETING WITH CANCER AND 1938 01:43:54,840 --> 01:44:00,680 AGING AND COVID AND SO FORTH. 1939 01:44:00,680 --> 01:44:03,120 IT'S TERRIFIC DETE AND DATA THAT 1940 01:44:03,120 --> 01:44:06,000 IS GOING TO BE A CHALLENGE WE'LL 1941 01:44:06,000 --> 01:44:15,600 CONTINUE TO MEET. 1942 01:44:15,600 --> 01:44:17,320 BEING THE TERRIFIC INSTITUTE 1943 01:44:17,320 --> 01:44:18,120 WITHIN THE INTRAMURAL PROGRAM 1944 01:44:18,120 --> 01:44:19,520 ONE THING I'VE BEEN COMMITTED TO 1945 01:44:19,520 --> 01:44:21,280 IS STRENGTHENING OUR CULTURE AND 1946 01:44:21,280 --> 01:44:21,920 PERSONNEL THROUGH DIVERSITY AND 1947 01:44:21,920 --> 01:44:31,720 INCLUSION. 1948 01:44:31,720 --> 01:44:34,960 I ASKED YEKA TO BE MY DIRECTOR 1949 01:44:34,960 --> 01:44:37,200 IN ADDITION TO RUNNING HER OWN 1950 01:44:37,200 --> 01:44:39,560 LABORATORY AND SHE'S REVAMPED 1951 01:44:39,560 --> 01:44:41,920 OUR FELLOWSHIP FOR DIVERSITY AND 1952 01:44:41,920 --> 01:44:43,520 RESEARCH PROGRAM. 1953 01:44:43,520 --> 01:44:46,280 THIS IS A PROGRAM WE'VE HAD OVER 1954 01:44:46,280 --> 01:44:48,440 10 YEARS THAT NEEDED TWEAKING 1955 01:44:48,440 --> 01:44:50,960 AND DEVELOPED A FANTASTIC 1956 01:44:50,960 --> 01:44:52,200 PROGRAM FOR POST-BACS WHO APPLY 1957 01:44:52,200 --> 01:44:54,120 THE PROGRAM AND IT'S COMPETITIVE 1958 01:44:54,120 --> 01:44:56,320 AND THEY NEED TO APPLY WITHIN 1959 01:44:56,320 --> 01:44:59,360 THE INTRAMURAL PROGRAM AND 1960 01:44:59,360 --> 01:45:01,400 THERE'S ALSO A STRONG MANDATE 1961 01:45:01,400 --> 01:45:04,600 FOR THE P.I.s TO HAVE STRONG 1962 01:45:04,600 --> 01:45:05,360 MENTORSHIP. 1963 01:45:05,360 --> 01:45:06,520 SHE MEETS WITH THEM EVERY MONTH 1964 01:45:06,520 --> 01:45:08,800 AND HAVE ACTIVITIES INCLUDING 1965 01:45:08,800 --> 01:45:09,760 WORKING ON THE COMMUNITY 1966 01:45:09,760 --> 01:45:12,360 OUTREACH GROUP WHICH IS A NEW WE 1967 01:45:12,360 --> 01:45:13,760 JUST STARTED AND DR. BRENDA 1968 01:45:13,760 --> 01:45:14,800 CURTIS IS LEADING THAT. 1969 01:45:14,800 --> 01:45:16,360 IN ADDITION WE HAVE A NEW 1970 01:45:16,360 --> 01:45:17,840 RESEARCH PROGRAM WITH THE 1971 01:45:17,840 --> 01:45:23,120 UNIVERSITY OF MARYLAND BALTIMORE 1972 01:45:23,120 --> 01:45:23,440 COUNTY. 1973 01:45:23,440 --> 01:45:28,080 THIS IS SOMETHING NORA HELPED US 1974 01:45:28,080 --> 01:45:30,160 SET UP WORKING ON MATH AND 1975 01:45:30,160 --> 01:45:32,360 SCIENCE THROUGH A LOCAL 1976 01:45:32,360 --> 01:45:32,680 UNIVERSITY. 1977 01:45:32,680 --> 01:45:37,200 STRONG S.T.E.M. AND COME IN AND 1978 01:45:37,200 --> 01:45:39,320 WORK IN OUR LABS FIVE OR TEN 1979 01:45:39,320 --> 01:45:40,640 HOURS PER WEEK DURING THE SCHOOL 1980 01:45:40,640 --> 01:45:44,560 YEAR AND IN THE SUMMER AND THIS 1981 01:45:44,560 --> 01:45:46,080 HAS BEEN HIGHLY SUCCESSFUL FOR 1982 01:45:46,080 --> 01:45:49,600 THEM AND HAVE AN INCLUSION LED 1983 01:45:49,600 --> 01:45:50,240 DIVERSITY, EQUITY, INCLUSION AND 1984 01:45:50,240 --> 01:45:50,880 ACCESSIBILITY COMMITTEE THAT 1985 01:45:50,880 --> 01:45:51,840 DOES GREAT THINGS IN 1986 01:45:51,840 --> 01:45:53,200 COMMUNICATIONS AND HAS SPEAKERS 1987 01:45:53,200 --> 01:45:55,440 FOR OUR ENTIRE INSTITUTE. 1988 01:45:55,440 --> 01:45:58,680 WE HAVE A WOMEN'S SCIENTIST 1989 01:45:58,680 --> 01:46:00,280 ADVISORY WE SHARE WITH NIA AND 1990 01:46:00,280 --> 01:46:00,880 HAVE THE FRIENDS AND FELLOWS 1991 01:46:00,880 --> 01:46:11,000 GROUP. 1992 01:46:15,440 --> 01:46:18,720 WE WANT THE COMMUNITY TO KNOW US 1993 01:46:18,720 --> 01:46:19,520 AND TAKE ADVANTAGE OF THE THE 1994 01:46:19,520 --> 01:46:23,160 WORK WE DO AND STARTED TO HAVE 1995 01:46:23,160 --> 01:46:25,360 BOOTHS AT PLACES LIKE THE 1996 01:46:25,360 --> 01:46:27,600 BALTIMORE ZOO AND HEALTH FAIRS 1997 01:46:27,600 --> 01:46:29,960 AND WE HAD OUR OWN HEALTH FAIR 1998 01:46:29,960 --> 01:46:31,480 IN BALTIMORE IN THE PARKING LOT 1999 01:46:31,480 --> 01:46:32,240 OF OUR INSTITUTE. 2000 01:46:32,240 --> 01:46:35,320 WE HAD MANY VENDORS FROM ACROSS 2001 01:46:35,320 --> 01:46:36,480 THE STATE THAT CAME IN DIFFERENT 2002 01:46:36,480 --> 01:46:38,880 ASPECTS OF HEALTH. 2003 01:46:38,880 --> 01:46:40,280 WE DID NALOXONE TRAINING AND 2004 01:46:40,280 --> 01:46:42,320 MANY OTHER THINGS AND THERE WAS 2005 01:46:42,320 --> 01:46:43,400 A FOOD TRUCK AND MUSIC AND IT 2006 01:46:43,400 --> 01:46:45,920 WAS FUN AND WE'LL DO IT AGAIN. 2007 01:46:45,920 --> 01:46:48,920 IT'S THE BEGINNING OF GETTING 2008 01:46:48,920 --> 01:46:49,960 OUR BALTIMORE COMMUNITY TO KNOW 2009 01:46:49,960 --> 01:46:52,160 WE'RE HERE, KNOW WHAT WE DO AND 2010 01:46:52,160 --> 01:46:53,960 TO PARTICIPATE IN OUR STUDIES IF 2011 01:46:53,960 --> 01:46:57,920 THEY CAN. 2012 01:46:57,920 --> 01:47:01,240 WE'VE DEVELOPED A FANTASTIC 2013 01:47:01,240 --> 01:47:02,360 COLLABORATION WITH STEVE THOMAS. 2014 01:47:02,360 --> 01:47:03,480 THERE'S FUNDING THROUGH THE 2015 01:47:03,480 --> 01:47:05,200 UNIVERSITY OF MARYLAND CENTER 2016 01:47:05,200 --> 01:47:06,520 FOR HEALTH EQUITY AND HE'S 2017 01:47:06,520 --> 01:47:08,920 CREATED THIS THING CALLED THE 2018 01:47:08,920 --> 01:47:11,080 HEALTH ADVOCATES IN REACH AND 2019 01:47:11,080 --> 01:47:12,640 RESEARCH CAMPAIGN WHERE HE GOES 2020 01:47:12,640 --> 01:47:15,880 TO LOCAL BARBERSHOPS AND MEETS 2021 01:47:15,880 --> 01:47:17,080 WITH PEOPLE AND TALKS ABOUT 2022 01:47:17,080 --> 01:47:18,520 THEIR HEALTH AND TALKS ABOUT 2023 01:47:18,520 --> 01:47:19,320 BLOOD PRESSURE AND TEMPERATURE 2024 01:47:19,320 --> 01:47:20,720 AND TALKS ABOUT THINGS AND WE'RE 2025 01:47:20,720 --> 01:47:23,000 JOINING STEVE TO GET INTO THE 2026 01:47:23,000 --> 01:47:24,080 COMMUNITY, TALKING ABOUT 2027 01:47:24,080 --> 01:47:25,520 SUBSTANCE USE DISORDER, 2028 01:47:25,520 --> 01:47:26,480 PREVENTION, TREATMENT AND ALL 2029 01:47:26,480 --> 01:47:27,120 THOSE THINGS. 2030 01:47:27,120 --> 01:47:28,720 I THINK THIS IS JUST THE 2031 01:47:28,720 --> 01:47:34,240 BEGINNING BUT I THINK WE HAVE A 2032 01:47:34,240 --> 01:47:37,640 GREAT THING GOING HERE. 2033 01:47:37,640 --> 01:47:39,160 I HOPE IT WILL IMPROVE OUR 2034 01:47:39,160 --> 01:47:40,880 STANDING IN THE COMMUNITY AND WE 2035 01:47:40,880 --> 01:47:44,080 CONTINUE TO BE A BEACON OF 2036 01:47:44,080 --> 01:47:44,640 INNOVATIVE RESEARCH WITH 2037 01:47:44,640 --> 01:47:45,480 EMPHASIS ON THE NEUROSCIENCE OF 2038 01:47:45,480 --> 01:47:48,160 ADDICTION AND OUR GOAL IS TO 2039 01:47:48,160 --> 01:47:50,800 TRANSLATE INTO PREVENTION AND 2040 01:47:50,800 --> 01:47:52,160 TREATMENT AND NEW MEDICATION 2041 01:47:52,160 --> 01:47:53,880 TREATMENT DEVELOPMENT BY 2042 01:47:53,880 --> 01:47:55,960 STRENGTHENING OUR CLINICAL 2043 01:47:55,960 --> 01:47:58,120 PORTFOLIO AND WORKING ON 2044 01:47:58,120 --> 01:48:00,480 DIVERSIFYING STAFF AND PROVIDING 2045 01:48:00,480 --> 01:48:01,520 MENTORSHIP AND TRAINING TO 2046 01:48:01,520 --> 01:48:03,040 STRENGTHEN OUR RESEARCH PROGRAM 2047 01:48:03,040 --> 01:48:04,240 AND THE ADDICTION RESEARCH 2048 01:48:04,240 --> 01:48:04,800 COMMUNITY GLOBALLY. 2049 01:48:04,800 --> 01:48:07,160 I HOPE I'VE CONVINCED YOU WE'RE 2050 01:48:07,160 --> 01:48:09,240 FULLY ENGAGED IN OUR RESEARCH 2051 01:48:09,240 --> 01:48:10,640 AND COMMUNITY OUTREACH AND SEE 2052 01:48:10,640 --> 01:48:11,880 OUR WEBSITE BECAUSE THERE'S MORE 2053 01:48:11,880 --> 01:48:12,200 TO COME. 2054 01:48:12,200 --> 01:48:13,440 THANKS SO MUCH FOR THE 2055 01:48:13,440 --> 01:48:14,320 OPPORTUNITY AND I AM HAPPY TO 2056 01:48:14,320 --> 01:48:15,200 TRY TO ANSWER ANY QUESTIONS YOU 2057 01:48:15,200 --> 01:48:25,400 MIGHT HAVE. 2058 01:48:36,800 --> 01:48:38,760 AND WITH FUCHSIA ON YOUR SLIDES 2059 01:48:38,760 --> 01:48:39,840 I LIKE THEM MORE. 2060 01:48:39,840 --> 01:48:41,920 >>I CAN'T HELP IT. 2061 01:48:41,920 --> 01:48:49,920 LOOK AT MY OUTFIT. 2062 01:48:49,920 --> 01:48:53,960 >>THANK YOU FOR THE 2063 01:48:53,960 --> 01:49:04,520 PRESENTATION AND GREAT OVERVIEW. 2064 01:49:06,560 --> 01:49:12,440 HOW DO YOU TRANSLATE NIDA'S 2065 01:49:12,440 --> 01:49:18,480 PRIORITIES AND WE SHAPE INTEREST 2066 01:49:18,480 --> 01:49:19,440 TOWARDS THOSE GOALS. 2067 01:49:19,440 --> 01:49:21,040 HOW DO YOU INTERACT WITH THOSE 2068 01:49:21,040 --> 01:49:24,040 PRIORITIES ON A DAY TO DAY BASIS 2069 01:49:24,040 --> 01:49:25,920 AND THEN TRANSLATE THAT WITH 2070 01:49:25,920 --> 01:49:27,520 YOUR INVESTIGATORS AND THE 2071 01:49:27,520 --> 01:49:34,600 DIFFERENT DIVISIONS TO ALSO BE 2072 01:49:34,600 --> 01:49:36,280 BRING THE INTRAMURAL WORK TO THE 2073 01:49:36,280 --> 01:49:37,920 CRISES AND EMERGENCIES AND 2074 01:49:37,920 --> 01:49:47,680 PRIORITIES WE'RE ALL FACING. 2075 01:49:47,680 --> 01:49:50,560 >>IT'S COMMUNICATION BETWEEN ME 2076 01:49:50,560 --> 01:49:52,040 AND NIDA AND SENIOR STAFF AND 2077 01:49:52,040 --> 01:49:53,640 LEARNING THAT LEVEL AND TALKING 2078 01:49:53,640 --> 01:49:56,480 TO COLLABORATORS AND THE PEOPLE 2079 01:49:56,480 --> 01:50:01,920 I WORK WITH AND TALKING WITH 2080 01:50:01,920 --> 01:50:07,760 EACH ONE OF MY AND WE'RE ALWAYS 2081 01:50:07,760 --> 01:50:09,160 SAYING WHAT ARE THE PRIORITIES. 2082 01:50:09,160 --> 01:50:10,960 THE OTHER THING I TRIED TO DO 2083 01:50:10,960 --> 01:50:15,720 BEST I CAN IS CONTINUE TO BRING 2084 01:50:15,720 --> 01:50:17,040 NEW YOUNG THINKERS AND PEOPLE IN 2085 01:50:17,040 --> 01:50:21,440 THE FOLD. 2086 01:50:21,440 --> 01:50:23,640 WHAT CAN THEY CONTRIBUTE 2087 01:50:23,640 --> 01:50:25,760 ULTIMATELY WE DO THE BEST WE 2088 01:50:25,760 --> 01:50:26,080 CAN. 2089 01:50:26,080 --> 01:50:28,960 WE HAVE A TREMENDOUS RESOURCE AT 2090 01:50:28,960 --> 01:50:32,480 THE INTRAMURAL PROGRAM AND WE 2091 01:50:32,480 --> 01:50:34,240 HAVE THIS PRIVILEGE TO BE ABLE 2092 01:50:34,240 --> 01:50:39,400 TO TAKE ON HIGH RISK AND 2093 01:50:39,400 --> 01:50:41,920 LONG-TERM PROJECTS THAT ARE IN 2094 01:50:41,920 --> 01:50:45,200 THE PRIORITIES OF NIDA. 2095 01:50:45,200 --> 01:50:46,480 I'M DISCOURAGED WITH THE NUMBERS 2096 01:50:46,480 --> 01:50:48,360 AND WHEN YOU SEE THE NUMBERS 2097 01:50:48,360 --> 01:50:50,960 CONTINUE TO CLIMB IT'S LIKE WHAT 2098 01:50:50,960 --> 01:50:53,880 THE HECK ARE WE DOING AND I'M A 2099 01:50:53,880 --> 01:50:55,480 MEDICINAL CHEMIST AND HAVE BEEN 2100 01:50:55,480 --> 01:50:57,920 MAKING MOLECULES TO TREAT 2101 01:50:57,920 --> 01:50:59,360 COCAINE AND OPIOID USE DISORDER 2102 01:50:59,360 --> 01:51:01,040 FOR YEARS AND WE FIGURED IT OUT 2103 01:51:01,040 --> 01:51:02,960 IN RATS AND IT WORK BUT GETTING 2104 01:51:02,960 --> 01:51:08,040 IT TO PEOPLE IS SUCH A 2105 01:51:08,040 --> 01:51:09,920 TREMENDOUS CHALLENGE AND REALLY 2106 01:51:09,920 --> 01:51:11,960 TRYING TO ENGAGE PHARMA TO HELP 2107 01:51:11,960 --> 01:51:13,520 US BECAUSE WE DO GREAT RESEARCH 2108 01:51:13,520 --> 01:51:18,600 BUT WE DON'T DO WHAT FAPHARMA A 2109 01:51:18,600 --> 01:51:21,040 NEED THEM TO WORK WITH US TO TRY 2110 01:51:21,040 --> 01:51:22,280 TO TAKE THESE MEDICATIONS AND 2111 01:51:22,280 --> 01:51:25,800 TREATMENTS INTO THE PEOPLE WHO 2112 01:51:25,800 --> 01:51:28,720 NEED THEM. 2113 01:51:28,720 --> 01:51:32,880 I MAD A MEET ABOUT TECHNOLOGY 2114 01:51:32,880 --> 01:51:35,640 TRANSFER AND HOW IT MARKET AND 2115 01:51:35,640 --> 01:51:37,400 MARKET AND ENCOURAGE THEM TO GET 2116 01:51:37,400 --> 01:51:38,080 COMPANIES TO TAKE THE WORK 2117 01:51:38,080 --> 01:51:45,800 FORWARD. 2118 01:51:45,800 --> 01:51:48,360 >>DO YOU FIND COMPANIES ARE 2119 01:51:48,360 --> 01:51:51,480 LESS SHY OR CAPABLE IN TERMS OF 2120 01:51:51,480 --> 01:51:57,440 COMING FORWARD TO COLLABORATE 2121 01:51:57,440 --> 01:52:04,560 CINCINNATI THE SHUT DOWN. 2122 01:52:04,560 --> 01:52:06,480 >>I THINK THE PEOPLE MAY HAVE A 2123 01:52:06,480 --> 01:52:07,560 BETTER ANSWER BECAUSE THEY HAVE 2124 01:52:07,560 --> 01:52:10,720 MORE INTERACTIONS THAN I DO BUT 2125 01:52:10,720 --> 01:52:13,520 ESSENTIALLY LITTLE COMPANIES 2126 01:52:13,520 --> 01:52:15,040 COME IN AND LICENSE OUR 2127 01:52:15,040 --> 01:52:17,200 TECHNOLOGIES AND RUN OUT OF 2128 01:52:17,200 --> 01:52:19,120 MONEY BEFORE THEY DO ANYTHING. 2129 01:52:19,120 --> 01:52:21,320 WE HAD A COMPANY WORKING WITH US 2130 01:52:21,320 --> 01:52:23,160 AND JUST DROPPED OUT LAST YEAR 2131 01:52:23,160 --> 01:52:28,640 AND NOW WE'RE LEFT HOLDING THE 2132 01:52:28,640 --> 01:52:31,920 BAG WITH BIG INVESTMENT AND WE 2133 01:52:31,920 --> 01:52:33,280 HAVE A BIG PORTFOLIO AND LOOKING 2134 01:52:33,280 --> 01:52:34,520 FOR SOMEONE TO TAKE IT ON AND 2135 01:52:34,520 --> 01:52:36,400 SEE WHERE IT COMES FROM. 2136 01:52:36,400 --> 01:52:38,520 THERE'S MORE SMALL COMPANIES 2137 01:52:38,520 --> 01:52:40,240 THAT THINK THEY'RE INTERESTED 2138 01:52:40,240 --> 01:52:41,520 BUT IT TAKES A LOT OF MONEY TO 2139 01:52:41,520 --> 01:52:44,720 DO THIS AND WE NEED THE BIGGER 2140 01:52:44,720 --> 01:52:46,160 COMPANIES WITH THE DEEPER POCKET 2141 01:52:46,160 --> 01:52:47,000 TO PAY ATTENTION. 2142 01:52:47,000 --> 01:52:57,400 THE OTHER THING I'M TRYING IS 2143 01:52:57,400 --> 01:53:01,400 AND THERE ARE COMPANIES 2144 01:53:01,400 --> 01:53:05,200 INTERESTED IN SCHIZOPHRENIA AND 2145 01:53:05,200 --> 01:53:07,520 THEY HAVE A HUGE MORBIDITY 2146 01:53:07,520 --> 01:53:09,320 SUBSTANCE USE DISORDER AND IF WE 2147 01:53:09,320 --> 01:53:11,000 GO THAT ANGLE MAYBE WE CAN GET 2148 01:53:11,000 --> 01:53:11,640 MORE INTEREST AND THAT'S WHAT 2149 01:53:11,640 --> 01:53:13,120 I'M TRYING TO DO. 2150 01:53:13,120 --> 01:53:14,680 >>AND IF THE COMPANY ALREADY 2151 01:53:14,680 --> 01:53:16,160 WENT THROUGH THE TROUBLE OF 2152 01:53:16,160 --> 01:53:21,920 GETTING THE INDICATION, HAVING A 2153 01:53:21,920 --> 01:53:26,720 SECONDARY INDICATION THEY 2154 01:53:26,720 --> 01:53:27,960 ALREADY HAVE THEIR PRIMARY 2155 01:53:27,960 --> 01:53:28,280 INDICATION. 2156 01:53:28,280 --> 01:53:30,280 >>THE ADJUNCT IS A GOOD IDEA 2157 01:53:30,280 --> 01:53:31,760 AND SOMETHING WE'RE TRYING TO 2158 01:53:31,760 --> 01:53:42,040 PROMOTE AS WELL. 2159 01:53:43,760 --> 01:53:47,840 >>MAYBE NIDA CAN CONSIDER SOME 2160 01:53:47,840 --> 01:53:53,920 BUSINESS DEVELOPMENT FUNCTION OR 2161 01:53:53,920 --> 01:53:58,400 EMISSARY WHERE SOMEBODY CAN 2162 01:53:58,400 --> 01:54:00,920 REACH OUT AND TALK TO PEOPLE 2163 01:54:00,920 --> 01:54:02,760 WITHIN PHARMA THAT MAY HAVE NO 2164 01:54:02,760 --> 01:54:04,680 OTHER WAY OF KNOWING ABOUT THE 2165 01:54:04,680 --> 01:54:07,240 KINDS OF EFFORTS AND RESEARCH 2166 01:54:07,240 --> 01:54:07,840 OPPORTUNITIES THAT THERE ARE. 2167 01:54:07,840 --> 01:54:13,200 I CAN TELL YOU FROM MY OWN 2168 01:54:13,200 --> 01:54:17,320 EXPERIENCE AND PERSPECTIVE IN MY 2169 01:54:17,320 --> 01:54:19,240 COMPANY WE NEVER WOULD HAVE 2170 01:54:19,240 --> 01:54:21,920 SUCCEEDED IN GETTING AN FDA 2171 01:54:21,920 --> 01:54:25,280 APPROACHED MEDICATION FOR OPIOID 2172 01:54:25,280 --> 01:54:27,680 USE DISORDER WITHOUT NIDA AND 2173 01:54:27,680 --> 01:54:28,320 THERE'S COMPANIES THAT WOULD 2174 01:54:28,320 --> 01:54:33,760 WANT TO PARTNER BUT DON'T KNOW 2175 01:54:33,760 --> 01:54:40,360 HOW TO ACCESS. 2176 01:54:40,360 --> 01:54:42,480 >>THERE'S HISTORICAL BACKGROUND 2177 01:54:42,480 --> 01:54:44,800 THAT HURTS US THAT'S HARD TO 2178 01:54:44,800 --> 01:54:46,440 WORK WITH NIH AND IT'S 2179 01:54:46,440 --> 01:54:49,640 BUREAUCRATIC BUT IT'S CHANGED A 2180 01:54:49,640 --> 01:54:49,800 LOT. 2181 01:54:49,800 --> 01:54:52,200 OUR TRANSFER IS 100% BETTER THAN 2182 01:54:52,200 --> 01:54:54,640 IT USED TO BE AND ARE DEDICATED 2183 01:54:54,640 --> 01:54:55,640 AND AT THE NIH LEVEL THEY'RE 2184 01:54:55,640 --> 01:54:57,640 TRYING TO DO WHAT YOU DESCRIBED. 2185 01:54:57,640 --> 01:55:03,120 MAYBE THERE'S A WAY TO PARTNER 2186 01:55:03,120 --> 01:55:06,120 WITH DTMC TO TARGET OUR PART OF 2187 01:55:06,120 --> 01:55:16,360 THE MARKET. 2188 01:55:17,400 --> 01:55:21,000 >>IT'S SOUGHT OUT THE VARIOUS 2189 01:55:21,000 --> 01:55:23,040 COMPANIES AND IDENTIFY HOW TO 2190 01:55:23,040 --> 01:55:28,560 THE POINT THAT IDENTIFY 2191 01:55:28,560 --> 01:55:35,840 MOLECULES THEY HAVE AND IT'S 2192 01:55:35,840 --> 01:55:43,360 EASIER FOR THEM TO MOVE AND 2193 01:55:43,360 --> 01:55:47,960 THERE'S A WAY TO LOOK AT THIS 2194 01:55:47,960 --> 01:55:51,000 FOR INSOMNIA IN THE OPIOID USE 2195 01:55:51,000 --> 01:55:51,240 DISORDER. 2196 01:55:51,240 --> 01:55:53,680 THAT IS SLOWLY COMING ABOUT WITH 2197 01:55:53,680 --> 01:55:54,640 PARTNERSHIPS FROM INDUSTRY. 2198 01:55:54,640 --> 01:55:58,000 WE'RE STILL WILLING TO PARTNER 2199 01:55:58,000 --> 01:55:59,880 FROM BIG INDUSTRY IN SUBSTANCE 2200 01:55:59,880 --> 01:56:01,360 USE DISORDER IN THE PAST IS 2201 01:56:01,360 --> 01:56:07,520 STILL EXTREMELY LIMITED. 2202 01:56:07,520 --> 01:56:11,400 AND WHERE WE'VE BEEN SUCCESSFUL 2203 01:56:11,400 --> 01:56:16,560 IS WITH SMALLER COMPANIES BUT 2204 01:56:16,560 --> 01:56:18,480 THERE ARE SEVERAL PROJECTS FOR 2205 01:56:18,480 --> 01:56:21,520 NEW MOLECULES EXPANDED WITH THE 2206 01:56:21,520 --> 01:56:23,480 ADDITION OF THE HEAL DOLLARS. 2207 01:56:23,480 --> 01:56:25,520 THE HEAL DOLLAR ALLOWS US TO 2208 01:56:25,520 --> 01:56:27,160 CREATE PARTNERSHIPS. 2209 01:56:27,160 --> 01:56:30,480 WE'RE DOING IT BUT AS YOU KNOW 2210 01:56:30,480 --> 01:56:32,440 THE ISSUE OF DEVELOPING 2211 01:56:32,440 --> 01:56:36,160 MEDICATION IS A RISKY BUSINESS 2212 01:56:36,160 --> 01:56:40,680 FULL OF THE LIKELIHOOD OF 2213 01:56:40,680 --> 01:56:41,120 FAILURE. 2214 01:56:41,120 --> 01:56:43,280 TRYING TO MOVE -- AND ONE THING 2215 01:56:43,280 --> 01:56:45,160 FOR FAILURE IS THE FACT THAT THE 2216 01:56:45,160 --> 01:56:50,200 COMPANIES AND PERCEPTION IN 2217 01:56:50,200 --> 01:56:55,280 GENERAL FOR FDA TO APPROVE A 2218 01:56:55,280 --> 01:56:56,400 MEDICATION FOR SUBSTANCE USE 2219 01:56:56,400 --> 01:57:01,520 DISORDER IS DIFFICULT TO 2220 01:57:01,520 --> 01:57:01,760 ACHIEVE. 2221 01:57:01,760 --> 01:57:03,640 YOU HAVE TO BE ABSTINENT FOR A 2222 01:57:03,640 --> 01:57:04,680 CERTAIN PERIOD OF TIME. 2223 01:57:04,680 --> 01:57:09,120 WHEN IN FACT THERE'S LIKELY TO 2224 01:57:09,120 --> 01:57:12,120 BE OTHER OUTCOMES. 2225 01:57:12,120 --> 01:57:14,280 THIS IS WHERE WE'RE INTERESTED 2226 01:57:14,280 --> 01:57:17,800 JOT JUST WITH INDUSTRY BUT TO 2227 01:57:17,800 --> 01:57:19,520 FIGURE OUT IF WE CAN ESTABLISH 2228 01:57:19,520 --> 01:57:21,920 ALTERNATIVE OUTCOMES TO 2229 01:57:21,920 --> 01:57:22,520 INCENTIVIZE INDUSTRY TO JUMP 2230 01:57:22,520 --> 01:57:26,000 INTO IT. 2231 01:57:26,000 --> 01:57:29,480 THIS IS RELEVANT TO WHAT WE DO 2232 01:57:29,480 --> 01:57:30,520 FOR MEDICATION DEVELOPMENT. 2233 01:57:30,520 --> 01:57:40,840 >>THAT'S EXCELLENT. 2234 01:57:41,280 --> 01:57:42,480 >>THANK YOU FOR THE 2235 01:57:42,480 --> 01:57:42,800 PRESENTATION. 2236 01:57:42,800 --> 01:57:45,840 I THOUGHT IT WAS FANTASTIC AND 2237 01:57:45,840 --> 01:57:49,760 GLAD TO HEAR YOU HAVE A 2238 01:57:49,760 --> 01:57:51,920 DEPARTMENT THAT FOCUSES ON 2239 01:57:51,920 --> 01:57:52,760 CULTURAL USE. 2240 01:57:52,760 --> 01:57:54,280 MY QUESTION TO YOU IN YOUR 2241 01:57:54,280 --> 01:57:56,440 VISION HOW DO YOU USE THAT 2242 01:57:56,440 --> 01:57:57,800 PARTICULAR DEPARTMENT TO BOLSTER 2243 01:57:57,800 --> 01:58:00,520 THE NUMBER OF UNDER SERVED 2244 01:58:00,520 --> 01:58:02,160 COMMUNITIES THAT RESEARCH IS 2245 01:58:02,160 --> 01:58:04,800 TAKING PLACE BUT ALSO NOT ONLY 2246 01:58:04,800 --> 01:58:09,520 THE UNDER SERVES COMMUNITIES BUT 2247 01:58:09,520 --> 01:58:10,920 INCLUDING RESEARCHERS REFLECTIVE 2248 01:58:10,920 --> 01:58:14,520 OF THOSE COMMUNITIES IN THEIR 2249 01:58:14,520 --> 01:58:14,800 RESEARCH? 2250 01:58:14,800 --> 01:58:16,280 I THINK THERE'S BEEN A HUGE NEED 2251 01:58:16,280 --> 01:58:17,920 FOR THAT. 2252 01:58:17,920 --> 01:58:19,680 SOME WE'RE SEEING BUT A LOT OF 2253 01:58:19,680 --> 01:58:22,920 IT WE ARE NOT. 2254 01:58:22,920 --> 01:58:23,960 >>I AGREE. 2255 01:58:23,960 --> 01:58:27,120 I DON'T KNOW I'LL TAKE THAT ON. 2256 01:58:27,120 --> 01:58:28,400 AS WELL AS I'D LOVE TO, BECAUSE 2257 01:58:28,400 --> 01:58:29,960 WE DON'T REALLY -- THE 2258 01:58:29,960 --> 01:58:31,480 DEPARTMENT WE HAVE AN ASSOCIATE 2259 01:58:31,480 --> 01:58:33,920 DIRECTOR AND A BUNCH OF P.I..ESE 2260 01:58:33,920 --> 01:58:35,600 AND TRAINEES WORKING AT A 2261 01:58:35,600 --> 01:58:36,560 DIFFERENT LEVEL. 2262 01:58:36,560 --> 01:58:38,760 FROM A TRAINEE STANDPOINT MAKING 2263 01:58:38,760 --> 01:58:40,360 NIDA A PLACE PEOPLE WANT TO COME 2264 01:58:40,360 --> 01:58:46,280 AND FEEL INCLUDED AND LIKE THEY 2265 01:58:46,280 --> 01:58:49,080 CAN CONTRIBUTE AND HAVING A 2266 01:58:49,080 --> 01:58:51,200 DEMOGRAPHIC OF FACULTY AND 2267 01:58:51,200 --> 01:58:52,880 HAVING THE REPUTATION OF BEING A 2268 01:58:52,880 --> 01:58:54,160 GREAT PLACE TO BE AND JUMP OFF 2269 01:58:54,160 --> 01:59:01,520 FROM COMING IN AS POST-BACS OR 2270 01:59:01,520 --> 01:59:05,920 GRADUATE STUDENTS AND GETTING 2271 01:59:05,920 --> 01:59:09,160 INTO FACULTY POSITIONS AND FROM 2272 01:59:09,160 --> 01:59:11,200 AND I'M FOCUSES ON THE NEXT 2273 01:59:11,200 --> 01:59:11,880 GENERATION AND GETTING THEM 2274 01:59:11,880 --> 01:59:13,720 EXCITED ABOUT WHAT WE DO AND GET 2275 01:59:13,720 --> 01:59:18,040 THEM OUT DOING WHAT THEY DO IN A 2276 01:59:18,040 --> 01:59:19,880 TERRIFIC WAY. 2277 01:59:19,880 --> 01:59:21,720 SERVING OUR COMMUNITY IS ANOTHER 2278 01:59:21,720 --> 01:59:23,200 BIG CHALLENGE. 2279 01:59:23,200 --> 01:59:25,520 AT THE INTRAMURAL PROGRAM IN 2280 01:59:25,520 --> 01:59:25,800 BALTIMORE. 2281 01:59:25,800 --> 01:59:28,720 WE HAVE A COMMUNITY HERE AND IF 2282 01:59:28,720 --> 01:59:31,520 WE CAN REACH THEM AND ONE THING 2283 01:59:31,520 --> 01:59:33,920 IN ADDITION TO THE COMMUNITY 2284 01:59:33,920 --> 01:59:37,560 OUTREACH WE HAVE A SPEAKERS' 2285 01:59:37,560 --> 01:59:43,560 BUREAU AND A NUMBER GAVE TALKS 2286 01:59:43,560 --> 01:59:46,600 AND OTHER PEOPLE THROUGHOUT THE 2287 01:59:46,600 --> 01:59:47,240 COMMUNITY TO EDUCATE THEM ABOUT 2288 01:59:47,240 --> 01:59:48,000 SUBSTANCE USE DISORDERS AND 2289 01:59:48,000 --> 01:59:49,280 ABOUT THE WORK WE'RE DOING AND 2290 01:59:49,280 --> 01:59:51,800 HOPE WE GET THEM EXCITED ABOUT 2291 01:59:51,800 --> 01:59:53,000 PARTICIPATING IN WHATEVER LEVEL 2292 01:59:53,000 --> 01:59:55,240 THEY MIGHT BE ABLE TO AND IT'S A 2293 01:59:55,240 --> 01:59:58,680 WORK IN PROGRESS AND I'M ALWAYS 2294 01:59:58,680 --> 01:59:59,280 OPEN FOR SUGGESTION. 2295 01:59:59,280 --> 02:00:00,840 I HAVE A DEDICATED GROUP OF 2296 02:00:00,840 --> 02:00:02,280 PEOPLE THAT WANT TO MAKE THIS 2297 02:00:02,280 --> 02:00:03,440 HAPPEN BUT WE'RE ALWAYS OPEN FOR 2298 02:00:03,440 --> 02:00:05,920 SUGGESTION. 2299 02:00:05,920 --> 02:00:12,400 THANK YOU. 2300 02:00:12,400 --> 02:00:14,320 >>I'LL REACH OUT TO YOU. 2301 02:00:14,320 --> 02:00:15,840 I'M WELL CONNECTED TO THE 2302 02:00:15,840 --> 02:00:17,440 COMMUNITY AROUND YOU AND OTHER 2303 02:00:17,440 --> 02:00:18,120 COMMUNITIES THAT ARE UNDER 2304 02:00:18,120 --> 02:00:23,040 SERVED. 2305 02:00:23,040 --> 02:00:24,640 I'LL REACH OUT AND SEE HOW I CAN 2306 02:00:24,640 --> 02:00:27,600 HELP. 2307 02:00:27,600 --> 02:00:28,520 >>THANK YOU TO THE PEOPLE 2308 02:00:28,520 --> 02:00:31,520 WORKING ON THIS BECAUSE I KNOW 2309 02:00:31,520 --> 02:00:32,880 THEY'D BE DELIGHTED IN WHAT YOU 2310 02:00:32,880 --> 02:00:33,960 HAVE TO SAY AND WORK WITH YOU. 2311 02:00:33,960 --> 02:00:37,600 >>THANK YOU FOR ALL YOU DO. 2312 02:00:37,600 --> 02:00:44,240 >>THANK YOU. 2313 02:00:44,240 --> 02:00:46,480 >>THANKS FOR THE PRESENTATION. 2314 02:00:46,480 --> 02:00:48,800 AMY KNOWS THIS FOR YEARS I WAS 2315 02:00:48,800 --> 02:00:51,400 AT JOHNS HOPKINS NEXT DOOR TO 2316 02:00:51,400 --> 02:00:52,400 WHAT WAS THE OLD IRP. 2317 02:00:52,400 --> 02:00:59,240 THE ARC WHEN I GOT THERE AND 2318 02:00:59,240 --> 02:01:00,880 OVER THE YEARS I'VE SEEN CHANGES 2319 02:01:00,880 --> 02:01:02,080 IN THE INTRAMURAL PROGRAM AND 2320 02:01:02,080 --> 02:01:07,520 THERE'S BEEN A METEORIC RISE IN 2321 02:01:07,520 --> 02:01:09,120 THE STATURE OF THE SCIENCE 2322 02:01:09,120 --> 02:01:13,280 HAPPENING AT THE INTRAMURAL 2323 02:01:13,280 --> 02:01:13,520 PROGRAM. 2324 02:01:13,520 --> 02:01:15,120 I THINK IT TAKES EVERYBODY TO DO 2325 02:01:15,120 --> 02:01:17,920 THAT BUT I THINK YOU'VE BEEN 2326 02:01:17,920 --> 02:01:19,560 INCREDIBLY EFFECTIVE AT 2327 02:01:19,560 --> 02:01:22,240 ATTRACTING REALLY STELLAR PEOPLE 2328 02:01:22,240 --> 02:01:27,560 AND EXCELLENCE TRACT -- 2329 02:01:27,560 --> 02:01:28,080 ATTRACTS EXCELLENCE. 2330 02:01:28,080 --> 02:01:29,640 YOU WANT IT TO BE A PLACE WHERE 2331 02:01:29,640 --> 02:01:30,320 PEOPLE WANT TO COME AND DO GREAT 2332 02:01:30,320 --> 02:01:31,760 WORK. 2333 02:01:31,760 --> 02:01:33,920 I'M THRILLED AND IT'S A NATIONAL 2334 02:01:33,920 --> 02:01:41,880 GEM. 2335 02:01:41,880 --> 02:01:48,520 YOU'RE TO BE CONGRATULATED AND I 2336 02:01:48,520 --> 02:01:52,360 KNOW YOU DIDN'T DO IT YOURSELF 2337 02:01:52,360 --> 02:01:54,920 BUT A COMMENT I HAVE IS I'D LOVE 2338 02:01:54,920 --> 02:01:57,920 TO HEAR MORE WHAT THE CLINICAL 2339 02:01:57,920 --> 02:01:59,400 PROGRAM DOING BECAUSE I DONE 2340 02:01:59,400 --> 02:02:02,440 THINK WE HAD A FOCUSSED 2341 02:02:02,440 --> 02:02:07,520 PRESENTATION AROUND -- I KNOW 2342 02:02:07,520 --> 02:02:10,720 YOU HAD TRANSITION ALSO WITH 2343 02:02:10,720 --> 02:02:10,960 FACULTY. 2344 02:02:10,960 --> 02:02:12,480 I'D LOVE TO HEAR THAT IF WE CAN 2345 02:02:12,480 --> 02:02:14,320 PUT THAT ON A FUTURE MEETING. 2346 02:02:14,320 --> 02:02:15,280 >>SHARON THANK YOU. 2347 02:02:15,280 --> 02:02:21,800 IT MEANS A LOT TO ME FROM YOU. 2348 02:02:21,800 --> 02:02:23,560 I GET GREAT SUPPORT FROM MY 2349 02:02:23,560 --> 02:02:28,160 INSTITUTE DIRECTOR AND ALSO THE 2350 02:02:28,160 --> 02:02:30,040 CLINICAL PROGRAM IS GOING TO 2351 02:02:30,040 --> 02:02:31,520 BE -- EXTEND THE METEOR. 2352 02:02:31,520 --> 02:02:34,200 WE'RE STILL WORKING TO GET IT TO 2353 02:02:34,200 --> 02:02:34,680 HAPPEN. 2354 02:02:34,680 --> 02:02:36,320 WE'VE NEVER HAD SIX CLINICAL 2355 02:02:36,320 --> 02:02:38,240 INVESTIGATORS AND FOUR ARE 2356 02:02:38,240 --> 02:02:42,000 TENURE PRAC AND THEY'RE ALL HOT. 2357 02:02:42,000 --> 02:02:44,720 THEY'RE WORKING HARD. 2358 02:02:44,720 --> 02:02:46,280 IT'S NOT EASY TO LEAVE ACADEMIA 2359 02:02:46,280 --> 02:02:48,920 AND COME TO THE NIH AND THE 2360 02:02:48,920 --> 02:02:50,600 FIRST YEAR OR TWO WAS A LITTLE 2361 02:02:50,600 --> 02:02:50,880 TOUGH. 2362 02:02:50,880 --> 02:02:52,440 IN ANOTHER YEAR OR TWO WE'LL 2363 02:02:52,440 --> 02:02:54,280 HAVE A LOT TO SAY AND PRESENT. 2364 02:02:54,280 --> 02:02:55,560 I THINK IT WOULD BE A TERRIFIC 2365 02:02:55,560 --> 02:02:56,720 OPPORTUNITY TO HAVE THEM COME 2366 02:02:56,720 --> 02:02:58,720 AND SPEAK TO ALL OF YOU AND 2367 02:02:58,720 --> 02:03:02,880 WE'LL BRING IT BACK, SHARON. 2368 02:03:02,880 --> 02:03:04,520 >>I'LL COME AS A GUEST. 2369 02:03:04,520 --> 02:03:05,800 I'D LOVE TO SEE THAT. 2370 02:03:05,800 --> 02:03:06,480 THANK YOU, AMY. 2371 02:03:06,480 --> 02:03:08,960 >>YOU'RE WELCOME. 2372 02:03:08,960 --> 02:03:10,000 >>OKAY. 2373 02:03:10,000 --> 02:03:13,280 WE'RE DUE FOR A BREAK UNLESS 2374 02:03:13,280 --> 02:03:13,840 THERE'S ANY OTHER URGENT 2375 02:03:13,840 --> 02:03:18,880 QUESTIONS. 2376 02:03:18,880 --> 02:03:22,040 THAT WAS A GREAT UPDATE THANK 2377 02:03:22,040 --> 02:03:29,920 YOU, AMY. 2378 02:03:29,920 --> 02:03:31,600 >>THANK YOU FOR YOUR COMMENTS. 2379 02:03:31,600 --> 02:03:33,240 SEND ME FEEDBACK. 2380 02:03:33,240 --> 02:03:43,720 >>WE'LL BREAK NOW TO 3:30. 2381 02:03:40,000 --> 02:03:41,880 >>I'M GOING TO DO THE NEXT 2382 02:03:41,880 --> 02:03:42,520 PRESENTATION WHICH IS GOING TO 2383 02:03:42,520 --> 02:03:44,840 BE AN UPDATE ON THE DISCUSSIONS 2384 02:03:44,840 --> 02:03:47,120 THAT HAPPENED WITH THE MERIT 2385 02:03:47,120 --> 02:03:48,280 WORK GROUP. 2386 02:03:48,280 --> 02:03:52,040 SO I'M JUST REPRESENTING WHAT 2387 02:03:52,040 --> 02:03:53,600 THEY HAVE DISCUSSED AND THOUGHT 2388 02:03:53,600 --> 02:03:56,280 ABOUT THIS PROGRAM. 2389 02:03:56,280 --> 02:03:58,720 AND HOPEFULLY WE'LL BE ABLE TO 2390 02:03:58,720 --> 02:04:00,240 CONTINUE THE DISCUSSION AND IT 2391 02:04:00,240 --> 02:04:02,480 WILL BE A RICH DISCUSSION TO 2392 02:04:02,480 --> 02:04:03,280 HELP NIDA DECIDE WHERE TO GO 2393 02:04:03,280 --> 02:04:13,560 WITH THE PROGRAM. 2394 02:04:20,760 --> 02:04:24,080 YOU'LL SEE THE SLIDE SHOWING WHO 2395 02:04:24,080 --> 02:04:26,080 IS ON THE WORK GROUP AND MEMBERS 2396 02:04:26,080 --> 02:04:30,600 OF THE COUNCIL AND FROM THE 2397 02:04:30,600 --> 02:04:31,160 RESEARCH COMMUNITY FROM 2398 02:04:31,160 --> 02:04:33,080 DIFFERENT SCIENTIFIC AREAS AND 2399 02:04:33,080 --> 02:04:43,360 POINTS IN THEIR CAREER. 2400 02:04:43,360 --> 02:04:45,320 AND COUNCIL FOR THE DISCUSSION. 2401 02:04:45,320 --> 02:04:46,800 SO THE MERIT AWARD HAS BEEN 2402 02:04:46,800 --> 02:04:47,960 AROUND A WHILE. 2403 02:04:47,960 --> 02:04:49,880 THE PURPOSE IS TO RECOGNIZE 2404 02:04:49,880 --> 02:04:51,640 INVESTIGATORS WHO DEMONSTRATED 2405 02:04:51,640 --> 02:04:53,400 AT A HIGH LEVEL COMPETENCE AND 2406 02:04:53,400 --> 02:04:55,200 HAVE BEEN PRODUCTIVE AND HAVE 2407 02:04:55,200 --> 02:04:57,840 BEEN LEADERS IN THE FIELD AND 2408 02:04:57,840 --> 02:05:00,680 HAVE TRANSFORMED THE FIELDS AND 2409 02:05:00,680 --> 02:05:02,640 PROVIDES THE INVESTIGATORS WITH 2410 02:05:02,640 --> 02:05:05,080 LONG-TERM STABLE SUPPORT SO THEY 2411 02:05:05,080 --> 02:05:09,040 CAN GET ANOTHER FOUR OR FIVE 2412 02:05:09,040 --> 02:05:11,880 YEARS ADDED ON TO THEIR CURRENT 2413 02:05:11,880 --> 02:05:16,760 GRANT DEPENDING ON WHEN THE 2414 02:05:16,760 --> 02:05:18,680 MERIT AWARD IS GIVEN. 2415 02:05:18,680 --> 02:05:20,880 THE INSTITUTE NOMINATES MERIT 2416 02:05:20,880 --> 02:05:21,160 CANDIDATES. 2417 02:05:21,160 --> 02:05:24,600 THIS IS NOT SOMETHING PEOPLE 2418 02:05:24,600 --> 02:05:26,680 APPLY FOR AND NOMINATIONS ARE 2419 02:05:26,680 --> 02:05:28,000 PRESENTED TO COUNCIL FOR 2420 02:05:28,000 --> 02:05:28,720 CONSIDERATION AND THE FINAL 2421 02:05:28,720 --> 02:05:33,040 SELECTIONS ARE MADE BY THE 2422 02:05:33,040 --> 02:05:34,720 INSTITUTE DIRECTOR. 2423 02:05:34,720 --> 02:05:35,440 THERE ARE SEVERAL CRITERIA USED 2424 02:05:35,440 --> 02:05:37,480 FOR THE MERIT AWARDS INCLUDING 2425 02:05:37,480 --> 02:05:42,160 THE FACT THE PERSON HAS TO 2426 02:05:42,160 --> 02:05:44,040 PREVIOUS LIZ SERVE AS A P.I. AS 2427 02:05:44,040 --> 02:05:46,560 ONE OR MORE 2428 02:05:46,560 --> 02:05:47,240 INVESTIGATOR-INITIATED PROJECTS. 2429 02:05:47,240 --> 02:05:48,720 THEY'RE NOT EARLY STAGE 2430 02:05:48,720 --> 02:05:50,160 INVESTIGATORS TYPICALLY OR NOT 2431 02:05:50,160 --> 02:05:52,080 AT ALL. 2432 02:05:52,080 --> 02:05:55,200 AND THEY ALSO HAVE TO HAVE THIS 2433 02:05:55,200 --> 02:05:56,120 IMPRESSIVE RECORD OF OVER ALL 2434 02:05:56,120 --> 02:05:59,840 ACHIEVEMENT AND HAVE TO HAVE AN 2435 02:05:59,840 --> 02:06:02,680 EXISTING RO1 OR RO1 EQUIVALENT 2436 02:06:02,680 --> 02:06:04,640 IN THE FIFTH PERCENTILE OR 2437 02:06:04,640 --> 02:06:05,680 BETTER AND PROVIDE TIME 2438 02:06:05,680 --> 02:06:09,280 COMMITMENT OF 15% OR MORE TO THE 2439 02:06:09,280 --> 02:06:13,080 GRANT. 2440 02:06:13,080 --> 02:06:13,720 THERE'S SEVERAL OTHER CRITERIA 2441 02:06:13,720 --> 02:06:21,720 AS WELL. 2442 02:06:21,720 --> 02:06:23,080 BACK IN MAY WE STARTED TO HAVE A 2443 02:06:23,080 --> 02:06:25,000 DISCUSSION LOOKING AT WHO HAS 2444 02:06:25,000 --> 02:06:30,920 GOTTEN THE MERIT AWARD FROM NIDA 2445 02:06:30,920 --> 02:06:33,480 FOR A NUMBER OF YEARS WHAT OTHER 2446 02:06:33,480 --> 02:06:35,840 INSTITUTES WERE DOING. 2447 02:06:35,840 --> 02:06:39,320 AND MERIT STANDS FOR METHOD TO 2448 02:06:39,320 --> 02:06:40,240 EXTEND RESEARCH IN TIME. 2449 02:06:40,240 --> 02:06:44,720 SOMETHING LIKE THAT. 2450 02:06:44,720 --> 02:06:46,960 ANYWAY, RIGHT NOW ABOUT HALF THE 2451 02:06:46,960 --> 02:06:48,080 OTHER INSTITUTES AT INSTITUTE 2452 02:06:48,080 --> 02:06:49,840 ARE NOT USING THE MERIT AWARD 2453 02:06:49,840 --> 02:06:53,960 ANY MORE AND AMONG THE OTHER 2454 02:06:53,960 --> 02:06:56,120 HALF SOME HAVE MODIFIED THE 2455 02:06:56,120 --> 02:07:01,320 INVESTIGATORS TO WHO THEY GIVE 2456 02:07:01,320 --> 02:07:02,440 IT TO INCLUDING THE NATIONAL 2457 02:07:02,440 --> 02:07:04,120 CANCER INSTITUTE WHICH GIVES THE 2458 02:07:04,120 --> 02:07:06,480 AWARD TO EARLY STAGE 2459 02:07:06,480 --> 02:07:06,800 INVESTIGATORS. 2460 02:07:06,800 --> 02:07:08,400 WHEN WE EXAMINED WHO RECEIVED 2461 02:07:08,400 --> 02:07:12,680 MERIT AWARDS FROM NIDA THERE WAS 2462 02:07:12,680 --> 02:07:15,440 A LACK OF GENDER AND RACIAL AND 2463 02:07:15,440 --> 02:07:16,760 ETHNIC DIVERSITY AND SCIENTIFIC 2464 02:07:16,760 --> 02:07:19,040 AREAS WERE ALSO NOT REPRESENTED. 2465 02:07:19,040 --> 02:07:24,600 WE MOSTLY THE AWARDS PENT TO 2466 02:07:24,600 --> 02:07:25,160 SCIENTISTS FROM THE BASIC 2467 02:07:25,160 --> 02:07:26,160 SCIENCE RESEARCH FIELD AND 2468 02:07:26,160 --> 02:07:31,120 CRITERIA CAN ONLY BE MET BY 2469 02:07:31,120 --> 02:07:31,760 EXPERIENCED INVESTIGATORS THAT 2470 02:07:31,760 --> 02:07:34,560 HAVE A HISTORY OF OUTSTANDING 2471 02:07:34,560 --> 02:07:35,920 CONTRIBUTIONS. 2472 02:07:35,920 --> 02:07:37,120 THESE INVESTIGATORS ARE ALL 2473 02:07:37,120 --> 02:07:41,920 EXCEPTIONAL OUTSTANDING 2474 02:07:41,920 --> 02:07:46,280 INVESTIGATORS OVER ALL THEIR 2475 02:07:46,280 --> 02:07:47,640 PAPERS TEND TO SHOW BETTER 2476 02:07:47,640 --> 02:07:49,120 CITATION RATES THAN OTHER 2477 02:07:49,120 --> 02:07:50,680 INVESTIGATORS IN THE FIELD. 2478 02:07:50,680 --> 02:07:54,120 THERE'S NO DOUBT THEY'RE HIGHLY 2479 02:07:54,120 --> 02:07:55,000 QUALIFIED AND ACCOMPLISHED 2480 02:07:55,000 --> 02:07:57,120 PEOPLE. 2481 02:07:57,120 --> 02:08:03,320 THE MERIT AWARD DOES NOT GIVES 2482 02:08:03,320 --> 02:08:04,760 THEM A BREAK FROM THE HAVE 2483 02:08:04,760 --> 02:08:05,960 THEIVE REQUIREMENTS OF 2484 02:08:05,960 --> 02:08:07,120 SUBMITTING ANOTHER GRANT AND 2485 02:08:07,120 --> 02:08:08,320 GETTING IT REVIEWED. 2486 02:08:08,320 --> 02:08:12,360 THESE ARE ALSO INVESTIGATORS WHO 2487 02:08:12,360 --> 02:08:16,720 ARE GOING TO CONTINUE TO GET 2488 02:08:16,720 --> 02:08:17,960 GRANT SUPPORT LIKELY IF THEY 2489 02:08:17,960 --> 02:08:21,120 WANT TO CONTINUE TO DO THAT. 2490 02:08:21,120 --> 02:08:23,040 AFTER THE DISCUSSION AND THE 2491 02:08:23,040 --> 02:08:24,520 CLEAR INDICATION THERE WAS A 2492 02:08:24,520 --> 02:08:27,280 LACK OF DIVERSITY WE DECIDED TO 2493 02:08:27,280 --> 02:08:28,840 CONVENE A WORK GROUP TO FUTURE 2494 02:08:28,840 --> 02:08:33,120 DISCUSS THE MERIT AWARDS AT NIDA 2495 02:08:33,120 --> 02:08:33,720 AND PROVIDE RECOMMENDATIONS TO 2496 02:08:33,720 --> 02:08:40,760 THE COUNCIL. 2497 02:08:40,760 --> 02:08:43,680 THE CHARGE IS COUNCIL CONVENE A 2498 02:08:43,680 --> 02:08:45,560 WORK GROUP TO ADVISE ON THE 2499 02:08:45,560 --> 02:08:51,040 FUTURE OF THESE AND THE WORK 2500 02:08:51,040 --> 02:08:54,000 GROUP WOULD LOOK AT THE CURRENT 2501 02:08:54,000 --> 02:08:56,640 CRITERIA AND DECIDE IF WE SHOULD 2502 02:08:56,640 --> 02:08:58,280 GET RID OF THE MERIT AWARD ALL 2503 02:08:58,280 --> 02:08:59,680 TOGETHER OR FIND OTHER CRITERIA. 2504 02:08:59,680 --> 02:09:00,400 THAT'S WHAT I'M PRESENTING TODAY 2505 02:09:00,400 --> 02:09:10,920 THE RESULTS OF THE DISCUSSION. 2506 02:09:11,200 --> 02:09:12,280 OF THE PEOPLE SHOWN ON THE SLIDE 2507 02:09:12,280 --> 02:09:17,520 WE HAVE A PEOPLE ON COUNCIL AND 2508 02:09:17,520 --> 02:09:19,320 NOT ON COUNCIL. 2509 02:09:19,320 --> 02:09:21,680 WHO ARE MERIT AWARDEES AND ALSO 2510 02:09:21,680 --> 02:09:22,440 ON OUR COUNCIL CURRENTLY NOT 2511 02:09:22,440 --> 02:09:28,840 PART OF THE GROUP. 2512 02:09:28,840 --> 02:09:30,240 WE HAD A DISCUSSION ON THE 2513 02:09:30,240 --> 02:09:31,640 VALUES WE NEED TO HOLD UP FOR 2514 02:09:31,640 --> 02:09:41,920 THE MERIT AWARDS. 2515 02:09:44,600 --> 02:09:47,960 CONTINUING THEM ALTOGETHER OR 2516 02:09:47,960 --> 02:09:49,160 CHANGE THE ELIGIBILITY OR CREATE 2517 02:09:49,160 --> 02:09:53,440 AN ADDITIONAL AWARD. 2518 02:09:53,440 --> 02:09:55,560 WE DISCUSSED THE NOMINATION 2519 02:09:55,560 --> 02:09:55,800 PROCESS. 2520 02:09:55,800 --> 02:09:59,440 THE NOMINATIONS COME FROM NIDA 2521 02:09:59,440 --> 02:10:01,560 STAFF IF AN INVESTIGATOR MEETS A 2522 02:10:01,560 --> 02:10:02,640 CERTAIN CRITERIA. 2523 02:10:02,640 --> 02:10:04,720 IT COULD BE DONE IN A DIFFERENT 2524 02:10:04,720 --> 02:10:04,880 WAY. 2525 02:10:04,880 --> 02:10:07,360 THERE WAS A SUGGESTION TO HAVE 2526 02:10:07,360 --> 02:10:09,960 EXTRAMURAL REVIEWERS BUT 2527 02:10:09,960 --> 02:10:11,440 EXTRAMURAL REVIEWERS HAVE 2528 02:10:11,440 --> 02:10:13,120 ALREADY REVIEWED THE GRANTS. 2529 02:10:13,120 --> 02:10:14,680 I DON'T KNOW IF THAT'S THE WAY 2530 02:10:14,680 --> 02:10:15,720 WE'D WANT TO GO. 2531 02:10:15,720 --> 02:10:17,120 WE CAN LOOK AT CAREER STAGE. 2532 02:10:17,120 --> 02:10:20,160 WE CAN RESTRICT THESE TO EARLY 2533 02:10:20,160 --> 02:10:22,720 STAGE INVESTIGATORS OR P.I.s AT 2534 02:10:22,720 --> 02:10:25,000 THE STAGE OF GETTING THEIR FIRST 2535 02:10:25,000 --> 02:10:29,280 RO1 RENEWAL AND THIS COULD BE A 2536 02:10:29,280 --> 02:10:30,440 STRONG BOOST EARLY IN THEIR 2537 02:10:30,440 --> 02:10:32,360 CAREER POTENTIALLY. 2538 02:10:32,360 --> 02:10:34,960 WE CAN CHANGE THE PERCENTILE 2539 02:10:34,960 --> 02:10:37,120 REQUIREMENT AND USE CUT-OFF 2540 02:10:37,120 --> 02:10:40,720 CRITERIA FOR SCIENTIFIC TOPIC OR 2541 02:10:40,720 --> 02:10:50,280 INVESTIGATOR CHARACTERISTICS. 2542 02:10:50,280 --> 02:10:53,480 ANOTHER CRITERIA IS THEY DON'T 2543 02:10:53,480 --> 02:10:56,400 GO TO MULTI-P.I. RO1s AND NOW 2544 02:10:56,400 --> 02:11:00,400 WE'RE MOVING IN THE DIRECTION OF 2545 02:11:00,400 --> 02:11:02,800 TEAM SCIENCE AND THE NEED FOR 2546 02:11:02,800 --> 02:11:03,600 DIFFERENT EXPERTISE AND 2547 02:11:03,600 --> 02:11:09,080 EXPERIENCE IT MAY NOT MAKE SENSE 2548 02:11:09,080 --> 02:11:13,120 TO RESTRICT THIS TO ONLY 2549 02:11:13,120 --> 02:11:20,920 INDIVIDUAL INVESTIGATORS. 2550 02:11:20,920 --> 02:11:23,080 WE LOOKED TO SEE APART FROM THE 2551 02:11:23,080 --> 02:11:26,240 CRITERIA OF HAVING THE 2552 02:11:26,240 --> 02:11:31,440 REQUIREMENT FOR PRIOR RO1 AND 2553 02:11:31,440 --> 02:11:33,040 LOOKED AT HOW MANY EARLY STAGE 2554 02:11:33,040 --> 02:11:34,720 INVESTIGATORS WOULD HAVE 2555 02:11:34,720 --> 02:11:35,800 QUALIFIED WITH THE EXISTING 2556 02:11:35,800 --> 02:11:37,400 CRITERIA AND IT WAS LITTLE OR 2557 02:11:37,400 --> 02:11:41,080 NONE. 2558 02:11:41,080 --> 02:11:43,320 WE DECIDED TO LOOK BETWEEN 2017 2559 02:11:43,320 --> 02:11:46,400 AND 2021 FOR INVESTIGATORS ESIs 2560 02:11:46,400 --> 02:11:49,520 AND MET THE CRITERIA OF HAVING 2561 02:11:49,520 --> 02:11:52,720 RO1 OR RO1 EQUIVALENT GRANT 2562 02:11:52,720 --> 02:11:56,240 USING DIFFERENT PERCENTILE 2563 02:11:56,240 --> 02:11:56,480 CUTOFFS. 2564 02:11:56,480 --> 02:12:03,640 IF YOU DID THE 1-10% CUT-OFF WE 2565 02:12:03,640 --> 02:12:08,600 HAD 12ESIs AND TO QUALIFY AND I 2566 02:12:08,600 --> 02:12:10,720 WILL MENTION WE DON'T GIVE THAT 2567 02:12:10,720 --> 02:12:15,920 MANY IN A YEAR. 2568 02:12:15,920 --> 02:12:18,480 WE USUALLY ONLY ONLY GIVE ONE OR 2569 02:12:18,480 --> 02:12:20,320 THREE OR FOUR AND A POOL TO WORK 2570 02:12:20,320 --> 02:12:21,680 WITH IF THIS IS THE DIRECTION WE 2571 02:12:21,680 --> 02:12:22,480 WANT TO GO IN. 2572 02:12:22,480 --> 02:12:26,920 WE ALSO TALKED ABOUT THE IDEA OF 2573 02:12:26,920 --> 02:12:29,160 HAVING A ONE TO ONE RATIO OF 2574 02:12:29,160 --> 02:12:36,560 MERIT AWARDS TO ESI AND SENIOR 2575 02:12:36,560 --> 02:12:37,200 SCIENTISTS. 2576 02:12:37,200 --> 02:12:39,560 AND THEY COULD DERIVE FROM 2577 02:12:39,560 --> 02:12:42,840 GETTING MERIT AWARDS. 2578 02:12:42,840 --> 02:12:44,800 WE COULD HAVE PRIOR SCORES FOR 2579 02:12:44,800 --> 02:12:50,280 ESIs THAN FOR SENIOR SCIENTISTS. 2580 02:12:50,280 --> 02:12:53,040 THE DISCUSSION AROUND SINGLE 2581 02:12:53,040 --> 02:12:56,000 VERSUS MULTI-P.I. RESEARCH 2582 02:12:56,000 --> 02:13:00,280 AWARDS WAS APART FROM THE FACT 2583 02:13:00,280 --> 02:13:01,200 MULTI-P.I. RESEARCH IS BECOMING 2584 02:13:01,200 --> 02:13:05,120 MORE COMMON IN MOST FIELDS OF 2585 02:13:05,120 --> 02:13:06,360 SCIENCE WE A DISCUSSION WHETHER 2586 02:13:06,360 --> 02:13:08,600 OR NOT THERE WERE CERTAIN AREAS 2587 02:13:08,600 --> 02:13:09,960 OF SCIENCE WHERE THAT WAS MORE 2588 02:13:09,960 --> 02:13:12,560 LIKELY TO OCCUR. 2589 02:13:12,560 --> 02:13:14,120 WE DID AN ANALYSIS LOOKING BY 2590 02:13:14,120 --> 02:13:18,960 DIVISION AT THE SINGLE VERSUS 2591 02:13:18,960 --> 02:13:22,720 MULTI P.I. AWARD BETWEEN FISCAL 2592 02:13:22,720 --> 02:13:24,680 YEAR '17 AND '21. 2593 02:13:24,680 --> 02:13:27,040 THERE ARE MORE SINGLE P.I. 2594 02:13:27,040 --> 02:13:28,720 AWARDS THAN MULTI-P.I. AWARDS 2595 02:13:28,720 --> 02:13:32,320 BUT THE PATTERN WAS NOT 2596 02:13:32,320 --> 02:13:33,440 DIFFERENT BASED ON THE 2597 02:13:33,440 --> 02:13:33,720 DIVISIONS. 2598 02:13:33,720 --> 02:13:35,480 THIS IS NOT WHAT WE WERE 2599 02:13:35,480 --> 02:13:36,440 ACCEPTING BUT THAT'S WHAT THE 2600 02:13:36,440 --> 02:13:37,000 DATA ARE. 2601 02:13:37,000 --> 02:13:41,400 ON THE OTHER HAND, WE'RE SEEING 2602 02:13:41,400 --> 02:13:43,840 QUITE A FEW MULTI-P.I. AWARDS. 2603 02:13:43,840 --> 02:13:46,920 THE NUMBERS ARE NOT QUITE HALF 2604 02:13:46,920 --> 02:13:54,840 BUT THEY'RE CLOSE TO HALF FOR 2605 02:13:54,840 --> 02:13:55,680 DMB AND OTHERS. 2606 02:13:55,680 --> 02:13:58,280 WE DON'T HAVE A STRONG BIAS 2607 02:13:58,280 --> 02:13:59,120 BETWEEN SINGLE AND 2608 02:13:59,120 --> 02:14:01,080 MULTI-RESEARCH AWARDS BUT 2609 02:14:01,080 --> 02:14:04,760 THEY'RE BECOMING MORE COMMON 2610 02:14:04,760 --> 02:14:08,320 ACROSS NIDA. 2611 02:14:08,320 --> 02:14:09,480 THESE WERE RECOMMENDATIONS THE 2612 02:14:09,480 --> 02:14:10,440 WORK GROUP DISCUSSED. 2613 02:14:10,440 --> 02:14:12,440 IN GENERAL THEY WERE FAVORABLE 2614 02:14:12,440 --> 02:14:18,400 ABOUT CONTINUING THE MERIT AWARD 2615 02:14:18,400 --> 02:14:20,800 AND WERE SUGGESTING SOME 2616 02:14:20,800 --> 02:14:21,120 MODIFICATION. 2617 02:14:21,120 --> 02:14:26,440 SOME WERE TO EXPAND BEYOND THE 2618 02:14:26,440 --> 02:14:30,240 RO1 EQUIVALENTS AND CONSIDER 2619 02:14:30,240 --> 02:14:33,120 EQUITY FOR THE CRITERIA AND 2620 02:14:33,120 --> 02:14:34,480 PRIORITIZE AS HEALTH EQUITY AS A 2621 02:14:34,480 --> 02:14:38,800 CRITERION AND THE RENEWAL PHASE 2622 02:14:38,800 --> 02:14:43,880 IS THE EXTENSION OF THE GRANT 2623 02:14:43,880 --> 02:14:45,800 THE TIME WHEN INVESTIGATORS ARE 2624 02:14:45,800 --> 02:14:47,040 NOT HAVING TO REAPPLY FOR 2625 02:14:47,040 --> 02:14:48,240 ANOTHER AWARD. 2626 02:14:48,240 --> 02:14:50,520 AT THAT POINT WE COULD REQUIRE A 2627 02:14:50,520 --> 02:14:53,120 DEMONSTRATION OF EITHER 2628 02:14:53,120 --> 02:14:53,920 PROMOTING OR ADVANCING EQUITY IN 2629 02:14:53,920 --> 02:14:54,480 THE FIELD. 2630 02:14:54,480 --> 02:14:56,600 FOR SOMEBODY WHO WAS A LESS 2631 02:14:56,600 --> 02:14:58,520 EXPERIENCED INVESTIGATOR THE 2632 02:14:58,520 --> 02:15:01,160 EXTENSION COULD REQUIRE A PLAN 2633 02:15:01,160 --> 02:15:02,920 TO ENHANCE DIVERSE PERSPECTIVES. 2634 02:15:02,920 --> 02:15:03,920 WE HADN'T TALKED ABOUT THIS VERY 2635 02:15:03,920 --> 02:15:08,280 MUCH AT COUNCIL. 2636 02:15:08,280 --> 02:15:09,600 IT'S SOMETHING WE ARE NOW ADDING 2637 02:15:09,600 --> 02:15:11,640 TO MORE AND MORE OF OUR FUNDING 2638 02:15:11,640 --> 02:15:22,160 OPPORTUNITY ANNOUNCEMENTS BUT 2639 02:15:22,960 --> 02:15:24,840 PEDP REQUIRES A DESCRIPTION WHAT 2640 02:15:24,840 --> 02:15:26,520 THEY'LL DO TO BRING MORE 2641 02:15:26,520 --> 02:15:28,840 DIVERSITY TO THE RESEARCH AND 2642 02:15:28,840 --> 02:15:39,360 PART OF THE SCORING CRITERIA. 2643 02:15:42,520 --> 02:15:45,520 AND THERE WEREN'T MULTI-P.I. 2644 02:15:45,520 --> 02:15:47,520 AWARDS AND THAT'S A FUNCTION OF 2645 02:15:47,520 --> 02:15:52,000 SOMETHING OLDER THAT BE NIH'S 2646 02:15:52,000 --> 02:15:53,320 WAY OF DOING THINGS AND THE 2647 02:15:53,320 --> 02:15:54,960 DURATION OF THE AWARD. 2648 02:15:54,960 --> 02:15:57,520 IT'S A MAXIMUM OF 10 YEARS. 2649 02:15:57,520 --> 02:16:01,880 SOME OTHER I.C.s OFFER 2650 02:16:01,880 --> 02:16:03,920 SEVEN-YEAR AWARDS SUCH AS NINDS 2651 02:16:03,920 --> 02:16:07,440 AND THERE WAS AN ARGUMENT MADE 2652 02:16:07,440 --> 02:16:10,040 TO KEEP THE MAXIMUM BECAUSE IT 2653 02:16:10,040 --> 02:16:10,880 ALLOWS INVESTIGATORS TO TAKE 2654 02:16:10,880 --> 02:16:15,880 SCIENTIFIC RISK OR CHANGE 2655 02:16:15,880 --> 02:16:18,320 DIRECTI 2656 02:16:18,320 --> 02:16:20,560 DIRECTIONS I THINK IF WE DECIDE 2657 02:16:20,560 --> 02:16:21,680 TO MAKE CHANGES IN THE PROGRAM I 2658 02:16:21,680 --> 02:16:30,240 THINK WE NEED TO THINK OF WAYS 2659 02:16:30,240 --> 02:16:33,720 WE'LL WANT TO EVALUATE IT. 2660 02:16:33,720 --> 02:16:34,680 ARE WE REACHING MORE DIVERSE 2661 02:16:34,680 --> 02:16:37,160 RESEARCHERS AND EXPANDING TO 2662 02:16:37,160 --> 02:16:39,600 OTHER FIELD BEYOND BASIC SCIENCE 2663 02:16:39,600 --> 02:16:39,880 FIELD. 2664 02:16:39,880 --> 02:16:44,200 BASIC SCIENCE IS NOT THE ONLY 2665 02:16:44,200 --> 02:16:46,480 AREA WHERE WE FUNDED MERIT 2666 02:16:46,480 --> 02:16:48,400 AWARDEES BUT IT DOES TEND TO 2667 02:16:48,400 --> 02:16:52,760 DOMINATE WHEN WE SHOWED THE 2668 02:16:52,760 --> 02:16:54,680 ORIGINAL DATA BACK IN MAY. 2669 02:16:54,680 --> 02:17:00,560 IF WE DO GIVE A MERIT TO ECI TO 2670 02:17:00,560 --> 02:17:01,760 THEIR FIRST COMPETING RENEWAL WE 2671 02:17:01,760 --> 02:17:03,080 CAN EVALUATE HOW IT AFFECTS 2672 02:17:03,080 --> 02:17:06,760 THEIR CAREER AND ACADEMIC 2673 02:17:06,760 --> 02:17:08,240 ADVANCEMENT, THEIR CONTINUED 2674 02:17:08,240 --> 02:17:12,640 GRANT SUPPORT AND WHETHER WE CAN 2675 02:17:12,640 --> 02:17:15,840 SEE EVIDENCE OF MORE 2676 02:17:15,840 --> 02:17:16,840 INNOVATIONAL RISK TAKING THOSE 2677 02:17:16,840 --> 02:17:19,360 THAT RECEIVE THE AWARD. 2678 02:17:19,360 --> 02:17:24,200 THIS IS THE LAST SLIDE. 2679 02:17:24,200 --> 02:17:26,560 I WANT TO OPEN THIS UP TO OTHER 2680 02:17:26,560 --> 02:17:27,720 MEMBERS OF THE GROUP AND COUNCIL 2681 02:17:27,720 --> 02:17:31,920 AND INCORPORATE FEEDBACK FROM 2682 02:17:31,920 --> 02:17:36,560 KANSAS AND CONSIDER RERISING -- 2683 02:17:36,560 --> 02:17:38,080 REVISING THE MERIT AWARD 2684 02:17:38,080 --> 02:17:39,520 CRITERIA AND WE'LL SHARE THAT 2685 02:17:39,520 --> 02:17:42,040 WITH THE WORK GROUP MEMBERS AND 2686 02:17:42,040 --> 02:17:43,360 COUNCIL AND FINALIZE THE 2687 02:17:43,360 --> 02:17:45,040 CRITERIA AND PUBLICLY POST THIS 2688 02:17:45,040 --> 02:17:46,040 FOR AWARENESS. 2689 02:17:46,040 --> 02:17:47,920 THAT'S ANOTHER ISSUE THAT CAME 2690 02:17:47,920 --> 02:17:48,520 UP IN THE DISCUSSION. 2691 02:17:48,520 --> 02:17:50,240 MANY PEOPLE WERE NOT AWARE OF 2692 02:17:50,240 --> 02:17:50,880 WHAT THE CRITERIA WERE FOR THE 2693 02:17:50,880 --> 02:18:01,120 MERIT AWARDS. 2694 02:18:05,200 --> 02:18:09,160 WE'LL POST THE CRITERIA AND WE 2695 02:18:09,160 --> 02:18:14,600 CAN GET RID OF THE SLIDES. 2696 02:18:14,600 --> 02:18:16,000 FOR PEOPLE PART OF THE WORK 2697 02:18:16,000 --> 02:18:17,400 GROUP, PLEASE JUMP IN AND IF 2698 02:18:17,400 --> 02:18:20,240 THERE'S THINGS I MISSED OR 2699 02:18:20,240 --> 02:18:22,440 MISCHARACTERIZED OR HAD OTHER 2700 02:18:22,440 --> 02:18:24,000 ADDITIONS YOU WANTED TO MAKE. 2701 02:18:24,000 --> 02:18:25,640 THIS ALSO GOES FOR THE PEOPLE 2702 02:18:25,640 --> 02:18:28,240 WHO WERE INVITED TO PARTICIPATE 2703 02:18:28,240 --> 02:18:30,160 IN THE OPEN SESSION THAT ARE NOT 2704 02:18:30,160 --> 02:18:31,040 ON COUNCIL BUT PART OF THE 2705 02:18:31,040 --> 02:18:41,280 WORKING GROUP. 2706 02:18:58,880 --> 02:19:04,320 >>MY IMPRESSION IS IT DOESN'T 2707 02:19:04,320 --> 02:19:06,200 COST NIDA VERY MUCH BECAUSE 2708 02:19:06,200 --> 02:19:07,240 THEY'RE LIKELY TO GET THEIR 2709 02:19:07,240 --> 02:19:13,360 GRANTS REVIEWED ANYWAY. 2710 02:19:13,360 --> 02:19:15,960 IT DOESN'T IMPACT THE BUDGET THE 2711 02:19:15,960 --> 02:19:21,960 WAY YOU MIGHT THINK WHEN GIVEN 2712 02:19:21,960 --> 02:19:22,240 I 2713 02:19:22,240 --> 02:19:24,440 IN AN AWARD LIKE THIS OR BEING 2714 02:19:24,440 --> 02:19:31,560 INVOLVED IN MAYBE MORE RISKY 2715 02:19:31,560 --> 02:19:31,800 THINGS. 2716 02:19:31,800 --> 02:19:33,360 IT MAY LEVERAGE THE TIME THE 2717 02:19:33,360 --> 02:19:35,000 INVESTIGATOR HAS TO ACCOMPLISH 2718 02:19:35,000 --> 02:19:37,520 OTHER GOALS NIDA MIGHT HAVE. 2719 02:19:37,520 --> 02:19:39,200 I USED MY TIME TO TAKE MORE OF 2720 02:19:39,200 --> 02:19:42,480 AN ACTIVE ROLE IN MENTORING AND 2721 02:19:42,480 --> 02:19:43,240 REACHING OUT TO YOUNGER 2722 02:19:43,240 --> 02:19:46,520 INVESTIGATORS AND SPENDING TIME 2723 02:19:46,520 --> 02:19:48,520 WORKING WITH YOUNG INVESTIGATORS 2724 02:19:48,520 --> 02:19:50,840 INSTEAD OF KEEPING MY NOSE TO 2725 02:19:50,840 --> 02:19:53,280 THE GRANT WRITING GRIND STONE 2726 02:19:53,280 --> 02:19:54,800 AND TAKE RISK IN TERMS OF 2727 02:19:54,800 --> 02:19:56,840 PROFESSIONAL DEVELOPMENT FOR 2728 02:19:56,840 --> 02:19:57,160 OTHERS. 2729 02:19:57,160 --> 02:20:01,480 THAT COULD BE OPERATIONALIZED IN 2730 02:20:01,480 --> 02:20:06,600 THE PROCESS SAYING WHAT IS YOUR 2731 02:20:06,600 --> 02:20:10,240 PLAN TO USE YOUR POSITION AS A 2732 02:20:10,240 --> 02:20:13,040 MERITORIOUS NIDA INVESTIGATOR TO 2733 02:20:13,040 --> 02:20:14,920 BRING UP OTHER INDIVIDUALS WHO 2734 02:20:14,920 --> 02:20:25,520 YOU HAVE INTERACTIONS WITH. 2735 02:20:25,520 --> 02:20:26,680 AND IT DIDN'T INCREASE THE WAY 2736 02:20:26,680 --> 02:20:33,040 IT NORMALLY WOULD WITH THE 2737 02:20:33,040 --> 02:20:34,880 RENEWAL. 2738 02:20:34,880 --> 02:20:37,920 IT MIGHT HAVE SAVED NIDA MONEY 2739 02:20:37,920 --> 02:20:40,760 AND USING AN INVESTIGATOR TO USE 2740 02:20:40,760 --> 02:20:41,960 THAT FREE TIME SOMEBODY CARES 2741 02:20:41,960 --> 02:20:45,520 ABOUT WOULD BE A WONDERFUL 2742 02:20:45,520 --> 02:20:47,320 OPPORTUNITY. 2743 02:20:47,320 --> 02:20:49,920 >>I DON'T THINK IT'S A COST 2744 02:20:49,920 --> 02:20:52,560 ISSUE BUT A QUESTION OF ARE WE 2745 02:20:52,560 --> 02:20:54,320 FURTHERING AN ELITISM IN WHICH 2746 02:20:54,320 --> 02:20:56,240 WE CONTINUE TO SORT OF GIVE MORE 2747 02:20:56,240 --> 02:20:57,560 TO THE PEOPLE WHO ALREADY HAVE A 2748 02:20:57,560 --> 02:21:01,600 LOT. 2749 02:21:01,600 --> 02:21:03,560 IT'S NOT A COST ISSUE AND I 2750 02:21:03,560 --> 02:21:04,320 ACTUALLY DON'T THINK THE 2751 02:21:04,320 --> 02:21:06,280 DISCUSSION REALLY FOCUSSED ON 2752 02:21:06,280 --> 02:21:07,920 LET'S GET RID OF IT FOR THE 2753 02:21:07,920 --> 02:21:08,840 SENIOR INVESTIGATORS BECAUSE 2754 02:21:08,840 --> 02:21:10,160 IT'S NOT WORTH WHILE. 2755 02:21:10,160 --> 02:21:12,080 IT'S MORE SHOULD WE EXPAND IT 2756 02:21:12,080 --> 02:21:16,640 AND GIVE IT AND IF WE DO EXPAND 2757 02:21:16,640 --> 02:21:18,520 IT WHAT ARE THE CRITERIA WE 2758 02:21:18,520 --> 02:21:21,160 SHOULD USE IN ORDER TO EXPAND 2759 02:21:21,160 --> 02:21:31,240 IT. 2760 02:21:43,400 --> 02:21:44,800 I HAVE A RESPONSE THAT THE COST 2761 02:21:44,800 --> 02:21:47,400 YOU ALL NOTICED, WHICH IS THIS 2762 02:21:47,400 --> 02:21:50,080 SORT OF FURTHERING ELITISM THE 2763 02:21:50,080 --> 02:21:52,680 FACT IT WAS SO WHITE AND SO MALE 2764 02:21:52,680 --> 02:22:03,560 IN TERMS OF THE AWARDEES THAT 2765 02:22:03,560 --> 02:22:06,120 SEEMS REALLY SIGNIFICANT LIKE A 2766 02:22:06,120 --> 02:22:07,200 MISTAKE THAT'S BEEN MADE THAT 2767 02:22:07,200 --> 02:22:08,680 MUST BE CORRECTED KNOW. 2768 02:22:08,680 --> 02:22:15,480 ONE THING I DON'T THINK I 2769 02:22:15,480 --> 02:22:16,760 UNDERSTOOD FROM THE PRESENTATION 2770 02:22:16,760 --> 02:22:21,080 IS HOW THE SELECTION CRITERIA 2771 02:22:21,080 --> 02:22:24,400 WOULD WORK IS THERE A GUARANTEE 2772 02:22:24,400 --> 02:22:27,280 YOU'RE FIXING THE PROBLEM RATHER 2773 02:22:27,280 --> 02:22:30,600 THAN FIXING THE PROBLEM. 2774 02:22:30,600 --> 02:22:33,160 JUNIOR FOLKS COULD NOW APPLY BUT 2775 02:22:33,160 --> 02:22:35,680 THE CRITERIA PRIVILEGES THE MOST 2776 02:22:35,680 --> 02:22:37,160 ESTABLISHED AND SUCCESSFUL FOLKS 2777 02:22:37,160 --> 02:22:38,400 THAT WOULDN'T GIVE US REASON TO 2778 02:22:38,400 --> 02:22:42,000 THINK IT'S ACTUALLY GOING TO BE 2779 02:22:42,000 --> 02:22:42,520 SUCCESSFUL AT FIXING THE 2780 02:22:42,520 --> 02:22:51,200 PROBLEM. 2781 02:22:51,200 --> 02:22:52,080 WONDERING ABOUT WHAT CRITERIA 2782 02:22:52,080 --> 02:22:55,680 AND DO YOU HOLD THAT BACK FOR 2783 02:22:55,680 --> 02:22:56,560 EARLY RESEARCHERS THERE'S A 2784 02:22:56,560 --> 02:22:57,400 NUMBER FOR SENIOR AND SOME FOR 2785 02:22:57,400 --> 02:23:00,160 JUNIOR OR WHAT. 2786 02:23:00,160 --> 02:23:02,600 >>ALL THAT IS ON THE TABLE. 2787 02:23:02,600 --> 02:23:06,160 THAT WAS WHAT WAS PRESENTED BUT 2788 02:23:06,160 --> 02:23:08,360 I DO THINK THAT'S THE SUGGESTION 2789 02:23:08,360 --> 02:23:09,440 OF HAVING AN EQUAL NUMBER EARLY 2790 02:23:09,440 --> 02:23:12,040 STAGE INVESTIGATORS. 2791 02:23:12,040 --> 02:23:14,720 IT DOESN'T NECESSARILY ENSURE 2792 02:23:14,720 --> 02:23:15,680 DIVERSITY AND EARLY STAGE 2793 02:23:15,680 --> 02:23:18,240 INVESTIGATORS COMING FROM THE 2794 02:23:18,240 --> 02:23:23,400 BEST AND MOST RESOURCED 2795 02:23:23,400 --> 02:23:23,720 INSTITUTIONS. 2796 02:23:23,720 --> 02:23:28,880 IT'S PART OF THE CRITERIA ON 2797 02:23:28,880 --> 02:23:31,560 RESEARCH WHERE WE CAN EXPAND ON 2798 02:23:31,560 --> 02:23:33,160 DIVERSITY OR REQUIREMENT FOR 2799 02:23:33,160 --> 02:23:33,360 PEDP. 2800 02:23:33,360 --> 02:23:37,400 THAT MAY BE A WAY TO START. 2801 02:23:37,400 --> 02:23:39,560 I DON'T THINK THERE'S ANY SIMPLE 2802 02:23:39,560 --> 02:23:41,160 ANSWER HOW TO DO THIS. 2803 02:23:41,160 --> 02:23:42,880 I THINK WE'RE OPEN TO CHANGING 2804 02:23:42,880 --> 02:23:43,760 THE CRITERIA. 2805 02:23:43,760 --> 02:23:48,320 WE DON'T HAVE TO AND WE DON'T 2806 02:23:48,320 --> 02:23:50,880 HAVE TO AND WE CAN -- WE CAN 2807 02:23:50,880 --> 02:23:53,160 HAVE TWO SEPARATE AWARDS AND ONE 2808 02:23:53,160 --> 02:23:54,560 BE MERIT. 2809 02:23:54,560 --> 02:23:57,120 I ALSO WANT TO CLARIFY, PEOPLE 2810 02:23:57,120 --> 02:24:07,640 DON'T APPLY FOR THESE AWARDS. 2811 02:24:26,040 --> 02:24:27,040 >>I HAVE TREMENDOUSLY 2812 02:24:27,040 --> 02:24:27,920 BENEFITTED IN THE SAME WAY HOW 2813 02:24:27,920 --> 02:24:37,800 IT WAS OUTLINED BEFORE. 2814 02:24:37,800 --> 02:24:41,120 AND IT REWARDS PEOPLE LONG IN 2815 02:24:41,120 --> 02:24:45,560 THE FIELD DOING A PERSISTENT 2816 02:24:45,560 --> 02:24:47,200 LINE OF RESEARCH AND COMMITTED 2817 02:24:47,200 --> 02:24:48,360 TO WHAT THEY'RE DOING. 2818 02:24:48,360 --> 02:24:51,360 IT HAS ITS MERITS. 2819 02:24:51,360 --> 02:24:57,160 WHAT I'M SHOCKED BY IS YOU DON'T 2820 02:24:57,160 --> 02:25:02,440 GET A DIVERSE POPULATION AND 2821 02:25:02,440 --> 02:25:03,080 YOUNG INVESTIGATORS. 2822 02:25:03,080 --> 02:25:04,080 THAT'S THE PROBLEM. 2823 02:25:04,080 --> 02:25:06,800 IF YOU WOULD HAVE THEM YOU WOULD 2824 02:25:06,800 --> 02:25:10,600 CONSIDER THOSE FOUR MERIT AWARD 2825 02:25:10,600 --> 02:25:13,320 AND THAT'S NOT THE CASE. 2826 02:25:13,320 --> 02:25:14,800 UNLESS YOU CHANGE THE CRITERIA 2827 02:25:14,800 --> 02:25:24,560 ABOUT THE PERCENTILE, THEN IT 2828 02:25:24,560 --> 02:25:28,560 BECOMES PROBLEMATIC AND IT'S 2829 02:25:28,560 --> 02:25:30,720 UNCLEAR HOW EXPANDING IT TO 2830 02:25:30,720 --> 02:25:34,640 YOUNGER INVESTIGATORS AND OTHER 2831 02:25:34,640 --> 02:25:40,800 THINGS IS GOING TO MAKE AN 2832 02:25:40,800 --> 02:25:41,120 IMPACT. 2833 02:25:41,120 --> 02:25:45,120 WHAT TRAVIS SAID FOR ME THINKING 2834 02:25:45,120 --> 02:25:52,960 WHY PEOPLE ARE NOT SCORING IN A 2835 02:25:52,960 --> 02:25:54,920 BETTER PERCENTILE IN EARLY 2836 02:25:54,920 --> 02:26:00,760 DIVERSE OR IN THEIR CAREER IS A 2837 02:26:00,760 --> 02:26:02,400 PROBLEM PROBLEM WE KNOW THAT 2838 02:26:02,400 --> 02:26:04,800 EXISTS AND AT THE CORE OF THE 2839 02:26:04,800 --> 02:26:05,160 PROBLEM. 2840 02:26:05,160 --> 02:26:06,840 I'M NOT SURE WHAT YOU OUTLINED 2841 02:26:06,840 --> 02:26:07,800 IS GOING TO CHANGE THAT CORE 2842 02:26:07,800 --> 02:26:14,600 ISSUE. 2843 02:26:14,600 --> 02:26:20,080 >>I WANT TO POINT OUT IF THOSE 2844 02:26:20,080 --> 02:26:21,400 NUMBERS I SHOWED QUICKLY ON THE 2845 02:26:21,400 --> 02:26:25,760 BAR GRAPH, THAT WAS A FOUR-YEAR 2846 02:26:25,760 --> 02:26:27,480 PERIOD AND STILL DIDN'T HAVE A 2847 02:26:27,480 --> 02:26:31,840 HUGE NUMBER OF ESIs THAT FELL IN 2848 02:26:31,840 --> 02:26:34,000 THE CRITERIA OF THE FIRST OF 2849 02:26:34,000 --> 02:26:34,280 15%. 2850 02:26:34,280 --> 02:26:38,480 IT'S NOT GOING TO OPEN IT UP 2851 02:26:38,480 --> 02:26:38,920 DRAMATICALLY. 2852 02:26:38,920 --> 02:26:39,880 IT DOESN'T ADDRESS THE ISSUES 2853 02:26:39,880 --> 02:26:41,640 YOU BROUGHT UP WHICH IS HOW DO 2854 02:26:41,640 --> 02:26:47,120 WE MAKE SURE THAT WE ARE HOW DO 2855 02:26:47,120 --> 02:26:48,480 WE IMPROVE THE SCORES OF PEOPLE 2856 02:26:48,480 --> 02:26:52,440 NOT SCORING SO WELL AND MAKE 2857 02:26:52,440 --> 02:26:55,520 SURE THEY -- I DON'T KNOW ALL 2858 02:26:55,520 --> 02:26:56,720 THE REASONS. 2859 02:26:56,720 --> 02:26:58,080 THERE'S PROBABLY MANY REASONS 2860 02:26:58,080 --> 02:26:59,640 FOR THAT. 2861 02:26:59,640 --> 02:27:04,800 >>OR IS THERE BIAS? 2862 02:27:04,800 --> 02:27:14,520 >>ABSOLUTELY. 2863 02:27:14,520 --> 02:27:17,120 >>THANK YOU, THIS BRINGS UP THE 2864 02:27:17,120 --> 02:27:19,600 ISSUE OF HOW BIAS GETS EMBEDDED 2865 02:27:19,600 --> 02:27:20,080 SOMETIMES. 2866 02:27:20,080 --> 02:27:22,280 ONE QUESTION I HAD IS IT'S NOT 2867 02:27:22,280 --> 02:27:24,440 CLEAR -- IS IT AUTOMATIC IF 2868 02:27:24,440 --> 02:27:27,400 SOMEONE HAS A GRANT BELOW 5% THE 2869 02:27:27,400 --> 02:27:31,560 MAIM IS BROUGHT UP OR ANOTHER 2870 02:27:31,560 --> 02:27:33,400 STEP IN THE MIDDLE? 2871 02:27:33,400 --> 02:27:43,480 HOW DOES THE BIAS CREEP IN? 2872 02:27:43,480 --> 02:27:44,520 BY UNDERSTANDING IS THAT AFTER 2873 02:27:44,520 --> 02:27:45,760 THAT YOU NEED TO BE NOMINATED 2874 02:27:45,760 --> 02:27:52,000 AND YOU HAVE THE MAJORITY AND 2875 02:27:52,000 --> 02:28:01,200 MALE AND THAT KIND OF WOKS WORK 2876 02:28:01,200 --> 02:28:02,400 AND DID THE GROUP TALK ABOUT 2877 02:28:02,400 --> 02:28:03,640 MOVING AWAY FROM THAT? 2878 02:28:03,640 --> 02:28:06,720 I WANTED TO BUILD ON WHAT 2879 02:28:06,720 --> 02:28:10,000 TRAVIS WAS SAYING BECAUSE IT'S 2880 02:28:10,000 --> 02:28:13,040 NOT CLEAR THE PROCESS OF HOW IT 2881 02:28:13,040 --> 02:28:14,280 WAS DONE WAS OUTLINED TO THINK 2882 02:28:14,280 --> 02:28:15,680 ABOUT AND FOR YOU TO REVIEW AND 2883 02:28:15,680 --> 02:28:26,040 POTENTIALLY CHANGE. 2884 02:28:27,280 --> 02:28:28,960 >>ONCE THE MINIMUM REQUIREMENTS 2885 02:28:28,960 --> 02:28:35,000 ARE MET, THE DIVISIONS WILL DO A 2886 02:28:35,000 --> 02:28:36,240 REVIEW OF ANY INVESTIGATORS 2887 02:28:36,240 --> 02:28:37,440 WITHIN THE FUNDING PERIOD THAT 2888 02:28:37,440 --> 02:28:40,760 COULD BE PUT FORWARD AS A MERIT 2889 02:28:40,760 --> 02:28:41,440 AWARDEE. 2890 02:28:41,440 --> 02:28:46,600 THEY'LL MAKE SUGGESTIONS. 2891 02:28:46,600 --> 02:28:49,200 AND I THINK I'D HAVE TO ASK THE 2892 02:28:49,200 --> 02:28:50,600 DIVISION DIRECTORS HOW TO DO 2893 02:28:50,600 --> 02:28:55,120 THAT AND I MAY BE A BIAS BUT 2894 02:28:55,120 --> 02:28:56,360 MAYBE NOT WHAT OTHER ISSUES 2895 02:28:56,360 --> 02:28:58,680 AROUND WHAT THE ACTUAL SCORES 2896 02:28:58,680 --> 02:28:58,840 ARE. 2897 02:28:58,840 --> 02:29:07,320 I'M NOT SURE PARTICULARLY 2898 02:29:07,320 --> 02:29:09,120 BECAUSE DMV GIVES THE MAJORITY 2899 02:29:09,120 --> 02:29:12,600 OF MERIT AWARDS BUT PERHAPS SHE 2900 02:29:12,600 --> 02:29:16,760 CAN TALK A LITTLE BIT MORE ABOUT 2901 02:29:16,760 --> 02:29:18,160 THE CRITERIA YOU USE. 2902 02:29:18,160 --> 02:29:23,920 >>WE HAVE GONE BY THE 5 2903 02:29:23,920 --> 02:29:32,240 PERCENTILE WE SAY WHO MEETS THE 2904 02:29:32,240 --> 02:29:32,960 CRITERIA AND LOOK AT THEM AND 2905 02:29:32,960 --> 02:29:40,560 DISCUSS THEM. 2906 02:29:40,560 --> 02:29:41,800 THERE AREN'T THAT MANY. 2907 02:29:41,800 --> 02:29:44,440 THERE'S FEW AND WE DISCUSS THEM 2908 02:29:44,440 --> 02:29:48,440 AS A GROUP AND PUT FORWARD 2909 02:29:48,440 --> 02:29:48,760 INDIVIDUALS. 2910 02:29:48,760 --> 02:29:50,040 SINCE I'VE BEEN THERE I FEEL 2911 02:29:50,040 --> 02:29:55,800 WE'VE BEEN SENSITIVE TO THE 2912 02:29:55,800 --> 02:29:59,840 ISSUE THERE'S BEEN FEW ER FEMALS 2913 02:29:59,840 --> 02:30:01,120 AND MINORITIES. 2914 02:30:01,120 --> 02:30:09,120 ONE OF THE THINGS THAT HAS COME 2915 02:30:09,120 --> 02:30:16,120 UP IS WITH JUNIOR ADVOCATORS SO 2916 02:30:16,120 --> 02:30:23,360 THOSE -- USUALLY YOU LOOK AT 2917 02:30:23,360 --> 02:30:24,160 SOMEONE ESTABLISHED AND IN THE 2918 02:30:24,160 --> 02:30:28,480 FIELD A LONG TIME AND CONSI 2919 02:30:28,480 --> 02:30:30,600 CONSISTENTLY SUCCESSFUL AND 2920 02:30:30,600 --> 02:30:31,280 THERE'S INVESTIGATORS THAT DON'T 2921 02:30:31,280 --> 02:30:33,240 REACH THAT. 2922 02:30:33,240 --> 02:30:39,400 SO THAT'S WHERE WE HAVE HAD THE 2923 02:30:39,400 --> 02:30:42,520 MOST DISCUSSION. 2924 02:30:42,520 --> 02:30:47,760 THAT'S ESSENTIALLY WHY THE 2925 02:30:47,760 --> 02:30:49,080 COMMITTEE WAS FORMED. 2926 02:30:49,080 --> 02:30:51,680 WE HAD QUESTIONS AND WHETHER THE 2927 02:30:51,680 --> 02:30:53,680 INDIVIDUALS SERVED WOULD BE 2928 02:30:53,680 --> 02:31:01,480 BETTER SERVED BY THEM THERE. 2929 02:31:01,480 --> 02:31:05,920 >> 2930 02:31:05,920 --> 02:31:08,240 >>I WAS A MEMBER OF THE WORK 2931 02:31:08,240 --> 02:31:11,720 GROUP AND CURRENT MERIT AWARDEE. 2932 02:31:11,720 --> 02:31:13,960 LIKE OTHERS I HAVE GREATLY 2933 02:31:13,960 --> 02:31:18,640 BENEFITTED FROM THE AWARD SUSAN 2934 02:31:18,640 --> 02:31:22,080 DID A NICE JOB SUMMARIZING AND 2935 02:31:22,080 --> 02:31:23,760 IT'S NOT JUST YOU HAVE TO SCORE 2936 02:31:23,760 --> 02:31:25,560 UNDER THE FIFTH PERCENTILE BUT 2937 02:31:25,560 --> 02:31:27,520 ALSO HAVE TO HAVE A RO1. 2938 02:31:27,520 --> 02:31:30,240 THAT OFF THE BAT TAKES OFF THE 2939 02:31:30,240 --> 02:31:31,400 EARLY STAGE INVESTIGATORS 2940 02:31:31,400 --> 02:31:33,040 BECAUSE BY DEFINITION ONCE YOU 2941 02:31:33,040 --> 02:31:34,800 HAVE AN RO1 YOU'RE NOT AN EARLY 2942 02:31:34,800 --> 02:31:36,400 STAGE INVESTIGATOR. 2943 02:31:36,400 --> 02:31:40,400 I GOT ONE AT MY SECOND RO1 AND 2944 02:31:40,400 --> 02:31:42,440 MID-CAREER AND DECENTLY EARLY 2945 02:31:42,440 --> 02:31:46,840 BUT NOT THE NORM. 2946 02:31:46,840 --> 02:31:48,760 WHEN WE WERE LOOKING AT THE DATA 2947 02:31:48,760 --> 02:31:50,160 IT'S NOT JUST DIVERSITY OR TYPE 2948 02:31:50,160 --> 02:31:52,320 OF PERSON THAT GETS THE AWARDS 2949 02:31:52,320 --> 02:31:52,920 BUT DIVERSITY OF SCIENCE AS 2950 02:31:52,920 --> 02:31:57,120 WELL. 2951 02:31:57,120 --> 02:32:06,000 THERE'S A HEAVY EMPHASIS ON 2952 02:32:06,000 --> 02:32:07,080 BIOLOGICAL FUNDING AND I WAS 2953 02:32:07,080 --> 02:32:09,160 TOLD I WAS THE FIRST 2954 02:32:09,160 --> 02:32:10,000 IMPLEMENTATION SCIENTIST TO GET 2955 02:32:10,000 --> 02:32:13,160 A MERIT AWARD AND I THINK IN 2956 02:32:13,160 --> 02:32:15,920 LARGE PART IS BECAUSE THESE ARE 2957 02:32:15,920 --> 02:32:17,720 BIG STUDIES, MULTI-SITES AND ALL 2958 02:32:17,720 --> 02:32:20,800 MY OTHERS IN MY PORTFOLIO ARE 2959 02:32:20,800 --> 02:32:21,520 MPI. 2960 02:32:21,520 --> 02:32:24,400 I WAS FORTUNATE TO GET A MERIT 2961 02:32:24,400 --> 02:32:27,120 ON MY ONLY SOLE P.I. GRANT. 2962 02:32:27,120 --> 02:32:28,800 THINGS WHERE MAKING THINGS 2963 02:32:28,800 --> 02:32:33,160 FLEXIBLE IN MY LINE OF WORK 2964 02:32:33,160 --> 02:32:35,520 THERE'S MANY MECHANISMS THAT ARE 2965 02:32:35,520 --> 02:32:37,360 RO1 EQUIVALENT AND THOSE CHANGES 2966 02:32:37,360 --> 02:32:38,200 COULD HAVE IMPACT ON DIVERSITY 2967 02:32:38,200 --> 02:32:48,440 OF SCIENCE. 2968 02:32:51,000 --> 02:32:52,840 >>WE HAVE TWO PEOPLE NAMED 2969 02:32:52,840 --> 02:32:53,040 ANNA. 2970 02:32:53,040 --> 02:32:54,480 >>A QUICK QUESTION RELATED TO 2971 02:32:54,480 --> 02:32:56,000 THE MPI COMPONENT. 2972 02:32:56,000 --> 02:32:58,240 FIRST I WANT TO THANK THE WORK 2973 02:32:58,240 --> 02:32:59,720 GROUP FOR CONSIDERING THAT. 2974 02:32:59,720 --> 02:33:01,520 FOR THOSE WHO DO TEAM SCIENCE'S 2975 02:33:01,520 --> 02:33:05,720 A GAME CHANGER IN TERMS OF 2976 02:33:05,720 --> 02:33:07,240 MAKING THAT AN OPPORTUNITY FOR 2977 02:33:07,240 --> 02:33:07,800 ELIGIBILITY. 2978 02:33:07,800 --> 02:33:12,680 WONDERING IF THE WORK GROUP HAD 2979 02:33:12,680 --> 02:33:14,240 ADVICE FOR WHETHER A MULTIPLE 2980 02:33:14,240 --> 02:33:16,040 P.I. PROGRAM WHETHER THEY 2981 02:33:16,040 --> 02:33:18,000 CONSIDER ALL THE P.I. OR EACH 2982 02:33:18,000 --> 02:33:20,640 P.I. IN COMBINATION WITH THEIR 2983 02:33:20,640 --> 02:33:22,800 FUNDING HISTORIES AND HOW THAT 2984 02:33:22,800 --> 02:33:23,400 IF THE COMMITTEE HAD 2985 02:33:23,400 --> 02:33:31,280 RECOMMENDATIONS FOR THAT? 2986 02:33:31,280 --> 02:33:33,040 >>THE ONE INSTITUTE THAT DOES 2987 02:33:33,040 --> 02:33:38,160 DO MULTI-P.I. AWARDS WILL ONLY 2988 02:33:38,160 --> 02:33:41,160 IF THEY THINK ALL THE P.I.s 2989 02:33:41,160 --> 02:33:51,640 WOULD MERIT A MERIT. 2990 02:33:51,640 --> 02:33:53,000 CAN'T IMAGINE A ONE AWARD AND 2991 02:33:53,000 --> 02:33:53,840 NOT THE OTHERS. 2992 02:33:53,840 --> 02:34:00,240 IT SEEMS LIKE THAT WOULD BE HARD 2993 02:34:00,240 --> 02:34:06,080 TO MAKE TO DISTINGUISH IN 2994 02:34:06,080 --> 02:34:06,720 DETERMINING THEIR CONTRIBUTIONS 2995 02:34:06,720 --> 02:34:16,960 TO THE FIELD. 2996 02:34:19,200 --> 02:34:21,240 >>I REMEMBER WITH MY MENTOR 2997 02:34:21,240 --> 02:34:29,000 RECEIVED ONE AND IT WAS A NICE 2998 02:34:29,000 --> 02:34:31,440 HONOR AND LOOKING AT IT NOW FROM 2999 02:34:31,440 --> 02:34:33,080 THE PERSPECTIVE OF 20 OR MORE 3000 02:34:33,080 --> 02:34:34,360 YEARS LATER AND THINKING WHAT 3001 02:34:34,360 --> 02:34:40,120 PROBLEM IT IS WE'RE TRYING TO 3002 02:34:40,120 --> 02:34:40,560 ADDRESS. 3003 02:34:40,560 --> 02:34:45,000 ARE WE MANY ARE MERIT AWARD 3004 02:34:45,000 --> 02:34:47,480 WINNERS AND SHOULD BE BUT IS THE 3005 02:34:47,480 --> 02:34:51,480 GOAL TO TRY TO BRING ALONG 3006 02:34:51,480 --> 02:34:52,800 PEOPLE WHO ARE EARLY OR DIVERSE 3007 02:34:52,800 --> 02:34:58,800 AND IF THAT'S THE GOAL, THAT MAY 3008 02:34:58,800 --> 02:35:05,440 BE A SEPARATE AWARD THE THING TO 3009 02:35:05,440 --> 02:35:07,680 THINK ABOUT IS THE TIME THE 3010 02:35:07,680 --> 02:35:10,360 AWARDS WERE STARTED MAYBE THERE 3011 02:35:10,360 --> 02:35:11,200 WASN'T THOUGHT WHETHER IT WOULD 3012 02:35:11,200 --> 02:35:12,960 INCREASE THE GAP BETWEEN PEOPLE 3013 02:35:12,960 --> 02:35:15,120 WHO ALREADY HAVE, WILL GET AND 3014 02:35:15,120 --> 02:35:19,160 WILL BE RENEWED BECAUSE THEY'RE 3015 02:35:19,160 --> 02:35:21,680 ALREADY SUPERIOR SCIENTISTS AND 3016 02:35:21,680 --> 02:35:25,000 SUPERIOR HMMS AND THEY'LL DO 3017 02:35:25,000 --> 02:35:25,840 PRETTY WELL. 3018 02:35:25,840 --> 02:35:26,960 THERE'S AN ISSUE IN OUR FIELD 3019 02:35:26,960 --> 02:35:28,680 WITH PEOPLE STRUGGLING TO GET 3020 02:35:28,680 --> 02:35:33,760 THEIR FORCEDD RO1. 3021 02:35:33,760 --> 02:35:38,160 WE HAVE A CHALLENGIING FIELD FO 3022 02:35:38,160 --> 02:35:40,080 PEOPLE TO GET OFF THE GROUND AND 3023 02:35:40,080 --> 02:35:41,720 GET LAUNCHED AND STAY LAUNCHED. 3024 02:35:41,720 --> 02:35:42,760 THERE'S A LOT OF THOSE PEOPLE 3025 02:35:42,760 --> 02:35:44,480 AND WONDERING HOW WE CAN 3026 02:35:44,480 --> 02:35:45,160 ENCOURAGE PEOPLE IN THE FIELD 3027 02:35:45,160 --> 02:35:50,240 AND KEEP THEM IN THE FIELD 3028 02:35:50,240 --> 02:35:52,280 KNOWING MANY PEOPLE ON THIS 3029 02:35:52,280 --> 02:35:53,560 PROPERLY RECOGNIZED FOR BEING 3030 02:35:53,560 --> 02:35:55,560 WONDERFUL WILL MAKE IT BUT WHAT 3031 02:35:55,560 --> 02:35:57,160 ABOUT THE LARGER GROUP OF PEOPLE 3032 02:35:57,160 --> 02:35:59,680 I GUESS MAKE UP THE BULK OF THE 3033 02:35:59,680 --> 02:36:04,160 FIELD WHO DID NOT GET A FIFTH 3034 02:36:04,160 --> 02:36:05,520 PERCENTILE OF THAT PARTICULAR 3035 02:36:05,520 --> 02:36:07,440 DAY OF THE PEER REVIEW. 3036 02:36:07,440 --> 02:36:09,840 YOU CAN GO FROM A FIFTH 3037 02:36:09,840 --> 02:36:10,840 PERCENTILE AND IT DOESN'T GET 3038 02:36:10,840 --> 02:36:13,280 THE FIFTH PERCENTILE AND NOW 3039 02:36:13,280 --> 02:36:15,000 WHERE ARE YOU? 3040 02:36:15,000 --> 02:36:17,040 ARE YOU LESS MERITORIOUS OR 3041 02:36:17,040 --> 02:36:19,320 SUBJECT TO THE VAGARIES OF PEER 3042 02:36:19,320 --> 02:36:21,120 REVIEW WE KNOW ABOUT? 3043 02:36:21,120 --> 02:36:26,160 SEEMS LIKE THERE'S TWO ISSUES. 3044 02:36:26,160 --> 02:36:35,800 ONE IS ABOUT INCREASE THE GAP 3045 02:36:35,800 --> 02:36:38,720 AND BRINGING PEOPLE ALONG AND 3046 02:36:38,720 --> 02:36:41,240 NEED GRANTEES AND PEOPLE WORKING 3047 02:36:41,240 --> 02:36:43,640 IN THE FIELD. 3048 02:36:43,640 --> 02:36:54,120 IT SEEMS THERE'S TWO IRISHES. 3049 02:36:55,280 --> 02:36:56,720 AND THEY PUB THEM IN THE 3050 02:36:56,720 --> 02:36:58,680 DIRECTION WHERE MAYBE THE 3051 02:36:58,680 --> 02:36:59,760 INTENTIONAL AWARD IS GREAT AND 3052 02:36:59,760 --> 02:37:01,720 ENABLED PEOPLE TO HAVE TIME AND 3053 02:37:01,720 --> 02:37:02,760 THAT'S WONDERFUL BUT WHERE ARE 3054 02:37:02,760 --> 02:37:13,120 WE NOW IN THIS FIELD? 3055 02:37:14,040 --> 02:37:17,920 >>THIS ISN'T CLEARLY THE LAUNCH 3056 02:37:17,920 --> 02:37:18,400 MECHANISM. 3057 02:37:18,400 --> 02:37:19,080 THERE'S OTHERS. 3058 02:37:19,080 --> 02:37:21,920 THE FOCUS ON ESIs IS IMPORTANT. 3059 02:37:21,920 --> 02:37:25,560 YOU LOSE YOUR NEW INVESTIGATOR 3060 02:37:25,560 --> 02:37:29,320 STATUS ONCE YOU HAD AN RO1 AND 3061 02:37:29,320 --> 02:37:30,880 MAINTAIN YOUR STATUS FOR THE 3062 02:37:30,880 --> 02:37:34,080 FIRST 10 YEARS POST GRADUATE. 3063 02:37:34,080 --> 02:37:35,800 I THINK HAVING AN EMPHASIS ON 3064 02:37:35,800 --> 02:37:41,280 THE ESI THE PEOPLE WHO ARE STILL 3065 02:37:41,280 --> 02:37:46,840 RELATIVELY EARLY BECAUSE THEY 3066 02:37:46,840 --> 02:37:49,200 GET IN THE PIPELINE BUT DON'T 3067 02:37:49,200 --> 02:37:51,280 STAY IN IT AND CAN SOLVE THAT 3068 02:37:51,280 --> 02:37:58,840 AND POTENTIALLY LOOKING AT THE 3069 02:37:58,840 --> 02:38:00,960 PERCENTILE MAYBE CONSIDERING 3070 02:38:00,960 --> 02:38:03,080 FLEXIBILITY BECAUSE I ENVISION 3071 02:38:03,080 --> 02:38:05,600 WHEN SOMEONE GETS THEIR FIRST 3072 02:38:05,600 --> 02:38:06,720 RO1 THEY'RE AN EARLY 3073 02:38:06,720 --> 02:38:07,520 INVESTIGATOR. 3074 02:38:07,520 --> 02:38:10,840 IT'S POSSIBLE THEY HAVE NOT AS 3075 02:38:10,840 --> 02:38:11,960 GREAT SCORES AS COUNTERPARTS. 3076 02:38:11,960 --> 02:38:14,760 WE DON'T WANT TO MAKE THEM 3077 02:38:14,760 --> 02:38:15,040 INELIGIBLE. 3078 02:38:15,040 --> 02:38:16,480 THIS IS A DIFFERENT KIND OF 3079 02:38:16,480 --> 02:38:19,040 MECHANISM AND I THINK THE FOCUS 3080 02:38:19,040 --> 02:38:24,200 ON ESI AND THE DIVERSITY STUFF 3081 02:38:24,200 --> 02:38:25,680 WOULD BETTER ALIGN WITH THE 3082 02:38:25,680 --> 02:38:30,560 INTENT OF THE MECHANISM. 3083 02:38:30,560 --> 02:38:32,880 >>YOU DO LOSE YOUR ESI STATUS 3084 02:38:32,880 --> 02:38:37,520 WHEN YOU GET AN RO1. 3085 02:38:37,520 --> 02:38:47,080 IT'S FOR SOMEBODY NEW TO NIH. 3086 02:38:47,080 --> 02:38:48,560 AND NEVER GOT ONE BEFORE AND 3087 02:38:48,560 --> 02:38:50,000 ONCE THEY GET IT THEY WOULD LOSE 3088 02:38:50,000 --> 02:38:52,240 THE NEW AWARD STATUS. 3089 02:38:52,240 --> 02:38:54,520 >>THAT'S NOT WHAT'S ON THE NIH 3090 02:38:54,520 --> 02:38:55,400 WEBSITE AND WHAT I'M TOLD IN MY 3091 02:38:55,400 --> 02:39:03,440 REVIEW PANEL. 3092 02:39:03,440 --> 02:39:06,320 THE NEW INVESTIGATOR NEVER HAD 3093 02:39:06,320 --> 02:39:09,120 AN RO1 AND 10 YEARS AND YOU'RE 3094 02:39:09,120 --> 02:39:10,680 SAYING IT'S NOT ACCURATE. 3095 02:39:10,680 --> 02:39:12,360 I PUT IT IN THE CHAT. 3096 02:39:12,360 --> 02:39:14,400 >>I GUESS I'M ON THE WRONG 3097 02:39:14,400 --> 02:39:15,080 SITE. 3098 02:39:15,080 --> 02:39:22,240 SORRY, I DIDN'T REALIZE THAT. 3099 02:39:22,240 --> 02:39:24,680 >>MANY ARE NOT NEW 3100 02:39:24,680 --> 02:39:25,000 INVESTIGATORS. 3101 02:39:25,000 --> 02:39:28,840 THEY'RE JUST NEW TO NIH 3102 02:39:28,840 --> 02:39:37,880 INVESTIGATORS. 3103 02:39:37,880 --> 02:39:40,040 >>THAT'S NEW TO ME, SORRY. 3104 02:39:40,040 --> 02:39:42,680 >>WE'RE GOING OVER TIME. 3105 02:39:42,680 --> 02:39:46,000 I'LL ASK NORA WOULD YOU WANT TO 3106 02:39:46,000 --> 02:39:53,120 ASK IVONNE TO UPDATE AT THE NEXT 3107 02:39:53,120 --> 02:39:53,960 COUNCIL MEETING TO CONTINUE 3108 02:39:53,960 --> 02:39:54,720 LONGER OR STOP AFTER THE NEXT 3109 02:39:54,720 --> 02:40:03,760 COMMENT? 3110 02:40:03,760 --> 02:40:05,560 I'D LIKE TO HEAR FROM COUNCIL 3111 02:40:05,560 --> 02:40:06,920 MEMBERS BECAUSE IT'S IMPORTANT 3112 02:40:06,920 --> 02:40:12,280 TO KEEP ON THE DISCUSSION AND 3113 02:40:12,280 --> 02:40:19,760 THEN ASK IVAN TO POST POINT TO 3114 02:40:19,760 --> 02:40:21,960 NEXT COUNCIL. 3115 02:40:21,960 --> 02:40:23,640 ALTERNATIVELY, IF YOU THINK WE 3116 02:40:23,640 --> 02:40:25,400 DISCUSSED IT SUFFICIENTLY, WE 3117 02:40:25,400 --> 02:40:27,880 CAN HAVE IVAN GO AHEAD. 3118 02:40:27,880 --> 02:40:29,800 WHY DON'T I POSE THE QUESTION TO 3119 02:40:29,800 --> 02:40:31,240 ALL OF YOU WHO WANT TO CONTINUE 3120 02:40:31,240 --> 02:40:32,000 THE DISCUSSION, PLEASE RAISE 3121 02:40:32,000 --> 02:40:32,640 YOUR HAND. 3122 02:40:32,640 --> 02:40:34,960 WE HAVE A SENSE OF WHAT YOU'RE 3123 02:40:34,960 --> 02:40:45,240 PREFERENCES ARE. 3124 02:41:00,400 --> 02:41:04,840 >>IT'S OKAY WE POSTPONE THIS 3125 02:41:04,840 --> 02:41:07,720 FOR NEXT COUNCIL IN MAY. 3126 02:41:07,720 --> 02:41:09,440 >>I'D LIKE A LITTLE BIT MORE 3127 02:41:09,440 --> 02:41:11,560 TIME BECAUSE I'VE BEEN 3128 02:41:11,560 --> 02:41:12,840 STRUGGLING THE WHOLE DAY TRYING 3129 02:41:12,840 --> 02:41:14,600 TO THINK I WAS GOING TO SAY IN 3130 02:41:14,600 --> 02:41:22,840 15 MINUTES ALLOCATED. 3131 02:41:22,840 --> 02:41:24,480 I WANT TO ANSWER ONE BURNING 3132 02:41:24,480 --> 02:41:25,960 QUESTION ABOUT THE INDUSTRY 3133 02:41:25,960 --> 02:41:26,280 INVOLVEMENT. 3134 02:41:26,280 --> 02:41:27,520 WE HAVE MANY PROJECTS WITH 3135 02:41:27,520 --> 02:41:33,760 INDUSTRY AND A PERSON IN CHARGE 3136 02:41:33,760 --> 02:41:36,520 OF INDUSTRY RELATIONS DAVE WHITE 3137 02:41:36,520 --> 02:41:40,040 TO REPLACE DAVE McCAN. 3138 02:41:40,040 --> 02:41:45,120 AND NOW HE'S IN CHARGE OF 3139 02:41:45,120 --> 02:41:46,360 INDUSTRY RELATIONS AND WE HAVE 3140 02:41:46,360 --> 02:41:52,840 SOMEONE IN CHARGE OF REGULATORY 3141 02:41:52,840 --> 02:41:54,520 SUPPORT AND WHO SUPPORTED 3142 02:41:54,520 --> 02:42:01,160 SUPPORT TO AMY IS MARTHA 3143 02:42:01,160 --> 02:42:02,320 DeSANTIS. 3144 02:42:02,320 --> 02:42:03,960 >>BECAUSE OF YOUR FLEXIBILITY 3145 02:42:03,960 --> 02:42:09,240 WE'LL WORK WITH YOU GIVING YOU 3146 02:42:09,240 --> 02:42:12,000 MORE TIME IN MAY. 3147 02:42:12,000 --> 02:42:14,440 LET'S GO AHEAD WITH THE 3148 02:42:14,440 --> 02:42:14,720 DISCUSSION. 3149 02:42:14,720 --> 02:42:15,640 >>DID YOU HAVE ANYTHING ELSE 3150 02:42:15,640 --> 02:42:18,720 YOU WANTED TO SAY? 3151 02:42:18,720 --> 02:42:26,080 >>I DIDN'T LOWER IT. 3152 02:42:26,080 --> 02:42:28,760 WE CAN STILL FOCUS ON PEOPLE 3153 02:42:28,760 --> 02:42:29,640 EARLIER IR THIN CAREERS. 3154 02:42:29,640 --> 02:42:32,360 WE WANT TO STOP PEOPLE FROM 3155 02:42:32,360 --> 02:42:34,160 FALLING OUT OF THE PIPELINE AND 3156 02:42:34,160 --> 02:42:39,720 HAVE IT BIASSED IN FAVOR OF MORE 3157 02:42:39,720 --> 02:42:42,000 SENIOR AND NOT OLDER BUT THE 3158 02:42:42,000 --> 02:42:42,640 EXPERIENCE AND THEY'VE BEEN AT 3159 02:42:42,640 --> 02:42:48,960 IT FOR A LONG TIME. 3160 02:42:48,960 --> 02:42:52,880 AS THE ABOUT THE STRATEGY TO 3161 02:42:52,880 --> 02:42:53,280 MINIMIZE THE BIAS. 3162 02:42:53,280 --> 02:42:58,000 THANK YOU. 3163 02:42:58,000 --> 02:43:02,000 >>THANK YOU. 3164 02:43:02,000 --> 02:43:07,800 IT'S AN IMPORTANT CONVERSATION 3165 02:43:07,800 --> 02:43:12,400 IT HAS A LOT TO WITH THE STAY IN 3166 02:43:12,400 --> 02:43:12,680 RESEARCH. 3167 02:43:12,680 --> 02:43:16,960 IT'S THE NEXT PHASE IN MID ERAND 3168 02:43:16,960 --> 02:43:21,040 SENIOR PHASE. 3169 02:43:21,040 --> 02:43:23,440 I THINK IT'S IMPORTANT BECAUSE 3170 02:43:23,440 --> 02:43:26,320 WE THINK OF THE SUSTAINABILITY 3171 02:43:26,320 --> 02:43:28,840 OF THE RESEARCH CAREER AND THINK 3172 02:43:28,840 --> 02:43:35,640 OF STRUCTURAL BIASES SOME OF THE 3173 02:43:35,640 --> 02:43:38,200 THINGS THE WORK GROUP SUGGESTS 3174 02:43:38,200 --> 02:43:39,400 ARE WORTH CONSIDERATION. 3175 02:43:39,400 --> 02:43:40,560 IT MAY BE GOOD TO HAVE TWO 3176 02:43:40,560 --> 02:43:42,080 CATEGORIES OF THE AWARDS. 3177 02:43:42,080 --> 02:43:43,760 ONE THAT'S MORE SENIOR AND ONE 3178 02:43:43,760 --> 02:43:45,400 MORE CAREER AND HOW YOU WANT TO 3179 02:43:45,400 --> 02:43:47,400 DO THAT MAYBE YOU CHANGE THE 3180 02:43:47,400 --> 02:43:48,680 ELIGIBILITY A BIT FOR EACH OF 3181 02:43:48,680 --> 02:43:50,440 THOSE SO IT REFLECTS THE 3182 02:43:50,440 --> 02:43:51,480 POPULATION YOU'RE TALKING ABOUT. 3183 02:43:51,480 --> 02:43:53,640 I THINK THE IDEA OF TRYING TO 3184 02:43:53,640 --> 02:43:57,840 FIGURE OUT A WAY TO EXTEND IT TO 3185 02:43:57,840 --> 02:43:59,320 MPI GRANTS GIVEN THE SCIENCE IN 3186 02:43:59,320 --> 02:44:04,880 OTHER FIELD IS A GOOD ONE AND I 3187 02:44:04,880 --> 02:44:10,880 THINK CHARLES SAID IF YOU'RE 3188 02:44:10,880 --> 02:44:12,560 GOING TO HAVE ONE OF THESE IS 3189 02:44:12,560 --> 02:44:23,040 THERE A WAY TO STRUCTURE THE 3190 02:44:25,200 --> 02:44:29,120 CRITERIA ABOUT WHAT YOU EXPECT 3191 02:44:29,120 --> 02:44:30,640 FROM IN THE CRITERIA AND 3192 02:44:30,640 --> 02:44:33,520 BRINGING UP THE NEXT SCIENTISTS 3193 02:44:33,520 --> 02:44:34,680 IN THE FIELD AND WHAT TO EXPECT 3194 02:44:34,680 --> 02:44:40,000 FROM AN AWARDEE AND HOPEFULLY IT 3195 02:44:40,000 --> 02:44:41,440 WOULD YIELD THOSE OTHER KINDS OF 3196 02:44:41,440 --> 02:44:41,760 GOALS. 3197 02:44:41,760 --> 02:44:44,000 >>ONE PLACE YOU CAN DO THAT 3198 02:44:44,000 --> 02:44:45,320 BECAUSE WE DO A SEPARATE 3199 02:44:45,320 --> 02:44:46,680 CONSIDERATION IT'S 3200 02:44:46,680 --> 02:44:51,160 ADMINISTRATIVE REVIEW OF THE 3201 02:44:51,160 --> 02:44:52,520 EXTENSION OF THE AWARD WHICH IS 3202 02:44:52,520 --> 02:44:53,960 THE EXTRA TIME AND WE COULD MAKE 3203 02:44:53,960 --> 02:44:56,760 IT A REQUIREMENT BECAUSE THE 3204 02:44:56,760 --> 02:44:57,400 INVESTIGATORS HAVE TO SUBMIT 3205 02:44:57,400 --> 02:44:58,560 INFORMATION ON WHAT THEY PLAN TO 3206 02:44:58,560 --> 02:45:04,560 DO AND THAT COULD BE THE TIME 3207 02:45:04,560 --> 02:45:06,040 WHEN IT'S A REQUIREMENT TO GET 3208 02:45:06,040 --> 02:45:07,080 THE EXTENSION THE VALUE OF A 3209 02:45:07,080 --> 02:45:14,280 MERIT AWARD. 3210 02:45:14,280 --> 02:45:16,600 I DON'T THINK IT'D BE DIFFICULT 3211 02:45:16,600 --> 02:45:26,720 TO DO. 3212 02:45:45,200 --> 02:45:45,360 DENNIS? 3213 02:45:45,360 --> 02:45:55,520 CHARLES. 3214 02:45:55,760 --> 02:45:58,880 >>MY IMPRESSION TO INCREASE THE 3215 02:45:58,880 --> 02:46:01,160 DIVERSITY OF OUR POOL AND THE 3216 02:46:01,160 --> 02:46:02,680 MOST IMPACTFUL WAY TO DO THAT IS 3217 02:46:02,680 --> 02:46:03,800 PUTTING MORE MONEY IN THE K99 3218 02:46:03,800 --> 02:46:08,400 PROCESS. 3219 02:46:08,400 --> 02:46:09,440 IDENTIFY INDIVIDUALS AT THE 3220 02:46:09,440 --> 02:46:10,680 EARLY STAGE AND MAKE SURE THEY 3221 02:46:10,680 --> 02:46:12,040 HAVE A STRONG START. 3222 02:46:12,040 --> 02:46:17,840 IF YOU GIVE THEM A K99 AND 3223 02:46:17,840 --> 02:46:27,200 INCREASE THE YOU'LL HAVE A BIG 3224 02:46:27,200 --> 02:46:29,200 IMPACT AND INDIVIDUALS STARTING 3225 02:46:29,200 --> 02:46:31,400 OUT MAY NEED THE EXTRA TIME. 3226 02:46:31,400 --> 02:46:34,680 IT'S NOT NECESSARILY STOPPING 3227 02:46:34,680 --> 02:46:35,960 TAKING MONEY FROM THIS PROGRAM 3228 02:46:35,960 --> 02:46:37,840 AND MAKING IT BETTER FOR SURE IN 3229 02:46:37,840 --> 02:46:40,840 THE WAYS YOU OUTLINED BUT 3230 02:46:40,840 --> 02:46:42,480 DEVOTING ATTENTION AND RESOURCES 3231 02:46:42,480 --> 02:46:48,080 WHERE THE INDIVIDUALS ARE WHO 3232 02:46:48,080 --> 02:46:51,280 WILL BECOME THE NEXT SENIOR 3233 02:46:51,280 --> 02:46:52,840 INVESTIGATORS REFLECTING THE 3234 02:46:52,840 --> 02:47:01,520 DIVERSITY WE WANT. 3235 02:47:01,520 --> 02:47:02,760 AND GOING BACK TO THE CRITERIA, 3236 02:47:02,760 --> 02:47:04,560 WHEN I REPRESENTED TO WHAT THEY 3237 02:47:04,560 --> 02:47:05,800 POSTED I SAID THEY'RE GOING IN 3238 02:47:05,800 --> 02:47:09,200 THE WRONG DISTRIBUTION. 3239 02:47:09,200 --> 02:47:11,480 THIS IS EXACTLY THE WRONG 3240 02:47:11,480 --> 02:47:13,640 DIRECTION TO INCREASE THE 3241 02:47:13,640 --> 02:47:14,840 DIVERSITY OF THE AWARDEES. 3242 02:47:14,840 --> 02:47:18,600 YOU CAN'T DO WHAT THEY'RE TRYING 3243 02:47:18,600 --> 02:47:20,400 TO DO. 3244 02:47:20,400 --> 02:47:22,000 IT'S NOT MY SCIENCE BUT MY 3245 02:47:22,000 --> 02:47:25,120 EXPERIENCE IS THE BIAS THAT 3246 02:47:25,120 --> 02:47:31,760 COMES INTO IDENTIFYING A SCORE 3247 02:47:31,760 --> 02:47:35,360 IS THE IMPLICIT BIAS AND WHEN 3248 02:47:35,360 --> 02:47:38,080 YOU DEAL WITH IMPLICIT BIASES WE 3249 02:47:38,080 --> 02:47:40,320 ALL HAVE, THE ONLY WAY TO GET 3250 02:47:40,320 --> 02:47:43,800 RID OF THEM IS TO MAKE THEM 3251 02:47:43,800 --> 02:47:44,040 EXPLICIT. 3252 02:47:44,040 --> 02:47:47,080 IF YOU SAY, WHAT IS YOUR SENSE 3253 02:47:47,080 --> 02:47:57,640 OF THIS PERSON AND SENSE OF THIS 3254 02:47:58,040 --> 02:48:00,160 MAKING THE BIASES EXPLICIT AND 3255 02:48:00,160 --> 02:48:10,600 NOW COUNTER WITH A SCORE. 3256 02:48:11,200 --> 02:48:15,560 IF YOU'RE NARROWING THE APPROACH 3257 02:48:15,560 --> 02:48:17,160 AND BOILS DOWN TO THE GUT 3258 02:48:17,160 --> 02:48:20,000 REACTION OF THE REVIEWER TOWARDS 3259 02:48:20,000 --> 02:48:20,520 THAT PERSON. 3260 02:48:20,520 --> 02:48:28,320 IT GETS BUDDIED UP. 3261 02:48:28,320 --> 02:48:33,120 THEY ARE CAN'T SEPARATE THAT 3262 02:48:33,120 --> 02:48:34,840 FROM THE SCIENTIST AND LOSE 3263 02:48:34,840 --> 02:48:36,160 SIGHT OF THE OTHERS AND WHEN 3264 02:48:36,160 --> 02:48:38,320 THEY WANT TO FOCUS ON AN 3265 02:48:38,320 --> 02:48:40,040 INVESTIGATOR MAYBE THEY'RE NOT 3266 02:48:40,040 --> 02:48:45,160 IN AWE OF THEY SUPPORT THEIR 3267 02:48:45,160 --> 02:48:47,440 FEELING AND NOT THEIR DATA. 3268 02:48:47,440 --> 02:48:50,920 BY IGNORING MAKING BIASES 3269 02:48:50,920 --> 02:48:53,640 COMPLICIT AND DILUTING THEM IS 3270 02:48:53,640 --> 02:48:56,040 NOT WHAT'S DONE THEY MADE THE 3271 02:48:56,040 --> 02:48:57,800 IMPLICIT BIASES EVEN MORE 3272 02:48:57,800 --> 02:48:58,040 STRONG. 3273 02:48:58,040 --> 02:49:05,520 THAT'S ALL I WANTED TO SAY. 3274 02:49:05,520 --> 02:49:06,720 >>I WANT TO MENTION IN THE CHAT 3275 02:49:06,720 --> 02:49:08,440 BECAUSE MANY ARE ON THE 3276 02:49:08,440 --> 02:49:09,560 VIDEOCAST AND CAN'T SEE THEM AND 3277 02:49:09,560 --> 02:49:16,160 ONE WAS A COMMENT BY SARA BECKER 3278 02:49:16,160 --> 02:49:17,640 WHICH I THINK IS INTERESTING TO 3279 02:49:17,640 --> 02:49:21,200 HAVE THE MERIT AWARD WINNERS AS 3280 02:49:21,200 --> 02:49:22,400 PARTICIPATE AS MENTORS IN THE 3281 02:49:22,400 --> 02:49:24,600 NIDA SUMMER MENTORSHIP PROGRAM 3282 02:49:24,600 --> 02:49:26,480 WHICH IS A CONCRETE SUGGESTION 3283 02:49:26,480 --> 02:49:29,840 AND MIGHT ALSO BE HELPFUL IN 3284 02:49:29,840 --> 02:49:33,880 TERMS OF DIVERSIFYING A 3285 02:49:33,880 --> 02:49:34,760 WORKFORCE. 3286 02:49:34,760 --> 02:49:37,120 THE OTHER POINT IS ABOUT THE 3287 02:49:37,120 --> 02:49:39,520 MENTORED K AWARD SAYING WE MAY 3288 02:49:39,520 --> 02:49:43,280 WANT TO CONSIDER BEYOND THE K99s 3289 02:49:43,280 --> 02:49:44,680 AND INCLUDING OTHER AREAS OF THE 3290 02:49:44,680 --> 02:49:46,360 SCIENCE LIKE THE K23s MORE 3291 02:49:46,360 --> 02:49:47,760 CLINICALLY ORIENTED. 3292 02:49:47,760 --> 02:49:49,720 I THINK THIS IS A SEPARATE 3293 02:49:49,720 --> 02:49:50,920 DISCUSSION WE HAD AND INCREASED 3294 02:49:50,920 --> 02:49:52,400 THE PERCENTAGE OF OUR BUDGET 3295 02:49:52,400 --> 02:49:58,880 THAT GO TO K AWARDS. 3296 02:49:58,880 --> 02:50:00,440 WE GET GOOD APPLICATIONS AND 3297 02:50:00,440 --> 02:50:02,960 IT'S HARD TO MAKE THOSE CHOICES. 3298 02:50:02,960 --> 02:50:04,880 I THINK THAT'S A SEPARATE 3299 02:50:04,880 --> 02:50:05,440 DISCUSSION AND ONE WORTH 3300 02:50:05,440 --> 02:50:11,480 CONSIDERATION. 3301 02:50:11,480 --> 02:50:15,680 >>I DON'T THINK I'M HEARING AS 3302 02:50:15,680 --> 02:50:18,520 MUCH CONVERSATION AROUND A POINT 3303 02:50:18,520 --> 02:50:20,200 ON YOUR SLIDE WHICH IS WHAT IF 3304 02:50:20,200 --> 02:50:21,640 WE CONSIDER THE COMMUNITIES WITH 3305 02:50:21,640 --> 02:50:23,800 WHICH THE APPLICANT WORKS? 3306 02:50:23,800 --> 02:50:25,480 WE KNOW HISTORICALLY THAT 3307 02:50:25,480 --> 02:50:29,040 COMMUNITY ENGAGED SCIENCE, CVPR 3308 02:50:29,040 --> 02:50:30,600 ISN'T UNDERSTAND OR REVIEWED AND 3309 02:50:30,600 --> 02:50:31,880 HAS DIFFERENT METRICS OF 3310 02:50:31,880 --> 02:50:33,440 SUCCESS, MAY HAVE 3311 02:50:33,440 --> 02:50:34,320 COMMUNITY-BASED INVESTIGATORS 3312 02:50:34,320 --> 02:50:36,880 WHO WON'T HAVE A BUNCH OF NIH 3313 02:50:36,880 --> 02:50:38,040 AWARDS UNDER THEIR BELT. 3314 02:50:38,040 --> 02:50:40,320 THAT'S A MIX UP OF THE GAME 3315 02:50:40,320 --> 02:50:42,160 HERE. 3316 02:50:42,160 --> 02:50:45,320 IT'S NOT CONFLATING EARLY CAREER 3317 02:50:45,320 --> 02:50:49,120 SCIENTISTS WITH THIS MERIT 3318 02:50:49,120 --> 02:50:49,320 THING. 3319 02:50:49,320 --> 02:50:52,680 IF YOU GET AN RO1 WE KNOW YOUR 3320 02:50:52,680 --> 02:50:53,160 PRETTY DANG GOOD. 3321 02:50:53,160 --> 02:50:55,400 YOU'RE HITTING THE MARKS OF 3322 02:50:55,400 --> 02:50:55,920 RIGOROUS SCIENCE. 3323 02:50:55,920 --> 02:51:01,040 I DON'T CARE SO MUCH WHAT 3324 02:51:01,040 --> 02:51:02,400 PERCENTAGE OF THE TOP SCORING 3325 02:51:02,400 --> 02:51:04,160 BUT WHERE THE MONEY WILL HAVE 3326 02:51:04,160 --> 02:51:08,080 IMPACT IN TERMS OF SAVING LIVES. 3327 02:51:08,080 --> 02:51:09,320 WE KNOW INEQUITIES ARE KILLING 3328 02:51:09,320 --> 02:51:11,720 PEOPLE ON THE GRANDER SCALE. 3329 02:51:11,720 --> 02:51:13,360 IF THAT'S WHAT WE ARE TRYING TO 3330 02:51:13,360 --> 02:51:15,080 CHANGE WITH A MERIT AWARD THAN 3331 02:51:15,080 --> 02:51:20,720 THAT'S WHERE THE MONEY SHOULD 3332 02:51:20,720 --> 02:51:22,600 FLOW IN MY OPINION BUT HAVEN'T 3333 02:51:22,600 --> 02:51:24,400 HEARD PEOPLE TALK ABOUT THAT SO 3334 02:51:24,400 --> 02:51:25,320 HOW DO YOU FEEL ABOUT THAT 3335 02:51:25,320 --> 02:51:34,480 PARTICULAR BULLET POINT? 3336 02:51:34,480 --> 02:51:36,200 >>WE TALKED ABOUT THE AREAS OF 3337 02:51:36,200 --> 02:51:38,480 SCIENCE WE WANT TO SUPPORT AND 3338 02:51:38,480 --> 02:51:41,960 DON'T NECESSARILY NEED A 3339 02:51:41,960 --> 02:51:49,480 PERCENTILE CUT OFF POINT. 3340 02:51:49,480 --> 02:51:54,760 IN FACT THEY AREN'T NECESSARILY 3341 02:51:54,760 --> 02:51:55,400 LOOKING AT THAT. 3342 02:51:55,400 --> 02:51:57,800 THERE'S MANY WAYS TO GO AND THAT 3343 02:51:57,800 --> 02:52:03,440 COULD BE AN AREA. 3344 02:52:03,440 --> 02:52:03,760 I 3345 02:52:03,760 --> 02:52:04,560 I'M CONCERNED BECAUSE WE HAVE 3346 02:52:04,560 --> 02:52:06,640 MANY CONCEPTS TO PRESENT AND 3347 02:52:06,640 --> 02:52:09,160 WANT TO MAYBE WANT TO GIVE IT 3348 02:52:09,160 --> 02:52:13,160 BACK TO NORA TO SUMMARIZE YOUR 3349 02:52:13,160 --> 02:52:19,440 THINKING ON IT. 3350 02:52:19,440 --> 02:52:22,840 I DON'T FEEL LIKE WE HAVE A 3351 02:52:22,840 --> 02:52:28,480 CONSENSUS YET. 3352 02:52:28,480 --> 02:52:31,920 >>WHAT I THINK THERE IS MORE OR 3353 02:52:31,920 --> 02:52:34,280 LESS IS THE CONSENSUS IS THAT 3354 02:52:34,280 --> 02:52:39,680 IT'S A VALUABLE MECHANISM AND 3355 02:52:39,680 --> 02:52:40,960 NIDA SHOULD CONTINUE AND CAN'T 3356 02:52:40,960 --> 02:52:43,400 JUSTIFY MERIT AWARDS THAT WILL 3357 02:52:43,400 --> 02:52:47,440 BE DIFFEN PREDOMINANTLY TO WHITE 3358 02:52:47,440 --> 02:52:49,760 MALES, NOT THAT I HAVE ANYTHING 3359 02:52:49,760 --> 02:52:51,120 AGAINST WHITE MALES, WE HAVE 3360 02:52:51,120 --> 02:52:52,240 EXTRAORDINARY SCIENTISTS BUT 3361 02:52:52,240 --> 02:52:53,800 THERE'S A PORTION OF SCIENTISTS 3362 02:52:53,800 --> 02:53:00,960 NEGLECTED AND NOTE CONSIDERED. 3363 02:53:00,960 --> 02:53:01,840 . 3364 02:53:01,840 --> 02:53:05,120 WE HAVE TO SOLVE THAT PROBLEM 3365 02:53:05,120 --> 02:53:08,360 AND NEED TO LOOK AT IF THE MERIT 3366 02:53:08,360 --> 02:53:09,760 AWARD IS THE BEST MECHANISM TO 3367 02:53:09,760 --> 02:53:12,960 DO THAT AND HOW TO USE THE MERIT 3368 02:53:12,960 --> 02:53:16,800 AWARDS TO ENGAGE THEM IN ORDER 3369 02:53:16,800 --> 02:53:21,240 THE RENEWAL TO ENSURE THEY'RE 3370 02:53:21,240 --> 02:53:21,960 PARTICIPATING AND DIVERSIFY 3371 02:53:21,960 --> 02:53:27,160 MINORITY SCIENTISTS. 3372 02:53:27,160 --> 02:53:35,160 THOSE ARE ISSUES THE LAST IS 3373 02:53:35,160 --> 02:53:37,240 STRAIGHTFORWARD AND IS IT A 3374 02:53:37,240 --> 02:53:39,320 MECHANISM WE SHOULD USE TO GIVE 3375 02:53:39,320 --> 02:53:45,160 AN OPPORTUNITY TO EARLIER STAGE 3376 02:53:45,160 --> 02:53:48,200 INVESTIGATORS INITIATING THEIR 3377 02:53:48,200 --> 02:53:53,040 CAREER AND MINORITY OR SHOULD WE 3378 02:53:53,040 --> 02:53:58,720 THINK OF ALTERNATIVE ONES? 3379 02:53:58,720 --> 02:54:01,880 AS A RESEARCHER THE MERIT AWARD 3380 02:54:01,880 --> 02:54:04,520 ITSELF IS A PRESTIGIOUS 3381 02:54:04,520 --> 02:54:04,880 MECHANISM. 3382 02:54:04,880 --> 02:54:09,120 DO WE GENERATE THE MECHANISMS 3383 02:54:09,120 --> 02:54:11,840 THAT WILL BE ASSOCIATED WITH 3384 02:54:11,840 --> 02:54:14,160 THAT RECOGNITION THAT MAKES IT 3385 02:54:14,160 --> 02:54:14,760 EASIER TO GET RESOURCES AND 3386 02:54:14,760 --> 02:54:20,560 SUPPORT. 3387 02:54:20,560 --> 02:54:24,760 OR LOOK AT AREAS OF SCIENCE WE 3388 02:54:24,760 --> 02:54:27,640 WANT MORE INVESTMENT IN BY YOUNG 3389 02:54:27,640 --> 02:54:29,640 INVESTIGATORS. 3390 02:54:29,640 --> 02:54:35,520 HOW WE INITIATED THE AWARD 3391 02:54:35,520 --> 02:54:37,120 ITS 3392 02:54:37,120 --> 02:54:42,560 ITSELF I THINK IT DESERVES 3393 02:54:42,560 --> 02:54:48,600 FURTHER CONSIDERATION AND WOULD 3394 02:54:48,600 --> 02:54:59,160 LIKE TO HERE ABOUT IT AND LOOK 3395 02:55:07,760 --> 02:55:08,360 AT THE SUBJECT MATTER. 3396 02:55:08,360 --> 02:55:18,720 I CANNOT GIVE A CLEAR 3397 02:55:20,120 --> 02:55:21,400 DETERMINATION OF WHAT WE SHOULD 3398 02:55:21,400 --> 02:55:27,000 BE DOING BUT CLEARLY IDENTIFY 3399 02:55:27,000 --> 02:55:30,680 WHAT ARE SOME OF THE ACTIONS TO 3400 02:55:30,680 --> 02:55:34,040 TAKE TO CREATE A FAIRER 3401 02:55:34,040 --> 02:55:35,000 DISTRIBUTION OF RESOURCES 3402 02:55:35,000 --> 02:55:45,080 THROUGH THE GRANT MECHANISMS. 3403 02:55:45,080 --> 02:55:45,680 >>TO BE CONTINUED. 3404 02:55:45,680 --> 02:55:48,520 >>AND WE NEED TO DO HOMEWORK 3405 02:55:48,520 --> 02:55:52,720 WITHIN NIDA AND COME BACK TO 3406 02:55:52,720 --> 02:55:53,400 COUNCIL IN MAY WITH SOME 3407 02:55:53,400 --> 02:55:58,720 DISCUSSIONS. 3408 02:55:58,720 --> 02:56:00,200 >>BY THE WAY, THE POINT WAS 3409 02:56:00,200 --> 02:56:02,280 TAKEN IN TERMS OF WHERE YOU 3410 02:56:02,280 --> 02:56:07,640 BEGIN TO REBALANCE INEQUITIES. 3411 02:56:07,640 --> 02:56:12,240 THOSE BEGINNING AWARDS ARE A WAY 3412 02:56:12,240 --> 02:56:17,960 OF OPENING UP THE FIELD TO GET 3413 02:56:17,960 --> 02:56:20,400 PEOPLE IN THE FIELD THEN YOU CAN 3414 02:56:20,400 --> 02:56:21,080 GO FROM THERE. 3415 02:56:21,080 --> 02:56:22,920 IT MAY BE A PIECE OF THE 3416 02:56:22,920 --> 02:56:24,280 DISCUSSION THAT'S SEPARATE BUT 3417 02:56:24,280 --> 02:56:25,280 SEEMS TO BE SOMETHING IMPORTANT 3418 02:56:25,280 --> 02:56:27,280 IF THE OVER ALL GOAL IS TO TRY 3419 02:56:27,280 --> 02:56:33,120 TO GET THINGS OPEN AND MORE 3420 02:56:33,120 --> 02:56:43,280 BALANCED. 3421 02:56:44,840 --> 02:56:45,640 >>THERE ARE STILL SOME 3422 02:56:45,640 --> 02:56:46,600 QUESTIONS IN THE CHAT BUT I'LL 3423 02:56:46,600 --> 02:56:47,080 TRY TO GET BACK TO THEM 3424 02:56:47,080 --> 02:56:51,040 SEPARATELY. 3425 02:56:51,040 --> 02:56:53,120 OWE THINK WE NEED TO MOVE ON 3426 02:56:53,120 --> 02:56:54,760 BECAUSE WE HAVE QUITE A NUMBER 3427 02:56:54,760 --> 02:56:56,160 OF CONCEPTS TO HAVE PRESENTED. 3428 02:56:56,160 --> 02:56:58,400 SEVERAL ARE FOR CONTRACTS AND 3429 02:56:58,400 --> 02:56:59,880 WHEN WE PRESENT THE CONCEPT OR 3430 02:56:59,880 --> 02:57:03,560 CONTRACT WE NEED A VOTE ON IT. 3431 02:57:03,560 --> 02:57:04,800 FOR THE OTHER CONCEPTS WE'RE 3432 02:57:04,800 --> 02:57:09,160 LOOKING FOR FEEDBACK AND INPUT 3433 02:57:09,160 --> 02:57:10,880 AND WE'LL GO THROUGH THEM 3434 02:57:10,880 --> 02:57:12,640 QUICKLY AND THEY WERE ALL IN THE 3435 02:57:12,640 --> 02:57:13,880 ELECTRONIC COUNCIL BOOK BUT 3436 02:57:13,880 --> 02:57:16,120 STILL A ONE-PAGER ON THE 3437 02:57:16,120 --> 02:57:16,360 CONCEPT. 3438 02:57:16,360 --> 02:57:18,080 IF THERE'S ANY YOU WANT US TO 3439 02:57:18,080 --> 02:57:20,400 DISCUSS STOP US ALONG THE WAY. 3440 02:57:20,400 --> 02:57:21,440 THAT'S WHY WE'RE BRINGING THEM 3441 02:57:21,440 --> 02:57:26,960 HERE. 3442 02:57:26,960 --> 02:57:33,120 WE HAVE A CONCEPT PRESENTED BY 3443 02:57:33,120 --> 02:57:34,880 THE OFFICE OF RESEARCH TRAINING 3444 02:57:34,880 --> 02:57:36,200 AND DISPARITIES, ARIA. 3445 02:57:36,200 --> 02:57:43,960 >>YES. 3446 02:57:43,960 --> 02:57:44,600 ENTITLED NIDA RESEARCH EDUCATION 3447 02:57:44,600 --> 02:57:45,600 PROGRAM FOR CLINICAL RESEARCHERS 3448 02:57:45,600 --> 02:57:50,480 AND CLINGS FOR FOA TO SUPPORT 3449 02:57:50,480 --> 02:57:53,880 RESEARCH EDUCATION AND 3450 02:57:53,880 --> 02:57:54,800 COMPLIMENTS OTHER FORMAL 3451 02:57:54,800 --> 02:57:55,680 TRAINING PROGRAMS THAT ALREADY 3452 02:57:55,680 --> 02:57:59,280 EXIST RELATED TO SUBSTANCE USE 3453 02:57:59,280 --> 02:57:59,920 AND SUBSTANCE USE DISORDER 3454 02:57:59,920 --> 02:58:00,240 RESEARCH. 3455 02:58:00,240 --> 02:58:03,120 THE FOCUS MAY BE ON ANY TOPIC 3456 02:58:03,120 --> 02:58:04,920 SUCH AS CLINICAL AND 3457 02:58:04,920 --> 02:58:06,960 DIAGNOSTICS, TREATMENT, 3458 02:58:06,960 --> 02:58:09,120 PREVENTION, TREATMENT, CLINICAL 3459 02:58:09,120 --> 02:58:14,080 NEUROSCIENCE, MEDICAL 3460 02:58:14,080 --> 02:58:16,000 CONSEQUENCES OF SUBSTANCE USE, 3461 02:58:16,000 --> 02:58:19,240 ANY OF THESE TOPICS ARE FAIR 3462 02:58:19,240 --> 02:58:23,840 GAME AS WELL AS HIV RELATED 3463 02:58:23,840 --> 02:58:30,320 RESEARCH AND ENCOURAGE MUL 3464 02:58:30,320 --> 02:58:31,000 MULTI-DISCIPLINARY RESEARCH AND 3465 02:58:31,000 --> 02:58:31,600 HOLD THERE AND SEE IF THERE'S 3466 02:58:31,600 --> 02:58:41,840 ANY COMMENTS. 3467 02:58:42,440 --> 02:58:52,840 >>ARE THERE ANY QUESTIONS? 3468 02:58:53,800 --> 02:58:54,440 >>WE CAN GO TO THE NEXT 3469 02:58:54,440 --> 02:59:00,040 CONCEPT. 3470 02:59:00,040 --> 02:59:01,120 >>FOR THE DIVISION OF 3471 02:59:01,120 --> 02:59:02,200 EPIDEMIOLOGY AND SERVICES AND 3472 02:59:02,200 --> 02:59:03,560 PREVENTION RESEARCH THE FIRST IS 3473 02:59:03,560 --> 02:59:07,520 A CONTRACT CONCEPT PRESENTED BY 3474 02:59:07,520 --> 02:59:17,960 JANET KURAMOTO-CRAWFORD. 3475 02:59:19,160 --> 02:59:20,240 >>GOOD AFTERNOON. 3476 02:59:20,240 --> 02:59:23,480 I'M PRESENTING THE NATIONAL 3477 02:59:23,480 --> 02:59:26,320 ADDICTION AND HIV DATA ARCHIVE 3478 02:59:26,320 --> 02:59:27,840 PROGRAM. 3479 02:59:27,840 --> 02:59:30,840 IT'S A NIDA FUNDED PROGRAM THAT 3480 02:59:30,840 --> 02:59:34,720 PRESERVES DATA RELEVANT TO A 3481 02:59:34,720 --> 02:59:36,880 DRUG ADDICTION AND THOSE THAT 3482 02:59:36,880 --> 02:59:38,320 INTERSECT WITH HIV RESEARCH 3483 02:59:38,320 --> 02:59:40,640 ESTABLISHED IN 2001 BASED ON THE 3484 02:59:40,640 --> 02:59:44,800 INCREASED IMPORTANCE OF DATA 3485 02:59:44,800 --> 02:59:47,240 SHARING AND HAS MADE OVER 500 3486 02:59:47,240 --> 02:59:49,160 AVAILABLE TO REUSE. 3487 02:59:49,160 --> 02:59:51,280 SOME HIGHLIGHTED STUDIES ARE THE 3488 02:59:51,280 --> 02:59:55,800 MONITORING THE FUTURE STUDY 3489 02:59:55,800 --> 02:59:57,640 MENTIONED IN DR. VOLKOW'S REPORT 3490 02:59:57,640 --> 02:59:59,160 AND THE POPULATION ASSESSMENT OF 3491 02:59:59,160 --> 03:00:05,120 TOBACCO AND HEALTH STUDY. 3492 03:00:05,120 --> 03:00:09,120 THEY HAVE PROVIDED END TO END 3493 03:00:09,120 --> 03:00:13,120 USES AND THE CONTINUATION OF 3494 03:00:13,120 --> 03:00:17,160 THAT IN LIGHT OF THE SHARING 3495 03:00:17,160 --> 03:00:19,360 POLICY TO BROADEN THE 3496 03:00:19,360 --> 03:00:20,200 REQUIREMENT FOR DATA SHARING FOR 3497 03:00:20,200 --> 03:00:22,160 NIH FUNDED PROJECTS. 3498 03:00:22,160 --> 03:00:25,600 AND THE GOAL OF THE CONCEPT IS 3499 03:00:25,600 --> 03:00:27,880 TO SUPPORT THE CONTINUATION, TO 3500 03:00:27,880 --> 03:00:29,120 ARCHIVE DRUG ADDICTION AND 3501 03:00:29,120 --> 03:00:30,280 SCIENTIFIC DATA AND THE DATA 3502 03:00:30,280 --> 03:00:33,600 THAT INTERSECTIONS WITH HIV 3503 03:00:33,600 --> 03:00:33,840 RESEARCH. 3504 03:00:33,840 --> 03:00:35,600 FOR THE FOCUS ON BEHAVIORAL 3505 03:00:35,600 --> 03:00:36,760 SCIENCE FIELD. 3506 03:00:36,760 --> 03:00:40,520 THE SPECIFIC GOALS INCLUDE 3507 03:00:40,520 --> 03:00:41,360 MAINTAINING, DEVELOPING AND 3508 03:00:41,360 --> 03:00:43,480 EXPANDING THE PROGRAM AND 3509 03:00:43,480 --> 03:00:44,520 PROVIDING TECHNICAL ASSISTANCE 3510 03:00:44,520 --> 03:00:46,560 TO INVESTIGATORS DEPOSITING THE 3511 03:00:46,560 --> 03:00:50,760 DATA AND A SYSTEM IN WHICH TO 3512 03:00:50,760 --> 03:00:52,120 PRIORITIZE IN THE ARCHIVE AND 3513 03:00:52,120 --> 03:00:54,200 APPLYING TECHNIQUES TO MAKE SURE 3514 03:00:54,200 --> 03:00:57,160 THE DATA ARE AVAILABLE IN A SAFE 3515 03:00:57,160 --> 03:00:59,080 AND SECURE MANNER AND FACILITATE 3516 03:00:59,080 --> 03:01:00,600 SHARING OF THE DATA INCLUDING 3517 03:01:00,600 --> 03:01:04,880 SUPPORT AND TECHNICAL ASSISTANCE 3518 03:01:04,880 --> 03:01:06,680 AND TRAINING IN THE FIELD. 3519 03:01:06,680 --> 03:01:07,840 THANK YOU FOR YOUR TIME AND 3520 03:01:07,840 --> 03:01:08,120 ATTENTION. 3521 03:01:08,120 --> 03:01:10,920 >>CAN WE GET A VOTE ON IT AND 3522 03:01:10,920 --> 03:01:21,240 MOTION TO APPROVE? 3523 03:01:33,160 --> 03:01:33,520 >>THANKS. 3524 03:01:33,520 --> 03:01:42,640 NEXT WILL BE BY KATHY ETZ 3525 03:01:42,640 --> 03:01:44,960 LOOKING AT OPIOID DRUG USE AND 3526 03:01:44,960 --> 03:01:45,320 PAIN. 3527 03:01:45,320 --> 03:01:51,840 >>THANK YOU FOR HAVING ME. 3528 03:01:51,840 --> 03:01:53,920 I'LL TRY TO MOVE QUICKLY BUT THE 3529 03:01:53,920 --> 03:01:54,680 BACKGROUND AND JUSTIFICATION FOR 3530 03:01:54,680 --> 03:01:58,880 THE CONCEPT IS WE KNOW AMERICAN 3531 03:01:58,880 --> 03:02:02,360 INDIAN AND ALASKAN NATIVE 3532 03:02:02,360 --> 03:02:05,200 COMMUNITIES BROUGHT INNOVATIONS 3533 03:02:05,200 --> 03:02:07,480 TO ADDRESS SUBSTANCE MISUSE BUT 3534 03:02:07,480 --> 03:02:09,480 HAVE THE HIGHEST RATES RELATIVE 3535 03:02:09,480 --> 03:02:11,320 TO DEATHS COMPARED TO OTHER 3536 03:02:11,320 --> 03:02:14,040 GROUPS AND DUE TO TRAUMA AND 3537 03:02:14,040 --> 03:02:16,880 STRUCTURAL BARRIERS TO GOOD 3538 03:02:16,880 --> 03:02:17,640 HEALTH. 3539 03:02:17,640 --> 03:02:20,880 TO THINK WHAT THE NIH COULD DO 3540 03:02:20,880 --> 03:02:22,600 TO ADDRESS THESE ISSUES, A 3541 03:02:22,600 --> 03:02:25,320 TRIBAL CONSULTATION WAS HELD IN 3542 03:02:25,320 --> 03:02:29,360 MARCH WHERE TRIBAL LEADERS WERE 3543 03:02:29,360 --> 03:02:31,760 INVITED IN AND SHARED WITH US 3544 03:02:31,760 --> 03:02:33,120 WHAT THEY WERE PRIORITIZING IN 3545 03:02:33,120 --> 03:02:35,320 THE AREA. 3546 03:02:35,320 --> 03:02:38,960 WHAT THEY TOLD US WAS THEY 3547 03:02:38,960 --> 03:02:40,160 HIGHLIGHTED RESEARCH GAPS THAT 3548 03:02:40,160 --> 03:02:41,640 REQUIRE CULTURAL EXPERTISE AND 3549 03:02:41,640 --> 03:02:44,160 KNOWLEDGE OF LOCAL COMMUNITY 3550 03:02:44,160 --> 03:02:46,080 CONDITIONS AND INTEGRATING 3551 03:02:46,080 --> 03:02:56,520 TRADITIONAL MEDICINE AND 3552 03:02:57,480 --> 03:02:58,040 CEREMONY AND SPIRITUALITY AND 3553 03:02:58,040 --> 03:03:00,520 LOOKING AT THE CAUSES OF SOCIAL 3554 03:03:00,520 --> 03:03:01,720 DETERMINATES OF HEALTH AND SO 3555 03:03:01,720 --> 03:03:05,760 SOMETHING WE HEARD OVER AND OVER 3556 03:03:05,760 --> 03:03:10,880 IS THE NEED TO SUPPORT TRIBES 3557 03:03:10,880 --> 03:03:13,400 THEMSELVES AND/OR AMERICAN 3558 03:03:13,400 --> 03:03:14,600 CANADIAN, ALASKAN NATIVE 3559 03:03:14,600 --> 03:03:18,520 POPULATIONS AND BUILDING AND 3560 03:03:18,520 --> 03:03:19,880 ENHANCING RESEARCH CAPACITY AND 3561 03:03:19,880 --> 03:03:21,160 INFRASTRUCTURE AND FINALLY 3562 03:03:21,160 --> 03:03:23,720 SOMETHING MELISSA BROUGHT UP 3563 03:03:23,720 --> 03:03:25,840 TODAY, THIS GRATE NEED FOR 3564 03:03:25,840 --> 03:03:28,880 IMPROVED DATA TO SUPPORT 3565 03:03:28,880 --> 03:03:31,840 COMMUNITY RESPONSE. 3566 03:03:31,840 --> 03:03:34,720 THE GOALS OF THE PROGRAM AS 3567 03:03:34,720 --> 03:03:39,360 WE'RE CALLING IT ARE TO DIRECTLY 3568 03:03:39,360 --> 03:03:40,600 RESPOND IT IN TRIBAL 3569 03:03:40,600 --> 03:03:42,920 CONSULTATION BY DEVELOPING AN 3570 03:03:42,920 --> 03:03:45,160 INNOVATIVE AND AGILE PROGRAM 3571 03:03:45,160 --> 03:03:47,800 FOUNDED ON TRIBAL SOVEREIGNTY 3572 03:03:47,800 --> 03:03:51,400 AND ARE REALIZE ON THE DEEP 3573 03:03:51,400 --> 03:03:52,760 ENGAGEMENT INCORPORATING 3574 03:03:52,760 --> 03:03:57,120 INDIGENOUS KNOWLEDGE, ETCETERA. 3575 03:03:57,120 --> 03:03:58,480 WE'RE THINKING ABOUT THIS 3576 03:03:58,480 --> 03:04:00,120 PROGRAM AS SOMETHING THAT WILL 3577 03:04:00,120 --> 03:04:02,800 BE FLEXIBLE AND WE'LL BE ABLE TO 3578 03:04:02,800 --> 03:04:04,480 ADAPT AS NEW SOLUTIONS EMERGE IN 3579 03:04:04,480 --> 03:04:04,920 REAL TIME. 3580 03:04:04,920 --> 03:04:09,560 THE GOALS OF THE PROGRAM ARE TO 3581 03:04:09,560 --> 03:04:12,000 SUPPORT TRIBES AND AMERICAN 3582 03:04:12,000 --> 03:04:13,120 INDIAN AND ALASKAN NATIVE 3583 03:04:13,120 --> 03:04:16,080 POPULATIONS TO IMPROVE THE DATA 3584 03:04:16,080 --> 03:04:18,040 AND RESEARCH AND LOOK AT FACTORS 3585 03:04:18,040 --> 03:04:19,880 RELATED TO DRUG MISUSE AND 3586 03:04:19,880 --> 03:04:24,040 OVERDOSE AND EXPAND RESEARCH 3587 03:04:24,040 --> 03:04:24,720 CAPACITY AND INFRASTRUCTURE TO 3588 03:04:24,720 --> 03:04:26,880 PROVIDE COMPREHENSIVE AND 3589 03:04:26,880 --> 03:04:29,640 ONGOING TECHNICAL ASSISTANCE AND 3590 03:04:29,640 --> 03:04:35,280 TO DEVELOP AND IMPLEMENT BEST 3591 03:04:35,280 --> 03:04:41,680 PRACTICES FOR SHARING PRINCIPLES 3592 03:04:41,680 --> 03:04:42,320 AND SOVEREIGNTY. 3593 03:04:42,320 --> 03:04:46,520 THANK YOU FOR YOUR TIME. 3594 03:04:46,520 --> 03:04:49,120 >>CAN I GET A MOTION TO APPROVE 3595 03:04:49,120 --> 03:04:57,120 IT? 3596 03:04:57,120 --> 03:05:03,040 ANY COMMENTS OR QUESTIONS? 3597 03:05:03,040 --> 03:05:03,840 NOT HEARING ANYTHING, CAN I GET 3598 03:05:03,840 --> 03:05:14,160 A MOTION TO APPROVE? 3599 03:05:23,560 --> 03:05:25,760 NOW THE OTHER CONCEPTS. 3600 03:05:25,760 --> 03:05:27,400 THIS SAY OF THEM AND THESE ARE 3601 03:05:27,400 --> 03:05:33,840 UST BEING PRESENTED FOR GENERAL 3602 03:05:33,840 --> 03:05:34,080 FEEDBACK. 3603 03:05:34,080 --> 03:05:39,600 PLEASE STOP IF YOU WANT TO ASK 3604 03:05:39,600 --> 03:05:40,880 QUESTIONS BUT I'LL TURN IT OVER. 3605 03:05:40,880 --> 03:05:43,280 SHE'S GOT EIGHT TO DO. 3606 03:05:43,280 --> 03:05:47,320 >>SEVEN, I BELIEVE. 3607 03:05:47,320 --> 03:05:51,720 I'M MEDICAL OFFICER IN THE 3608 03:05:51,720 --> 03:05:58,560 MEDICAL SERVICES BRANCH AND I'M 3609 03:05:58,560 --> 03:06:00,400 FIRST IS ENDING THE EPIDEMIC, 3610 03:06:00,400 --> 03:06:03,320 NEW MODELS OF INTEGRATED 3611 03:06:03,320 --> 03:06:04,920 HIV/AIDS ADDICTION AND PRIMARY 3612 03:06:04,920 --> 03:06:06,560 CARE SERVICES SUPPORTING THE NEW 3613 03:06:06,560 --> 03:06:09,160 MODELS OF CARE THAT FUNCTION AS 3614 03:06:09,160 --> 03:06:14,400 ONE STOP SHOPS CAPABLE OF 3615 03:06:14,400 --> 03:06:17,120 INTEGRATING SERVICES INCLUDING 3616 03:06:17,120 --> 03:06:18,240 HIV/AIDS AND ADDICTION AND 3617 03:06:18,240 --> 03:06:19,640 PRIMARY CARE SERVICES. 3618 03:06:19,640 --> 03:06:22,000 IT EXPANDS THE SCOPE TO INCLUDE 3619 03:06:22,000 --> 03:06:23,520 HEPATITIS B AND C AND RE-STRICKS 3620 03:06:23,520 --> 03:06:26,520 INTERNATIONAL SETTINGS TO LOW 3621 03:06:26,520 --> 03:06:28,160 AND MIDDLE INCOME COUNTRIES. 3622 03:06:28,160 --> 03:06:30,080 THE SECOND IS ENGAGING SURVIVORS 3623 03:06:30,080 --> 03:06:31,680 OF SEXUAL VIOLENCE AND 3624 03:06:31,680 --> 03:06:32,960 TRAFFICKING IN HIV AND SUBSTANCE 3625 03:06:32,960 --> 03:06:37,200 USE DISORDER SERVICES. 3626 03:06:37,200 --> 03:06:40,880 THIS IS ALSO LED BY MINNJUAN FOR 3627 03:06:40,880 --> 03:06:43,920 INTERVENTIONS TO ADDRESS THE 3628 03:06:43,920 --> 03:06:46,880 INTERRELATED AND COMPOUNDING 3629 03:06:46,880 --> 03:06:50,360 CONTEXTUAL FACTORS THAT 3630 03:06:50,360 --> 03:06:51,400 CONTRIBUTE TO FACTORS AND BUILD 3631 03:06:51,400 --> 03:06:53,840 NEW INTERVENTIONS AND MODELS OF 3632 03:06:53,840 --> 03:06:55,720 CARE TO ENGAGE SEXUAL 3633 03:06:55,720 --> 03:06:57,760 TRAFFICKING SURVIVORS IN CARE 3634 03:06:57,760 --> 03:06:59,640 FOR SUBSTANCE USE DISORDER, HIV, 3635 03:06:59,640 --> 03:07:01,280 TRAUMA AND OTHER MENTAL HEALTH 3636 03:07:01,280 --> 03:07:04,200 OUTCOMES AND ADDRESS KEY 3637 03:07:04,200 --> 03:07:05,560 STRUCTURAL AND SOCIAL 3638 03:07:05,560 --> 03:07:06,200 DETERMINATES OF HEALTH THAT 3639 03:07:06,200 --> 03:07:07,760 CONTRIBUTE TO RISK FOR SEXUAL 3640 03:07:07,760 --> 03:07:11,000 TRAFFICS AND BARRIERS TO AND 3641 03:07:11,000 --> 03:07:13,120 FACILITATING OF ESCAPE OF 3642 03:07:13,120 --> 03:07:15,240 CONTINUED EXPLOITATION. 3643 03:07:15,240 --> 03:07:16,800 THE THIRD IS ADDRESSING HIV IN 3644 03:07:16,800 --> 03:07:18,840 THE HIGHEST RISK SEXUAL AND 3645 03:07:18,840 --> 03:07:22,560 GENDER MINORITIES LED BY RICHARD 3646 03:07:22,560 --> 03:07:22,880 JENKINS. 3647 03:07:22,880 --> 03:07:24,880 IT LOOKS TO ADDRESS THE 3648 03:07:24,880 --> 03:07:27,800 PROPORTIONS OF HIV CASES IN 3649 03:07:27,800 --> 03:07:31,800 GENDER AND ETHNIC MINORITIES. 3650 03:07:31,800 --> 03:07:37,040 IT WILL SUPPORT EPIDEMIOLOGIC 3651 03:07:37,040 --> 03:07:38,840 RESEARCH AND LOOKING AT 3652 03:07:38,840 --> 03:07:40,920 COMORBIDITIES SUCH AS SEXUALLY 3653 03:07:40,920 --> 03:07:42,120 TRANSMITTED INFECTIONS AND 3654 03:07:42,120 --> 03:07:44,920 HEPATITIS C AND PSYCHIATRIC 3655 03:07:44,920 --> 03:07:45,320 DISORDERS. 3656 03:07:45,320 --> 03:07:47,600 IT WILL INCLUDE INCLUSION OF END 3657 03:07:47,600 --> 03:07:49,280 USERS OF RESEARCH FINDINGS AND 3658 03:07:49,280 --> 03:07:51,640 SOCIAL DETERMINATES OF HEALTH 3659 03:07:51,640 --> 03:07:56,480 WITH HIV AND PROBLEMATIC 3660 03:07:56,480 --> 03:07:57,440 SUBSTANCE USE. 3661 03:07:57,440 --> 03:08:00,520 THE FOURTH CONCEPT IS COHORT 3662 03:08:00,520 --> 03:08:05,240 STUDIES OF HIV/AIDS AND 3663 03:08:05,240 --> 03:08:10,040 SUBSTANCE USE LED BY SHEBA 3664 03:08:10,040 --> 03:08:12,480 DUNSTON AND CONTINUE ADDRESSING 3665 03:08:12,480 --> 03:08:14,000 HIGH-PRIORITY RESEARCH ON 3666 03:08:14,000 --> 03:08:15,600 MULTI-DISCIPLINARY ASPECTS OF 3667 03:08:15,600 --> 03:08:18,800 HIV/AIDS AND SUBSTANCE USE IN 3668 03:08:18,800 --> 03:08:22,200 ALIGNMENT WITH NIH PRIORITIES. 3669 03:08:22,200 --> 03:08:26,000 TO ALIGN SYSTEM LEVEL OR 3670 03:08:26,000 --> 03:08:29,080 MULTILEVEL HIV PREVENTIONS FOR 3671 03:08:29,080 --> 03:08:31,160 TESTING AND DIAGNOSIS AND 3672 03:08:31,160 --> 03:08:32,560 TREATMENT AS WELL AS INFORM 3673 03:08:32,560 --> 03:08:33,920 IMPLEMENTATION RESEARCH IN 3674 03:08:33,920 --> 03:08:35,280 SUBSTANCE USE AND HIV 3675 03:08:35,280 --> 03:08:37,120 PREVENTION, SCREENING, TREATMENT 3676 03:08:37,120 --> 03:08:41,080 AND MEDICAL CARE. 3677 03:08:41,080 --> 03:08:46,920 -- BEFORE YOU GO ONP, ARE THERE 3678 03:08:46,920 --> 03:08:49,120 COMMENTS OR QUESTIONS? 3679 03:08:49,120 --> 03:08:53,200 >>SURE, SINCE THIS IS THE HIV 3680 03:08:53,200 --> 03:09:03,320 GROUP? 3681 03:09:27,800 --> 03:09:30,520 >>WE CAN MOVE ON. 3682 03:09:30,520 --> 03:09:35,080 >>OUR FIFTH CONCEPT IS RESEARCH 3683 03:09:35,080 --> 03:09:38,480 TO ADDRESS SUD IN CRIMINAL-LEGAL 3684 03:09:38,480 --> 03:09:39,000 SYSTEM. 3685 03:09:39,000 --> 03:09:40,360 IT BUILDS ON THE HISTORY OF 3686 03:09:40,360 --> 03:09:43,120 CONDUCTING SERVICES RESEARCH TO 3687 03:09:43,120 --> 03:09:44,040 ADDRESS SUBSTANCE USE DISORDER 3688 03:09:44,040 --> 03:09:45,680 AMONG INDIVIDUALS INVOLVED IN 3689 03:09:45,680 --> 03:09:47,360 THE CRIMINAL LEGAL SYSTEM. 3690 03:09:47,360 --> 03:09:49,160 IT SEEKS TO BUILD ON PAST 3691 03:09:49,160 --> 03:09:50,920 INITIATIVES TO TAKE EFFECTIVE 3692 03:09:50,920 --> 03:09:56,600 INTERVENTIONS TO SCALE IN JAILS, 3693 03:09:56,600 --> 03:09:58,920 COURTS AND COMMUNITY CORRECTIONS 3694 03:09:58,920 --> 03:10:00,720 AND ADDRESSING THE COMPLEX NEEDS 3695 03:10:00,720 --> 03:10:04,560 OF INDIVIDUALS WITH SUBSTANCE 3696 03:10:04,560 --> 03:10:07,680 USE DISORDERS AT EARLIER POINTS. 3697 03:10:07,680 --> 03:10:09,320 THE SIXTH IS RESEARCH TO 3698 03:10:09,320 --> 03:10:10,880 INCREASE IMPLEMENTATION OF 3699 03:10:10,880 --> 03:10:12,680 SUBSTANCE USE PREVENTION 3700 03:10:12,680 --> 03:10:14,280 SERVICES LED BY NAMY GOLDSTEIN. 3701 03:10:14,280 --> 03:10:19,080 IT WILL BE PART OF THE HEAL 3702 03:10:19,080 --> 03:10:20,520 RESEARCH PROGRAM AND ADDRESSES 3703 03:10:20,520 --> 03:10:22,960 EXISTING GAPS TO IDENTIFY 3704 03:10:22,960 --> 03:10:24,920 EFFECTIVE STRATEGIES TO 3705 03:10:24,920 --> 03:10:26,160 DISSEMINATE AND SUPPORT THE 3706 03:10:26,160 --> 03:10:28,920 CREATION AND STRENGTHEN OF A 3707 03:10:28,920 --> 03:10:30,080 PREVENTION INFRASTRUCTURE. 3708 03:10:30,080 --> 03:10:32,000 EXAMPLE AREAS OF INTEREST 3709 03:10:32,000 --> 03:10:34,440 INCLUDE SCIENTIFIC SOLUTIONS TO 3710 03:10:34,440 --> 03:10:36,880 WORKFORCE CAPACITY CHALLENGE, 3711 03:10:36,880 --> 03:10:37,960 RESEARCH TO LEVEL TECHNOLOGY TO 3712 03:10:37,960 --> 03:10:39,440 FACILITATE ACCESS TO PREVENTIVE 3713 03:10:39,440 --> 03:10:40,920 CARE AND STUDIES OF STRATEGIES 3714 03:10:40,920 --> 03:10:45,720 TO IMPACT ORGANIZATIONAL 3715 03:10:45,720 --> 03:10:46,320 STRUCT 3716 03:10:46,320 --> 03:10:48,280 STRUCTURE, CLIMBATE AND 3717 03:10:48,280 --> 03:10:49,880 STRUCTURE AND LOOK AT SERVICES. 3718 03:10:49,880 --> 03:10:53,960 THE SEVEN AND FINAL SERVICES IS 3719 03:10:53,960 --> 03:10:57,080 RESOURCE NETWORKS TO ADVANCE THE 3720 03:10:57,080 --> 03:10:59,520 ADDICTION OF RESOURCES RESEARCH 3721 03:10:59,520 --> 03:11:00,680 THROUGH RESEARCHER DECISION 3722 03:11:00,680 --> 03:11:02,000 MAKER COLLABORATIONS. 3723 03:11:02,000 --> 03:11:04,600 IT BY SARAH DUFFY. 3724 03:11:04,600 --> 03:11:11,280 IT WOULD LOOK AT MULTI-DECISION 3725 03:11:11,280 --> 03:11:12,520 NETWORKS IN ENHANCING THE 3726 03:11:12,520 --> 03:11:15,200 QUALITY AND EFFECTIVENESS OF 3727 03:11:15,200 --> 03:11:16,040 ADDICTION TREATMENT AND FOCUS ON 3728 03:11:16,040 --> 03:11:18,800 THE TIMELY GENERATION, 3729 03:11:18,800 --> 03:11:20,240 DISSEMINATION AND APPLICATION OF 3730 03:11:20,240 --> 03:11:21,960 RELEVANT RESEARCH FINDINGS IN 3731 03:11:21,960 --> 03:11:22,800 REAL-WORLD SETTINGS. 3732 03:11:22,800 --> 03:11:24,720 THOSE ARE ALL OF OUR CONCEPTS 3733 03:11:24,720 --> 03:11:25,320 AND WE'RE HAPPY TO TAKE 3734 03:11:25,320 --> 03:11:35,680 ADDITIONAL QUESTIONS. 3735 03:11:44,600 --> 03:11:48,840 >>NEXT TO DTNC, TANYA RAMIE. 3736 03:11:48,840 --> 03:11:49,800 >>HI, EVERYONE. 3737 03:11:49,800 --> 03:11:52,280 THANK YOU FOR GIVING ME THE 3738 03:11:52,280 --> 03:11:54,680 OPPORTUNITY TO PRESENT THIS 3739 03:11:54,680 --> 03:11:55,720 CONCEPT. 3740 03:11:55,720 --> 03:11:59,520 THIS IS THE DEVELOPMENT OF 3741 03:11:59,520 --> 03:12:01,320 CLINICAL OUTCOME ASSESSMENTS AS 3742 03:12:01,320 --> 03:12:03,160 NEW FDA-QUALIFIED DRUG 3743 03:12:03,160 --> 03:12:04,720 DEVELOPMENT TOOLS FOR OPIOID AND 3744 03:12:04,720 --> 03:12:08,240 STIMULANT USE DISORDERS TO AC 3745 03:12:08,240 --> 03:12:09,120 ACCELERATE THERAPEUTIC 3746 03:12:09,120 --> 03:12:16,240 DEVELOPMENT. 3747 03:12:16,240 --> 03:12:21,760 I'LL TALK ABOUT THIS CONCEPT. 3748 03:12:21,760 --> 03:12:23,280 THE CONCEPT WAS PUT TOGETHER IN 3749 03:12:23,280 --> 03:12:25,200 ORDER TO ACCELERATE THE 3750 03:12:25,200 --> 03:12:26,680 DEVELOPMENT OF NEW THERAPEUTICS 3751 03:12:26,680 --> 03:12:27,920 FOR OPIOID USE DISORDER AND 3752 03:12:27,920 --> 03:12:34,240 STIMULANT USE DISORDER. 3753 03:12:34,240 --> 03:12:35,320 THERE'S A NEED TO LOOK AT 3754 03:12:35,320 --> 03:12:43,680 CLINICAL OUTCOME ASSESSMENTS. 3755 03:12:43,680 --> 03:12:46,560 THAT WILL NEED THE DRUG 3756 03:12:46,560 --> 03:12:50,280 DEVELOPMENT TOOL QUALIFICATION 3757 03:12:50,280 --> 03:12:51,480 FROM THE FDA. 3758 03:12:51,480 --> 03:12:56,720 THERE'S A PROCESS WHICH IS 3759 03:12:56,720 --> 03:13:03,840 EMBEDDED IN THE REQUIREMENTS. 3760 03:13:03,840 --> 03:13:05,400 AND THERE'S A GUIDANCE RELATED 3761 03:13:05,400 --> 03:13:06,840 TO THAT. 3762 03:13:06,840 --> 03:13:08,520 CURRENTLY WE DON'T HAVE IN THE 3763 03:13:08,520 --> 03:13:13,160 ADDICTION FIELD THE FDA 3764 03:13:13,160 --> 03:13:16,880 QUALIFIER AND OUTCOME ASSES 3765 03:13:16,880 --> 03:13:18,200 ASSESSMENTS BEING CONSIDERED TO 3766 03:13:18,200 --> 03:13:23,360 BE DRUG DEVELOPMENT TOOLS. 3767 03:13:23,360 --> 03:13:25,280 WHY IS THIS IMPORTANT? 3768 03:13:25,280 --> 03:13:30,160 BECAUSE IT WOULD SPEED UP THE 3769 03:13:30,160 --> 03:13:34,400 REGULATORY REVIEW PROCESS AS 3770 03:13:34,400 --> 03:13:36,160 THERE WILL BE NO ASSESSMENTS 3771 03:13:36,160 --> 03:13:40,920 NEEDED TO ESTABLISH THE CLINICAL 3772 03:13:40,920 --> 03:13:42,800 OUTCOMES ASSESSMENTS IN EACH AND 3773 03:13:42,800 --> 03:13:44,800 EVERY DRUG DEVELOPMENT PROGRAM 3774 03:13:44,800 --> 03:13:50,080 THAT HAS ADDICTION END POINTS. 3775 03:13:50,080 --> 03:13:53,080 THIS IS TO SUPPORT THE 3776 03:13:53,080 --> 03:13:54,880 DEVELOPMENT OF THE CLINICAL 3777 03:13:54,880 --> 03:13:57,160 OUTCOME ASSESSMENTS FOR OPIOID 3778 03:13:57,160 --> 03:14:03,720 AND STIMULANT USE DISORDERS AND 3779 03:14:03,720 --> 03:14:07,640 FOLLOW THE FDA QUALIFICATION 3780 03:14:07,640 --> 03:14:08,320 PATHWAY OUTLINED WITH SPECIFIC 3781 03:14:08,320 --> 03:14:13,120 GUIDANCE. 3782 03:14:13,120 --> 03:14:15,960 >>WE DON'T DISCUSS THE 3783 03:14:15,960 --> 03:14:16,280 MECHANISMS. 3784 03:14:16,280 --> 03:14:18,320 IT'S JUST THE SCIENTIFIC CONCEPT 3785 03:14:18,320 --> 03:14:21,360 WHICH YOU LAID OUT VERY WELL. 3786 03:14:21,360 --> 03:14:24,120 >>THANK YOU VERY MUCH. 3787 03:14:24,120 --> 03:14:28,240 ALSO NOTE IT ALIGNS WITH THE 3788 03:14:28,240 --> 03:14:31,000 HEAL GOALS AND MISSION. 3789 03:14:31,000 --> 03:14:32,240 >>DID YOU HAVE A COMMENT? 3790 03:14:32,240 --> 03:14:35,320 >>I DID. 3791 03:14:35,320 --> 03:14:40,680 I WAS WONDERING IF THIS IS 3792 03:14:40,680 --> 03:14:41,960 DESPERATELY NED EDED AND WOULD 3793 03:14:41,960 --> 03:14:44,120 APPLY FOR POLY SUBSTANCE USE 3794 03:14:44,120 --> 03:14:44,360 DISORDER? 3795 03:14:44,360 --> 03:14:46,920 IT GETS COMPOUNDED THERE AND 3796 03:14:46,920 --> 03:14:48,360 OPIOID AND STIMULANT USE IS 3797 03:14:48,360 --> 03:14:49,880 COMBINED WITH OTHER SUBSTANCES. 3798 03:14:49,880 --> 03:14:52,360 I KNOW THAT'S A NIDA PRIORITY 3799 03:14:52,360 --> 03:14:53,760 BUT IT BECOMES A BIGGER ISSUE 3800 03:14:53,760 --> 03:14:57,600 WHEN WE START TO THINK OF 3801 03:14:57,600 --> 03:14:58,920 TREATMENT DEVELOPMENT IN PSUD 3802 03:14:58,920 --> 03:15:00,560 ANA. 3803 03:15:00,560 --> 03:15:00,800 >>YES. 3804 03:15:00,800 --> 03:15:10,400 VERY GOOD QUESTION. 3805 03:15:10,400 --> 03:15:14,280 THE DRUG DEVELOPMENT PROCESS IS 3806 03:15:14,280 --> 03:15:14,520 RIGOROUS. 3807 03:15:14,520 --> 03:15:16,680 IT TAKES TIME AND A TEAM WITH 3808 03:15:16,680 --> 03:15:17,920 FDA TO REVIEW THE PLAN, 3809 03:15:17,920 --> 03:15:23,400 ETCETERA. 3810 03:15:23,400 --> 03:15:27,800 THIS FOR US IS ONLY THE 3811 03:15:27,800 --> 03:15:28,040 BEGINNING. 3812 03:15:28,040 --> 03:15:29,120 WE WILL CERTAINLY CONTINUE AND 3813 03:15:29,120 --> 03:15:34,120 THE FUTURE GOAL TO BE ABLE TO 3814 03:15:34,120 --> 03:15:36,840 INCLUDE THE POLY SUBSTANCE USE 3815 03:15:36,840 --> 03:15:38,240 DISORDER RELEVANT END POINTS TOO 3816 03:15:38,240 --> 03:15:43,400 THE PROCESS THAT WOULD BE A HUGE 3817 03:15:43,400 --> 03:15:44,080 ACCOMPLISHMENT. 3818 03:15:44,080 --> 03:15:49,120 WE ARE GOING TO START FROM WHAT 3819 03:15:49,120 --> 03:15:52,080 IS SEEN AS KEY AND CURRENT OUD 3820 03:15:52,080 --> 03:15:57,640 AND STIMULANT USE DISORDERS AND 3821 03:15:57,640 --> 03:16:07,640 WE HOPE WE'LL BE ABLE TO HAVE 3822 03:16:07,640 --> 03:16:09,400 THE QUALIFICATION WITH TO THE 3823 03:16:09,400 --> 03:16:13,120 FIRST BUT WILL CONSIDER POLY 3824 03:16:13,120 --> 03:16:14,120 SUBSTANCE ONCE WE PUT OUR FOOT 3825 03:16:14,120 --> 03:16:14,640 IN THE DOOR. 3826 03:16:14,640 --> 03:16:15,880 >>THANK YOU VERY MUCH. 3827 03:16:15,880 --> 03:16:18,440 SORRY TO BE CUTTING YOU OFF BUT 3828 03:16:18,440 --> 03:16:19,120 I'M WORRIED ABOUT TIME. 3829 03:16:19,120 --> 03:16:21,720 WE'RE SUPPOSED TO BE FINISHED IN 3830 03:16:21,720 --> 03:16:24,760 TWO MINUTES AND HAVE ALL DNB AND 3831 03:16:24,760 --> 03:16:26,720 ENERGY CONTRACT. 3832 03:16:26,720 --> 03:16:27,920 UNLESS THERE'S ANY CONCERNS OR 3833 03:16:27,920 --> 03:16:33,120 OBJECTS I THINK WE SHOULD MOVE 3834 03:16:33,120 --> 03:16:34,360 ON TO DNB. 3835 03:16:34,360 --> 03:16:37,960 >>OKAY. 3836 03:16:37,960 --> 03:16:38,160 DA-YU. 3837 03:16:38,160 --> 03:16:40,040 >>THANK YOU. 3838 03:16:40,040 --> 03:16:40,520 GOOD AFTERNOON. 3839 03:16:40,520 --> 03:16:42,160 DNB HAS 10 CONCEPTS. 3840 03:16:42,160 --> 03:16:45,480 I'LL MAKE IT VERY BRIEF. 3841 03:16:45,480 --> 03:16:49,200 ONE, EX VIVO MODELS FOR THE 3842 03:16:49,200 --> 03:16:54,000 STUDY OF HIV AND POLY SUBSTANCE 3843 03:16:54,000 --> 03:16:54,160 USE. 3844 03:16:54,160 --> 03:16:59,520 THIS IS ELUCIDATING IMMUNE AND 3845 03:16:59,520 --> 03:17:07,360 PATHOPHYSIOLOGY USING EX VIVO 3846 03:17:07,360 --> 03:17:14,320 PLATFORMS FROM HUMAN INDUCED 3847 03:17:14,320 --> 03:17:16,320 PLURIPOTENT CELLS. 3848 03:17:16,320 --> 03:17:20,840 TWO, MECHANISM STUDIES ON THE 3849 03:17:20,840 --> 03:17:24,080 EFFECTS OF FIEZO SOCIAL STRESS 3850 03:17:24,080 --> 03:17:26,000 IN COMPLEX MORBIDITY INVOLVING 3851 03:17:26,000 --> 03:17:30,600 SUDs, PSYCHIATRIC DISORDERS AND 3852 03:17:30,600 --> 03:17:30,800 HIV. 3853 03:17:30,800 --> 03:17:33,400 THIS IS TO SUPPORT HUMAN 3854 03:17:33,400 --> 03:17:35,200 SUBJECTS AND ANIMAL MODEL 3855 03:17:35,200 --> 03:17:40,040 RESEARCH AIMING TO ELUCIDATE THE 3856 03:17:40,040 --> 03:17:42,080 NEUROCOGNITIVE AND 3857 03:17:42,080 --> 03:17:42,760 NEUROBIOLOGICAL MECHANISMS THAT 3858 03:17:42,760 --> 03:17:44,960 UNDER LIE THE ASSOCIATIONS 3859 03:17:44,960 --> 03:17:47,120 BETWEEN PSYCHOSOCIAL STRESS AND 3860 03:17:47,120 --> 03:17:50,040 SUDs, PSYCHIATRIC DISORDERS AND 3861 03:17:50,040 --> 03:17:55,160 HIV RELATED CNS PATHOLOGY. 3862 03:17:55,160 --> 03:17:56,880 THREE, EFFECTS OF HIV AND 3863 03:17:56,880 --> 03:17:59,920 SUBSTANCE USE COMORBIDITY ON THE 3864 03:17:59,920 --> 03:18:05,800 PLACENTA, ALSO BY SUNILA NAIR. 3865 03:18:05,800 --> 03:18:08,120 THIS IS TO TARGET THE 3866 03:18:08,120 --> 03:18:09,800 UNDERSTANDING OF THE EFFECTS OF 3867 03:18:09,800 --> 03:18:12,560 HIV ON THE GROWTH, DEVELOPMENT 3868 03:18:12,560 --> 03:18:16,040 AND FUNCTIONING OF THE PLACENTA 3869 03:18:16,040 --> 03:18:19,240 IN PREGNANT INDIVIDUALS WITH 3870 03:18:19,240 --> 03:18:21,680 SUBSTANCE USE, MISUSE AND THE 3871 03:18:21,680 --> 03:18:24,040 UNDERLYING MECHANISMS AND THE 3872 03:18:24,040 --> 03:18:27,240 IMPACT OF A PLACENTAL 3873 03:18:27,240 --> 03:18:29,200 ABNORMALITIES ON MATERNAL FETAL 3874 03:18:29,200 --> 03:18:33,800 AND OTHER NEONATAL OUTCOMES. 3875 03:18:33,800 --> 03:18:38,000 FOUR, INTERPLAY OF AUTOPHAGY 3876 03:18:38,000 --> 03:18:40,600 RELATED CELL DEATH AND HIV 3877 03:18:40,600 --> 03:18:45,160 PATHOGENESIS IN SUBSTANCE USE 3878 03:18:45,160 --> 03:18:49,120 DISORDERS BY ANNE TSAI. 3879 03:18:49,120 --> 03:18:51,680 FOCUSSING ON THE IMMUNE 3880 03:18:51,680 --> 03:18:53,160 RESPONSES OF SUBSTANCE USE IN 3881 03:18:53,160 --> 03:18:55,800 HIV DISEASE PROGRESSION WITH A 3882 03:18:55,800 --> 03:18:58,600 FOCUS ON THE INTERPLAY OF 3883 03:18:58,600 --> 03:19:01,160 AUTOPHAGY AND HIV IN EARLY 3884 03:19:01,160 --> 03:19:05,120 INFECTION AND REPLICATION. 3885 03:19:05,120 --> 03:19:12,320 FIVE, TARGETING INFLAMASOMES IN 3886 03:19:12,320 --> 03:19:13,960 HIV BY ANNE TSAI. 3887 03:19:13,960 --> 03:19:16,040 TO INVESTIGATE THE UNDERLYING 3888 03:19:16,040 --> 03:19:20,640 MECHANISMS IN CNS SEQUENCES OF 3889 03:19:20,640 --> 03:19:26,600 MYELOID CELL TRIGGERED IN 3890 03:19:26,600 --> 03:19:31,800 FLAMAS 3891 03:19:31,800 --> 03:19:34,040 FLAMASOME AND SUBSTANCE USE. 3892 03:19:34,040 --> 03:19:35,160 ANY QUESTIONS FOR THE FIRST 3893 03:19:35,160 --> 03:19:45,280 FIVE? 3894 03:19:46,960 --> 03:19:49,760 >>PLEASE GO AHEAD. 3895 03:19:49,760 --> 03:19:51,880 >>SIX, RESEARCH ON THE 3896 03:19:51,880 --> 03:19:54,520 NEUROIMMUNE AXIS IN THE CONTEXT 3897 03:19:54,520 --> 03:19:57,040 OF HIV AND SUBSTANCE USE. 3898 03:19:57,040 --> 03:20:03,480 THIS IS BY KIRA VEMURI. 3899 03:20:03,480 --> 03:20:05,400 TO ENCOURAGE RESEARCH FOR 3900 03:20:05,400 --> 03:20:09,080 IDENTIFYING BIOLOGICAL TARGETS 3901 03:20:09,080 --> 03:20:10,880 AND PATHWAYS THAT REGULATE 3902 03:20:10,880 --> 03:20:12,880 NEUROIMMUNE INTERACTIONS THAT 3903 03:20:12,880 --> 03:20:14,760 ARE AT THE INTERSECTION OF HIV 3904 03:20:14,760 --> 03:20:15,760 AND SUBSTANCE USE. 3905 03:20:15,760 --> 03:20:17,720 IT ALSO ENCOURAGES THE RESEARCH 3906 03:20:17,720 --> 03:20:19,920 TOWARDS THE DISCOVERY OF NOVEL 3907 03:20:19,920 --> 03:20:25,120 CHEMICAL ENTITIES THAT ARE 3908 03:20:25,120 --> 03:20:27,920 EFFECTIVE IN MITIGATING 3909 03:20:27,920 --> 03:20:30,440 CONDITIONS ASSOCIATED WITH HIV 3910 03:20:30,440 --> 03:20:32,800 AND SUBSTANCE USE INCLUDING HIV 3911 03:20:32,800 --> 03:20:33,480 ASSOCIATED NEUROCOGNITIVE 3912 03:20:33,480 --> 03:20:39,640 DISORDER, PAIN AND AGING. 3913 03:20:39,640 --> 03:20:40,720 SEVEN, CHEMICAL PROBES AND DRUGS 3914 03:20:40,720 --> 03:20:43,160 FOR MODULATING HIV TRANSCRIPTION 3915 03:20:43,160 --> 03:20:43,960 IN PEOPLE WITH SUBSTANCE USE 3916 03:20:43,960 --> 03:20:48,480 DISORDERS. 3917 03:20:48,480 --> 03:20:52,080 BY SAM ANATHAN. 3918 03:20:52,080 --> 03:20:53,840 THE FIRST IS TO IDENTIFICATION 3919 03:20:53,840 --> 03:20:58,880 OF TARGETS AND PANEL WAYS BY 3920 03:20:58,880 --> 03:21:01,120 WHICH TRANSCRIPTIONAL ACTIVITY 3921 03:21:01,120 --> 03:21:06,280 OF HIV CAN BE EXPRESSED IN HIV 3922 03:21:06,280 --> 03:21:06,920 RESERVOIRS INCLUDING PEOPLE WITH 3923 03:21:06,920 --> 03:21:09,880 SUD AND THE SECOND ONE IS 3924 03:21:09,880 --> 03:21:13,160 APPLICATION OF EMERGING SMALL 3925 03:21:13,160 --> 03:21:16,280 MOLECULE DRUG DISCOVERY 3926 03:21:16,280 --> 03:21:17,760 APPROACHES TO IDENTIFY NOVEL 3927 03:21:17,760 --> 03:21:19,720 COMPOUNDS THAT CAN BE UTILIZED 3928 03:21:19,720 --> 03:21:23,720 AS PHARMACOLOGIC PROBES AND AS 3929 03:21:23,720 --> 03:21:26,480 DRUGS TO SUPPRESS HIV 3930 03:21:26,480 --> 03:21:28,920 TRANSCRIPTION IN PEOPLE WITH 3931 03:21:28,920 --> 03:21:34,920 HIV, SUD, COMORBIDITY. 3932 03:21:34,920 --> 03:21:38,640 EIGHT, MICROGLIAL 3933 03:21:38,640 --> 03:21:40,920 PATHOPHYSIOLOGY IN HIV AND SUD 3934 03:21:40,920 --> 03:21:51,000 BY TRISTAN McCLURE-BEGLEY. 3935 03:21:51,000 --> 03:21:55,240 TO IDENTIFY MICROGLIAL PROTEIN 3936 03:21:55,240 --> 03:21:58,920 TYPES AND EMPHASIZING THE 3937 03:21:58,920 --> 03:21:59,920 MICROGLIAL PROTEIN EXPRESSION 3938 03:21:59,920 --> 03:22:03,240 AND POST TRANSLATIONAL 3939 03:22:03,240 --> 03:22:04,880 MODIFICATIONS IN THE BRAIN 3940 03:22:04,880 --> 03:22:06,360 REGIONS IN THE CONTEXT OF EACH 3941 03:22:06,360 --> 03:22:09,200 CONDITIONS ALONE OR WHEN 3942 03:22:09,200 --> 03:22:11,600 PRESENTED TOGETHER. 3943 03:22:11,600 --> 03:22:14,080 NINE, SCORCH. 3944 03:22:14,080 --> 03:22:16,640 SINGLE CELL OPIOID RESPONSES IN 3945 03:22:16,640 --> 03:22:20,440 THE CONTEXT OF HIV PROGRAM. 3946 03:22:20,440 --> 03:22:23,280 THIS IS FOR DATA COORDINATION, 3947 03:22:23,280 --> 03:22:25,880 ANALYSIS AND SCIENTIFIC OUTREACH 3948 03:22:25,880 --> 03:22:27,760 BY JOHN SATTERLEE. 3949 03:22:27,760 --> 03:22:31,040 AMONG OTHER THINGS THIS CONCEPT 3950 03:22:31,040 --> 03:22:33,680 SEEMS TO INGEST ADDITIONAL DATA 3951 03:22:33,680 --> 03:22:36,960 SETS FROM SCORCH DATA GENERATION 3952 03:22:36,960 --> 03:22:42,760 PROJECTS LINK THE MOLECULAR DATA 3953 03:22:42,760 --> 03:22:43,920 WITH APPROPRIATE METADATA 3954 03:22:43,920 --> 03:22:48,560 INCLUDING CLINICAL METADATA FROM 3955 03:22:48,560 --> 03:22:50,040 NATIONAL HIV TISSUE CONSORTIUM 3956 03:22:50,040 --> 03:22:53,200 AND OTHER BRAIN BANKS AND 3957 03:22:53,200 --> 03:22:53,840 SOURCES. 3958 03:22:53,840 --> 03:22:56,680 TEN, SCORCH, SINGLE CELL OPIOID 3959 03:22:56,680 --> 03:23:00,200 RESPONSES IN THE CONTEXT OF HIV 3960 03:23:00,200 --> 03:23:01,120 PROGRAM. 3961 03:23:01,120 --> 03:23:03,560 THIS IS FOR DATA MINING AND 3962 03:23:03,560 --> 03:23:04,520 FUNCTIONAL VALIDATION ALSO BY 3963 03:23:04,520 --> 03:23:10,920 JOHN SATTERLEE. 3964 03:23:10,920 --> 03:23:15,600 THE AIM IS TO IDENTIFY CELL 3965 03:23:15,600 --> 03:23:19,000 TYPES TRANSCRIPTS, ENHANCERS OR 3966 03:23:19,000 --> 03:23:22,440 TRANSCRIPTIONAL NETWORKS THAT 3967 03:23:22,440 --> 03:23:26,440 PLAY A ROLE IN HIV ARC OR SUD 3968 03:23:26,440 --> 03:23:28,120 MOLECULAR RESPONSES. 3969 03:23:28,120 --> 03:23:30,120 IT SUPPORTS FUNCTIONAL 3970 03:23:30,120 --> 03:23:33,400 VALIDATION STUDIES TO CONFIRM OR 3971 03:23:33,400 --> 03:23:37,520 DENY A BIOLOGICAL ROLE FOR DATA 3972 03:23:37,520 --> 03:23:41,480 MINED CELL TYPES, TRANSCRIPTS, 3973 03:23:41,480 --> 03:23:43,880 ENHANCERS OR TRANSCRIPTIONAL 3974 03:23:43,880 --> 03:23:45,120 NETWORKS IN HIV ART OR MOLECULAR 3975 03:23:45,120 --> 03:23:49,200 RESPONSES. 3976 03:23:49,200 --> 03:23:50,800 THESE ARE THE OTHER FIVE AND IF 3977 03:23:50,800 --> 03:24:01,200 YOU HAVE ANY QUESTIONS? 3978 03:24:04,760 --> 03:24:06,200 >>I'M NOT SEEING HANDS RAISED. 3979 03:24:06,200 --> 03:24:07,400 >>THEN I'M DONE. 3980 03:24:07,400 --> 03:24:09,520 >>THIS IS THE LAST CONCEPT FOR 3981 03:24:09,520 --> 03:24:10,920 A CONTRACT AND SO WE'LL NEED IT 3982 03:24:10,920 --> 03:24:15,320 GET A VOTE FROM YOU ON THIS AND 3983 03:24:15,320 --> 03:24:16,120 ELIZABETH HOFFMAN WILL BE 3984 03:24:16,120 --> 03:24:16,520 PRESENTING THIS. 3985 03:24:16,520 --> 03:24:17,920 >>I'LL BE QUICK. 3986 03:24:17,920 --> 03:24:21,800 THIS IS A CONCEPT TO SUPPORT 3987 03:24:21,800 --> 03:24:28,920 DATA SHARING PLATFORM FOR THE 3988 03:24:28,920 --> 03:24:34,400 ABCD STUDY. 3989 03:24:34,400 --> 03:24:39,200 AS YOU KNOW THE ABCD STUDY HAD 3990 03:24:39,200 --> 03:24:40,800 DATA BROADLY AVAILABLE TO THE 3991 03:24:40,800 --> 03:24:43,160 SCIENTIFIC COMMUNITY SINCE 2018. 3992 03:24:43,160 --> 03:24:44,920 THE DATA SET INCLUDES A VARIETY 3993 03:24:44,920 --> 03:24:50,160 OF DATA FROM DATA AND TO DATE 3994 03:24:50,160 --> 03:24:51,960 APPROXIMATELY 500 PAPERS HAVE 3995 03:24:51,960 --> 03:24:53,520 BEEN PUBLISHED USING THE DATA. 3996 03:24:53,520 --> 03:24:55,560 AS THE DATA COLLECTION HAS 3997 03:24:55,560 --> 03:24:57,920 PROGRESSED, THE AMOUNT AND TIMES 3998 03:24:57,920 --> 03:25:00,640 OF COMPLEXITY OF THE DATA HAVE 3999 03:25:00,640 --> 03:25:01,400 SIGNIFICANTLY INCREASED AND WILL 4000 03:25:01,400 --> 03:25:03,120 CONTINUE TO DO SO THROUGH THE 4001 03:25:03,120 --> 03:25:05,560 LIFE CYCLE OF THE STUDY AND THE 4002 03:25:05,560 --> 03:25:07,440 NICE OF THE COMMUNITY EVOLVED 4003 03:25:07,440 --> 03:25:09,480 WHERE AN ANALYTIC PLATFORM IS 4004 03:25:09,480 --> 03:25:12,440 CRITICAL TO FACILITATE THE USE 4005 03:25:12,440 --> 03:25:14,760 OF THE DATA FROM DIFFERENT 4006 03:25:14,760 --> 03:25:15,920 SCIENTISTS FROM DIFFERENT 4007 03:25:15,920 --> 03:25:16,920 BACKGROUNDS AND DIFFERENT LEVELS 4008 03:25:16,920 --> 03:25:18,360 OF EXPERTISE AND TRAINING. 4009 03:25:18,360 --> 03:25:20,200 THE CURRENT PLATFORM CAN NO 4010 03:25:20,200 --> 03:25:22,200 LONGER MEET THE NEEDS OR SCALE 4011 03:25:22,200 --> 03:25:22,920 AS THE DATA SET CONTINUES TO 4012 03:25:22,920 --> 03:25:26,960 GROW. 4013 03:25:26,960 --> 03:25:29,280 WHAT WE'RE LOOKING FOR IS A DATA 4014 03:25:29,280 --> 03:25:31,200 SHARING PLATFORM OPTIMIZED FOR 4015 03:25:31,200 --> 03:25:33,120 GENOMICS AND OTHER COMPLEX DATA 4016 03:25:33,120 --> 03:25:35,240 AND FLEXIBLE BY DESIGN. 4017 03:25:35,240 --> 03:25:37,120 PLATFORM ALSO MUST PROVIDE 4018 03:25:37,120 --> 03:25:46,760 MULTIPLE WAYS TO ACCESS AND 4019 03:25:46,760 --> 03:25:48,080 ANALYZE THE DATA AND SUPPORTING 4020 03:25:48,080 --> 03:25:51,120 A PLATFORM THAT'S WELL SUITED TO 4021 03:25:51,120 --> 03:25:52,960 SHARING MYRIAD COMPLEX DATA 4022 03:25:52,960 --> 03:25:55,320 TYPES INCLUDING NEUROIMAGING AND 4023 03:25:55,320 --> 03:25:56,560 GENOMICS AND INTEGRATED DATA 4024 03:25:56,560 --> 03:26:00,360 ANALYSIS TO ENSURE THE STUDIES 4025 03:26:00,360 --> 03:26:01,680 CONTINUITY FOR THE FUTURE AS 4026 03:26:01,680 --> 03:26:04,160 WELL AS A HOMOGENOUS SOLUTION 4027 03:26:04,160 --> 03:26:06,920 FOR PLANNED DATA FROM THE 4028 03:26:06,920 --> 03:26:09,240 HEALTHY BRAIN AND CHILD STUDY. 4029 03:26:09,240 --> 03:26:12,640 THANKS. 4030 03:26:12,640 --> 03:26:13,720 >>ANY COMMENTS OR QUESTIONS 4031 03:26:13,720 --> 03:26:14,640 BEFORE WE TAKE A VOTE? 4032 03:26:14,640 --> 03:26:19,040 >>I HAVE A QUICK QUESTION. 4033 03:26:19,040 --> 03:26:20,280 IS THIS A CONTRACT? 4034 03:26:20,280 --> 03:26:24,120 >>YES, IT IS A CONTRACT. 4035 03:26:24,120 --> 03:26:25,320 THAT'S WHY WE NEED A VOTE. 4036 03:26:25,320 --> 03:26:25,920 >>GOT IT. 4037 03:26:25,920 --> 03:26:32,440 >>ANY OTHER QUESTIONS. 4038 03:26:32,440 --> 03:26:33,120 -- ANY OTHER QUESTIONS? 4039 03:26:33,120 --> 03:26:40,920 MOTION TO AAPPRPPRAPPROVE? 4040 03:26:40,920 --> 03:26:41,160 SECOND. 4041 03:26:41,160 --> 03:26:44,840 ANYBODY DISAPPROVE? 4042 03:26:44,840 --> 03:26:46,920 THANK YOU ALL VERY MUCH. 4043 03:26:46,920 --> 03:26:51,680 ANNAROSE YOU HAD A QUESTION? 4044 03:26:51,680 --> 03:26:53,520 >>NOPE, JUST TRYING TO GET MY 4045 03:26:53,520 --> 03:26:54,560 HAND DOWN. 4046 03:26:54,560 --> 03:26:57,360 >>DENNIS, DID YOU HAVE A 4047 03:26:57,360 --> 03:26:58,520 QUESTION? 4048 03:26:58,520 --> 03:27:01,960 >>NO, JUST FOR MY VOTE. 4049 03:27:01,960 --> 03:27:02,160 OKAY. 4050 03:27:02,160 --> 03:27:04,040 THANKS VERY MUCH, ELIZABETH. 4051 03:27:04,040 --> 03:27:06,200 THE LAST PART OF THIS IS 4052 03:27:06,200 --> 03:27:08,280 SUPPOSED TO BE PUBLIC COMMENTS. 4053 03:27:08,280 --> 03:27:09,840 WE DID NOT RECEIVE ANY COMMENTS 4054 03:27:09,840 --> 03:27:10,720 AHEAD OF TIME. 4055 03:27:10,720 --> 03:27:11,840 IF THERE ARE PEOPLE WHO ARE 4056 03:27:11,840 --> 03:27:13,440 WATCHING THIS AND WANT TO SEND 4057 03:27:13,440 --> 03:27:17,040 COMMENTS, YOU HAVE 10 DAYS FROM 4058 03:27:17,040 --> 03:27:21,200 TODAY TO SEND COMMENTS WHICH WE 4059 03:27:21,200 --> 03:27:21,680 WILL READ AND CONSIDER. 4060 03:27:21,680 --> 03:27:25,120 I WILL TURN IT BACK OVER TO NORA 4061 03:27:25,120 --> 03:27:28,200 TO THANK YOU ALL AND BID YOU 4062 03:27:28,200 --> 03:27:28,480 FAREWELL. 4063 03:27:28,480 --> 03:27:38,760 GO AHEAD, NORA. 4064 03:27:45,000 --> 03:27:50,640 >>I WANTED TO THANK ALL THE 4065 03:27:50,640 --> 03:27:51,960 COUNCIL MEMBERS FOR ALL THEIR 4066 03:27:51,960 --> 03:27:53,480 INPUT AND GREAT PRESENTATIONS 4067 03:27:53,480 --> 03:27:54,280 MADE BY EVERYONE. 4068 03:27:54,280 --> 03:28:00,520 AND THANK YOU, SUSAN AND KATHY 4069 03:28:00,520 --> 03:28:02,920 FOR MAKING THIS POSSIBLE. 4070 03:28:02,920 --> 03:28:06,160 I HOPE AS WE GO ALONG THERE WILL 4071 03:28:06,160 --> 03:28:08,080 BE AN OPPORTUNITY TO GET 4072 03:28:08,080 --> 03:28:13,400 TOGETHER IN A REAL PLACE AND 4073 03:28:13,400 --> 03:28:13,920 DISCUSS. 4074 03:28:13,920 --> 03:28:15,160 SOMETIMES I FEEL THERE'S ISSUES 4075 03:28:15,160 --> 03:28:15,880 THAT COME ABOUT. 4076 03:28:15,880 --> 03:28:21,720 WE RELIED ULTIMATELY ON YOUR 4077 03:28:21,720 --> 03:28:27,880 INPUT AND WARE REPRESENTING 4078 03:28:27,880 --> 03:28:29,080 CONCEPTS BASICALLY THESE ARE 4079 03:28:29,080 --> 03:28:33,640 DRIVEN BY MULTIPLE SOURCES BUT 4080 03:28:33,640 --> 03:28:36,240 WANT TO BE CERTAIN COUNCIL IS 4081 03:28:36,240 --> 03:28:38,440 INVOLVED WITH THEM. 4082 03:28:38,440 --> 03:28:40,000 WHETHER WE ARE IN CONSULT 4083 03:28:40,000 --> 03:28:41,080 OFFICIALLY OR NOT REACH OUT IF 4084 03:28:41,080 --> 03:28:44,640 YOU HAVE SUGGESTIONS HOW TO MOVE 4085 03:28:44,640 --> 03:28:45,040 FORWARD. 4086 03:28:45,040 --> 03:28:49,800 AGAIN, THANKS VERY MUCH FOR ALL 4087 03:28:49,800 --> 03:28:51,640 YOUR PARTICIPATION AND WORK TO 4088 03:28:51,640 --> 03:28:54,840 ENSURE THE SCIENCE OF NIDA IS AS 4089 03:28:54,840 --> 03:28:56,840 RIGOROUS AND IMPACTFUL AND 4090 03:28:56,840 --> 03:28:59,800 EQUITABLE AS POSSIBLE. 4091 03:28:59,800 --> 03:29:01,920 THANKS VERY MUCH AND I WISH YOU 4092 03:29:01,920 --> 03:29:04,240 I NICE DAY. 4093 03:29:04,240 --> 03:29:06,680 >>AND OUR PLAN SO FAR IS TO 4094 03:29:06,680 --> 03:29:08,720 HAVE THE NEXT COUNCIL MEETING IN 4095 03:29:08,720 --> 03:29:10,640 PERSON OR HYBRID IN MAY AND 4096 03:29:10,640 --> 03:29:14,560 THAT'S THE TWO-DAY MEETING. 4097 03:29:14,560 --> 03:29:16,920 WE HOPE WE WILL BE ABLE TO SEE 4098 03:29:16,920 --> 03:29:17,360 YOU ALL. 4099 03:29:17,360 --> 03:29:22,200 THANKS SO MUCH FOR ALL OF YOUR 4100 03:29:22,200 --> 03:29:25,120 TIME AND FOR YOUR VERY HELPFUL 4101 03:29:25,120 --> 03:29:25,320 INPUT. 4102 03:29:25,320 --> 03:29:35,680 >>GOOD-BYE, EVERYONE.